24_F_S5617_SC_V09 INT_24_1011613_C_Final_3_i
Medicare Prescription Drug Plans
2024 Cigna Healthcare
Comprehensive Drug List
(Formulary)
Please read:
This document contains information about
all of the drugs we cover in this plan.
Plan covered
Cigna Healthcare Secure Rx (PDP)
HPMS Approved Formulary File Submission 00024185, Version Number 20.
This formulary was updated on 9/1/2024. For more recent information or other questions, please contact Cigna Healthcare Customer
Service, at 1-800-222-6700 (TTY users should call 711), 8 a.m. - 8 p.m. local time, 7 days a week. Our automated phone system may
answer your call during weekends from April 1 - September 30, or visit CignaMedicare.com.
The Formulary and pharmacy network may change at any time.
September 2024
September 2024 1
Note to existing customers: This formulary has changed since last year. Please review this document to make sure
that it still contains the drugs you take.
When this drug list (formulary) refers to “we,” “us,” or “our,” it means Cigna Healthcare. When it refers to “plan” or
“our plan,” it means Cigna Healthcare Secure Rx (PDP).
This document includes a list of the drugs (formulary) for our plans, which is current as of September 2024. For an
updated formulary, please contact us. Our contact information, along with the date we last updated the formulary,
appears on the front and back cover pages.
You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, pharmacy
network, and/or copayments/coinsurance may change on January 1, 2025, and from time to time during the year.
What is the Cigna Healthcare Comprehensive Drug List?
A drug list is a list of covered drugs selected by Cigna
Healthcare in consultation with a team of health care providers,
which represents the prescription therapies believed to be a
necessary part of a quality treatment program. Cigna Healthcare
will generally cover the drugs listed in our drug list as long as
the drug is medically necessary, the prescription is filled at a
Cigna Healthcare network pharmacy, and other plan rules are
followed. For more information on how to fill your prescriptions,
please review your Evidence of Coverage (EOC).
Can the Drug List (formulary) change?
Most changes in drug coverage happen on January 1, but we
may add or remove drugs on the drug list during the year, move
them to different cost-sharing tiers, or add new restrictions. We
must follow Medicare rules in making these changes.
Changes that can affect you this year. In the below cases,
you will be affected by coverage changes during the year:
New generic drugs. We may immediately remove a brand
name drug on our drug list if we are replacing it with a new
generic drug that will appear on the same or lower cost-
sharing tier and with the same or fewer restrictions. Also,
when adding the new generic drug, we may decide to keep
the brand name drug on our drug list, but immediately move
it to a different cost-sharing tier or add new restrictions. If you
are currently taking that brand name drug, we may not tell
you in advance before we make that change, but we will later
provide you with information about the specific change(s) we
have made.
If we make such a change, you or your prescriber can ask
us to make an exception and continue to cover the brand
name drug for you. The notice we provide you will also
include information on how to request an exception, and
you can also find information in the section entitled “How do
I request an exception to the Cigna Healthcare Drug List?”
Drugs removed from the market. If the Food and Drug
Administration (FDA) deems a drug on our drug list to be
unsafe or the drug’s manufacturer removes the drug from the
market, we will immediately remove the drug from our drug
list and provide notice to customers who take the drug.
Other changes. We may make other changes that affect
customers currently taking a drug. For instance, we may
add a generic drug that is not new to the market to replace
a brand name drug currently on the drug list, or add new
restrictions to the brand name drug or move it to a different
cost-sharing tier or both. Or we may make changes based
on new clinical guidelines and/or studies. If we remove drugs
from our drug list, add prior authorization, quantity limits, and/
or step therapy restrictions on a drug or move a drug to a
higher cost-sharing tier, we must notify affected customers
of the change at least 30 days before the change becomes
effective, or at the time the customer requests a refill of the
drug, at which time the customer will receive a 30-day supply
of the drug.
If we make these other changes, you or your prescriber
can ask us to make an exception and continue to cover the
brand name drug for you. The notice we provide you will
also include information on how to request an exception,
and you can find information in the section below titled
“How do I request an exception to the Cigna Healthcare
Drug List?”
Changes that will not affect you if you are currently taking
the drug. Generally, if you are taking a drug on our 2024 drug
list that was covered at the beginning of the year, we will not
discontinue or reduce coverage of the drug during the 2024
coverage year except as described above. This means these
drugs will remain available at the same cost-sharing and with
September 2024 2
no new restrictions for those customers taking them for the
remainder of the coverage year. You will not get direct notice
this year about changes that do not affect you. However, on
January 1 of the next year, such changes would affect you, and
it is important to check the drug list for the new benefit year for
any changes to drugs.
The enclosed drug list is current as of September 2024. To
get updated information about the drugs covered by Cigna
Healthcare, please contact us. Our contact information appears
on the front and back cover pages. If there are significant
changes made to the printed drug list within the covered year,
you may be notified by mail identifying the changes. Drug lists
located on our website are reviewed and updated on a monthly
basis.
How do I use the Drug List?
There are two ways to find your drug within the drug list:
Medical Condition
The drug list begins on page 10. The drugs in this drug list
are grouped into categories depending on the type of medical
conditions that they are used to treat. For example, drugs
used to treat a heart condition are listed under the category,
“CARDIOVASCULAR, HYPERTENSION / LIPIDS.” If you know
what your drug is used for, look for the category name in the list
that begins on page 10. Then look under the category name for
your drug.
Covered Drug Index
If you are not sure what category to look under, you should look
for your drug in the Covered Drugs Index that begins on page
58. The Covered Drugs Index provides an alphabetical list of all
of the drugs included in this document. Both brand name drugs
and generic drugs are listed in the Index. Look in the Index and
find your drug. Next to your drug, you will see the page number
where you can find coverage information. Turn to the page
listed in the Covered Drug Index and find the name of your drug
in the drug name column of the list.
What are generic drugs?
Cigna Healthcare covers both brand name drugs and generic
drugs. A generic drug is approved by the FDA as having the
same active ingredient as the brand name drug. Generally,
generic drugs cost less than brand name drugs.
Are there any restrictions on my coverage?
Some covered drugs may have additional requirements or limits
on coverage. These requirements and limits may include:
Prior Authorization: Cigna Healthcare requires you or your
doctor to get prior authorization for certain drugs. This means
that you will need to get approval from Cigna Healthcare
before you fill these prescriptions. If you don’t get approval,
Cigna Healthcare may not cover the drug.
Quantity Limits: For certain drugs, Cigna Healthcare limits
the amount of the drug that Cigna Healthcare will cover. For
example, Cigna Healthcare allows for 1 tablet per day for
atorvastatin 40mg. This applies to a standard one-month
supply (for total quantity of 30 per 30 days) or three-month
supply (for total quantity of 90 per 90 days).
Step Therapy: In some cases, Cigna Healthcare requires you
to first try certain drugs to treat your medical condition before
we will cover another drug for that condition. For example, if
Drug A and Drug B both treat your medical condition, Cigna
Healthcare may not cover Drug B unless you try Drug A first.
If Drug A does not work for you, Cigna Healthcare will then
cover Drug B.
Non-Extended Days Supply: For certain drugs, Cigna
Healthcare limits the amount of the drug that Cigna
Healthcare will cover to only a 30-day supply or less, at
one time. For example, customers who have not had any
recent fill of opioid pain medications within the past 108 days
(referred to as “opioid naïve”) are limited to a maximum of 7
days’ supply of opioid pain medication. Customers who have
received a recent fill of an opioid pain medication (not opioid
naïve) are limited to up to a month’s supply of that medication
at one time. Other high cost drugs may be subject to a non-
extended day supply restriction, as well.
You can find out if your drug has any additional requirements
or limits by looking in the drug list that begins on page 10. You
can also get more information about the restrictions applied to
specific covered drugs by visiting our website. We have posted
online documents that explain our prior authorization and step
therapy restrictions. You may also ask us to send you a copy.
Our contact information, along with the date we last updated the
drug list, appears on the front and back cover pages.
You can ask Cigna Healthcare to make an exception to these
restrictions or limits or for a list of other, similar drugs that may
treat your health condition. See the section, “How do I request
an exception to the Cigna Healthcare drug list?” on page 3 for
information about how to request an exception.
September 2024 3
Options for Maintenance Medications
Taking the medications prescribed by your doctor (or other
prescriber) is important to your health.
We are committed to helping you control your chronic conditions
by making it easy for you to receive your maintenance
medications. There are several ways we can work together
to accomplish this goal:
Talk with your doctor about whether a 90-day supply of your
ongoing, stable medications may be appropriate. Taking
these medications every day as prescribed is important for
your overall health, and getting 90-day prescriptions of these
medications can help ensure that you do not miss a dose.
You can receive a 90-day supply at most retail pharmacies or
through one of our mail-order pharmacies.
Talk to your pharmacist if you are experiencing any new
challenges with your maintenance medications.
How can I use my prescription drug coverage to save
money on my medications?
There may be opportunities for you to save money on your
medications using your Cigna Healthcare coverage.
Ask your doctor (or other prescriber) if there are any lower-
cost generic alternatives available for any of your current
medications.
Some plans may offer a $0 copay for Tier 1 generic drugs
filled at a preferred retail and/or mail-order pharmacies.
Check the Drug Tier and Cost-share Tables on page 6 to see
if your plan offers these savings.
Explore whether the ‘CMS Extra Help’ program may offer
additional financial support for your medications.
If your medication is not covered in the Cigna Healthcare drug
list, talk with your doctor about alternative medications which
are covered on the drug list.
What if my drug is not on the Drug List?
If your drug is not included in this drug list, you should first
contact Customer Service and ask if your drug is covered. If
you learn that Cigna Healthcare does not cover your drug, you
have two options:
You can ask Customer Service for a list of similar drugs that
are covered by Cigna Healthcare. When you receive the list,
show it to your doctor and ask them to prescribe a similar
drug that is covered by Cigna Healthcare.
You can ask Cigna Healthcare to make an exception and
cover your drug. See the next section for information about
how to request an exception.
How do I request an exception to the Cigna Healthcare
Drug List?
You can ask Cigna Healthcare to make an exception to our
coverage rules. There are several types of exceptions that you
can ask us to make.
You can ask us to cover a drug even if it is not on our drug
list. If approved, this drug will be covered at a pre-determined
cost-sharing level, and you would not be able to ask us to
provide the drug at a lower cost-sharing level.
You can ask us to waive coverage restrictions or limits on
your drug. For example, for certain drugs, Cigna Healthcare
limits the amount of the drug that we will cover. If your drug
has a quantity limit, you can ask us to waive the limit and
cover a greater amount.
You can ask us to cover a formulary drug at a lower cost-
sharing level, unless the drug is on the specialty tier. If
approved, this would lower the amount you must pay for
your drug. This applies to the following circumstances:
If the drug you’re taking is a brand name drug, you can
ask us to cover your drug at the cost-sharing amount
that applies to the lowest tier that contains brand name
alternatives for treating your condition.
If the drug you’re taking is a generic drug, you can ask us
to cover your drug at the cost-sharing amount that applies
to the lowest tier that contains either brand or generic
alternatives for treating your condition.
If the drug you’re taking is a biological product, you can
ask us to cover your drug at the cost-sharing amount that
applies to the lowest tier that contains biological product
alternatives for treating your condition.
Please note, if we grant your request to cover a drug that is
not on our drug list, you may not ask us to provide this drug
at a lower cost-sharing level.
Generally, Cigna Healthcare will only approve your request for
an exception if the alternative drug is included in our drug list,
the lower cost-sharing drug or additional utilization restrictions
would not be as effective in treating your condition and/or would
cause you to have adverse medical effects.
You should contact us to ask us for an initial coverage decision
for a drug list, tiering or utilization restriction exception. When
you request a drug list, tiering or utilization restriction
exception you should submit a statement from your
prescriber or doctor supporting your request. Generally,
we must make our decision within 72 hours of getting your
prescriber’s supporting statement. You can request an
expedited (fast) exception if you or your doctor believe that your
September 2024 4
health could be seriously harmed by waiting up to 72 hours for
a decision. If your request to expedite is granted, we must give
you a decision no later than 24 hours after we get a supporting
statement from your doctor or other prescriber.
What do I do before I can talk to my doctor about changing
my drugs or requesting an exception?
As a new or existing customer in our plan you may be taking
drugs that are not on our drug list. Or, you may be taking a drug
that is on our drug list but your ability to get it is limited. For
example, you may need a prior authorization from us before
you can fill your prescription. You should talk to your doctor
to decide if you should switch to an appropriate drug that we
cover or request a drug list exception so that we will cover the
drug you take. While you talk to your doctor to determine the
right course of action for you, we may cover your drug up to a
30-day supply, in certain cases during the first 90 days you are
a customer of our plan.
For each of your drugs that is not on our drug list or if your
ability to get your drugs is limited, we will cover a temporary
30-day supply. If your prescription is written for fewer days,
we’ll allow refills to provide up to a maximum 30-day supply of
medication. After your first 30-day supply, we will not pay for
these drugs without a drug list exception, even if you have been
a customer of the plan less than 90 days.
If you are a resident of a long-term care facility and you need a
drug that is not on our drug list or if your ability to get your drugs
is limited, but you are past the first 90 days of membership in
our plan, we will cover a 31-day emergency supply of that drug
while you pursue a drug list exception.
In order to accommodate unexpected transitions of our
customers that do not leave time for advanced planning, such
as level-of-care changes due to discharge from a hospital to a
nursing facility or to a home, Cigna Healthcare will allow a one-
time 31-day supply (unless the prescription is written for fewer
days).
Cigna Healthcare’s Drug List
The comprehensive drug list that begins on page 10 provides
coverage information about all of the drugs covered by Cigna
Healthcare. If you have trouble finding your drug in the list, turn
to the Covered Drug Index that begins on page 58.
The first column of the chart lists the drug name. Brand name
drugs are capitalized (e.g., TRELEGY ELLIPTA) and generic
drugs are listed in lower-case italics (e.g., atorvastatin).
The information in the Requirements/Limits column tells you if
Cigna Healthcare has any special requirements for coverage of
your drug.
We provide quantity limits on certain drugs which are indicated
with a QL in the Covered Drugs by Category list on page 10
along with the amount dispensed per the days supplied. (For
example: atorvastatin 40mg QL 30/30; this means the drug
atorvastatin 40mg is limited to 30 tablets per 30 days. For 90-
day supplies, this quantity limit would be expanded to 90 tablets
per 90 days).
(TTY 711), or you can visit CignaMedicare.com for the most
current Pharmacy Directory.
For more information
For more detailed information about your Cigna Healthcare prescription drug coverage, please review your Evidence of
Coverage (EOC) and other plan materials. To access a copy of your most recent EOC, go to CignaMedicare.com.
If you have questions about Cigna Healthcare, please contact us. Our contact information, along with the date we last updated
the drug list, appears on the front and back cover pages.
If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800-MEDICARE
(1-800-633-4227), 24 hours a day, 7 days a week. TTY users should call 1-877-486-2048. Or, visit http://www.medicare.gov.
What is a preferred network pharmacy?
If your plan has preferred network pharmacies, you will typically
save money by using these pharmacies. Your prescription
drug costs (like a copay or coinsurance) will typically be less
at a preferred network pharmacy because it has a preferred
agreement with your plan. If you need help finding a network
pharmacy, please call Customer Service at 1-800-222-6700
September 2024 5
Drug Tier and Cost-Share Table
The following table represents the plan service area, the drug
tier number as it appears on the drug list, and the cost-share
amount for that tier number. Tier 1 is for Preferred Generic
drugs. Tier 2 is for Generic drugs. Tier 3 is for Preferred Brand
drugs. Tier 4 is for Non-Preferred drugs. Tier 5 is for Specialty
tier drugs. Please refer to the following chart. You may also refer
to your Evidence of Coverage (EOC) document for additional
details.
Cigna Healthcare is not always able to keep all generic
medications in the Preferred Generic and Generic drug tiers.
Some generic medications may be in Tier 3, Tier 4, or Tier 5.
Keep in mind that the name “Tier 3: Preferred Brand Drugs”
isjust a description of the majority of the drugs in the tier. It does
not mean that there are only brand drugs in that tier.
For customers receiving Extra Help: Your Low Income
Subsidy (LIS) copay level will be based on how the Food
and Drug Administration (FDA) classifies certain drugs. Due
to this, a generic drug may receive a preferred brand copay,
or a preferred brand drug may receive a generic drug copay.
Please see your LIS Rider for additional information on these
copay levels. Or call Customer Service for further clarification
regarding a specific drug.
Locate your drug cost
To locate your drug cost, please refer to the table(s) on the next few pages to find your service area and the
Prescription Drug plan in which you are currently enrolled or would like to enroll.
If you qualified for Extra Help with your drug costs, your costs may be different from those described in these tables.
Please refer to your Evidence of Coverage (EOC) or call Customer Service to find out what your costs are.
Cigna Healthcare uses preferred network pharmacies. See your Pharmacy Directory or visit CignaMedicare.com to
search for a preferred retail or mail-order pharmacy near you.
For insulins that are covered by our plans, you will pay only $35 for each 30-day script and $0 for each covered adult vaccine.
Long-term care (LTC) and home infusion pharmacies use standard pharmacy cost-sharing. For LTC you can get up to a 31-day supply.
At an out-of-network pharmacy you will pay the in-network pharmacy copay or percentage of the cost plus the amount that the out of
network pharmacy billed charges are higher than our typical standard retail pharmacy billed charges. If you receive Extra Help, these
costs do not apply. You typically pay only a low copay.
September 2024 6
Preferred
Retail Cost-sharing
30 day supply
60 and 90-day copays are
2x and 3x the 30-day copays
Regional States Tier 1 Tier 2 Tier 3 Tier 4 Tier 5
Northern NE (NH,ME) $0 $3 16% 42% 25%
Central NE (CT, MA, RI, VT) $0 $3 16% 46% 25%
New York $0 $3 16% 42% 25%
New Jersey $0 $3 16% 45% 25%
Mid-Atlantic (DE, DC, MD) $0 $3 16% 42% 25%
Pennsylvania, West Virginia $0 $3 16% 42% 25%
Virginia $0 $3 17% 48% 25%
North Carolina $0 $3 17% 47% 25%
South Carolina $0 $3 17% 46% 25%
Georgia $0 $3 17% 46% 25%
Florida $0 $3 17% 43% 25%
Alabama, Tennessee $0 $3 17% 46% 25%
Michigan $0 $3 16% 42% 25%
Ohio $0 $3 16% 43% 25%
Indiana, Kentucky $0 $3 16% 46% 25%
Wisconsin $0 $2 16% 40% 25%
Illinois $0 $3 17% 48% 25%
Missouri $0 $3 16% 47% 25%
Arkansas $0 $3 16% 42% 25%
Mississippi $0 $3 16% 43% 25%
Louisiana $0 $3 16% 42% 25%
Texas $0 $3 16% 48% 25%
Oklahoma $0 $3 16% 46% 25%
Kansas $0 $3 16% 43% 25%
Upper MW and N. Plains* $0 $3 16% 47% 25%
New Mexico $0 $3 16% 42% 25%
Colorado $0 $3 16% 41% 25%
Arizona $0 $3 16% 42% 25%
Nevada $0 $3 16% 43% 25%
Oregon, Washington $0 $3 16% 41% 25%
Idaho, Utah $0 $3 16% 43% 25%
California $0 $3 16% 40% 25%
Hawaii $0 $3 17% 42% 25%
Alaska $0 $3 17% 41% 25%
Puerto Rico $0 $3 19% 50% 25%
*IA, MN, MT, ND, NE, SD, WY associated with the regional states of Upper MW and N. Plains.
September 2024 7
Standard
Retail Cost-sharing
30 day supply
60 and 90-day copays are
2x and 3x the 30-day copays
Regional States Tier 1 Tier 2 Tier 3 Tier 4 Tier 5
Northern NE (NH,ME) $4 $8 16% 43% 25%
Central NE (CT, MA, RI, VT) $4 $8 16% 46% 25%
New York $3 $7 16% 43% 25%
New Jersey $4 $8 16% 46% 25%
Mid-Atlantic (DE, DC, MD) $4 $8 16% 43% 25%
Pennsylvania, West Virginia $4 $8 16% 43% 25%
Virginia $4 $10 17% 48% 25%
North Carolina $4 $10 17% 48% 25%
South Carolina $4 $10 17% 47% 25%
Georgia $4 $10 17% 47% 25%
Florida $4 $10 17% 44% 25%
Alabama, Tennessee $4 $10 17% 46% 25%
Michigan $3 $7 16% 42% 25%
Ohio $4 $10 17% 44% 25%
Indiana, Kentucky $4 $9 17% 47% 25%
Wisconsin $2 $7 16% 40% 25%
Illinois $4 $10 17% 48% 25%
Missouri $4 $10 17% 48% 25%
Arkansas $4 $10 17% 43% 25%
Mississippi $4 $10 17% 43% 25%
Louisiana $4 $7 17% 43% 25%
Texas $4 $10 17% 48% 25%
Oklahoma $4 $10 17% 46% 25%
Kansas $4 $8 17% 43% 25%
Upper MW and N. Plains* $4 $10 17% 47% 25%
New Mexico $4 $10 17% 42% 25%
Colorado $4 $8 17% 42% 25%
Arizona $4 $10 17% 42% 25%
Nevada $4 $9 17% 44% 25%
Oregon, Washington $4 $8 17% 42% 25%
Idaho, Utah $4 $8 17% 43% 25%
California $2 $7 17% 40% 25%
Hawaii $4 $9 17% 42% 25%
Alaska $4 $10 17% 42% 25%
Puerto Rico $4 $10 20% 50% 25%
*IA, MN, MT, ND, NE, SD, WY associated with the regional states of Upper MW and N. Plains.
September 2024 8
Preferred
Mail-order Cost-sharing
90 day supply
Regional States
Northern NE (NH,ME)
Central NE (CT, MA, RI, VT)
New York
New Jersey
Mid-Atlantic (DE, DC, MD)
Pennsylvania, West Virginia
Virginia
North Carolina
South Carolina
Georgia
Florida
Alabama, Tennessee
Michigan
Ohio
Indiana, Kentucky
Wisconsin
Illinois
Missouri
Arkansas
Mississippi
Louisiana
Texas
Oklahoma
Kansas
Upper MW and N. Plains*
New Mexico
Colorado
Arizona
Nevada
Oregon, Washington
Idaho, Utah
California
Hawaii
Alaska
Puerto Rico
$0 copay Tier 1
$3 copay Tier 2 ($2 in Wisconsin)
All other drug Tiers,
see Preferred Retail chart.
*IA, MN, MT, ND, NE, SD, WY associated with the regional states of Upper MW and N. Plains.
September 2024 9
Drug List Table of Contents:
The drugs on the drug list are grouped into categories depending on the type of medical condition they are used to treat.
If you know what your drug is used for, look for the category name in the list below. Then look under the category name
within the drug list for your drug.
Page
ANTI - INFECTIVES ...................................................................................................................................................................10
ANTINEOPLASTIC / IMMUNOSUPPRESSANT DRUGS ........................................................................................................16
AUTONOMIC / CNS DRUGS, NEUROLOGY / PSYCH ...........................................................................................................23
CARDIOVASCULAR, HYPERTENSION / LIPIDS ....................................................................................................................33
DERMATOLOGICALS/TOPICAL THERAPY ...........................................................................................................................36
DIAGNOSTICS / MISCELLANEOUS AGENTS ........................................................................................................................39
EAR, NOSE / THROAT MEDICATIONS ....................................................................................................................................40
ENDOCRINE/DIABETES ...........................................................................................................................................................40
GASTROENTEROLOGY ...........................................................................................................................................................44
IMMUNOLOGY, VACCINES / BIOTECHNOLOGY ...................................................................................................................46
MISCELLANEOUS SUPPLIES .................................................................................................................................................47
MUSCULOSKELETAL / RHEUMATOLOGY ............................................................................................................................48
OBSTETRICS / GYNECOLOGY ...............................................................................................................................................50
OPHTHALMOLOGY ..................................................................................................................................................................53
RESPIRATORY AND ALLERGY ...............................................................................................................................................54
UROLOGICALS .........................................................................................................................................................................56
VITAMINS, HEMATINICS / ELECTROLYTES ..........................................................................................................................56
Drug List Key:
B/D This prescription drug has a Part B versus D
administrative prior authorization requirement. This drug
may be covered under Medicare Part B or D depending on
circumstances.
LALimited Availability. This prescription may be available
only at certain pharmacies. For more information consult
your Pharmacy Directory or call Cigna Healthcare Customer
Service, at 1-800-222-6700 (TTY users should call 711),
8 a.m. – 8 p.m. local time, 7 days a week. Our automated
phone system may answer your call during weekends from
April 1 – September 30, or visit CignaMedicare.com.
NDS – Non-extended day supply medication. This drug is
only available for a one month supply.
PAThis drug requires prior authorization
QL – This drug has quantity limits
ST – This drug has step therapy requirements
V This vaccine is provided at no cost when used based on
recommendations by the Centers for Disease Control and
Prevention’s (CDC) Advisory Committee on Immunization
Practices (ACIP).
Generally all medications on the drug list are available
through mail-order, except when special circumstances
or situations prohibit mailing a particular medication to
your home.
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
10
September 2024
Covered Drugs By Category
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ANTI - INFECTIVES
ANTIFUNGAL AGENTS
ABELCET 4 PA
amphotericin b 4 PA
amphotericin b liposome 5 PA; NDS
caspofungin intravenous recon
soln 50 mg
5 PA; NDS
caspofungin intravenous recon
soln 70 mg
4 PA
clotrimazole mucous
membrane
3
CRESEMBA ORAL 4
uconazole in nacl (iso-osm) 4 PA
uconazole oral suspension for
reconstitution
3
uconazole oral tablet 2
ucytosine 5 NDS
griseofulvin microsize 4
griseofulvin ultramicrosize 4
itraconazole oral capsule 4 QL (120/30)
itraconazole oral solution 4
ketoconazole oral 3
nystatin oral 3
posaconazole oral tablet,
delayed release (dr/ec)
5 QL (96/30); NDS
terbinane hcl oral 2
voriconazole intravenous 4 PA
voriconazole oral suspension
for reconstitution
5 NDS
voriconazole oral tablet 4
ANTIVIRALS
abacavir oral solution 3 QL (960/30)
abacavir oral tablet 4 QL (60/30)
abacavir-lamivudine 3 QL (30/30)
acyclovir oral capsule 2
acyclovir oral suspension
200 mg/5 ml
4
acyclovir oral tablet 2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
acyclovir sodium intravenous
solution
4 B/D PA
amantadine hcl 3
APRETUDE 4
APTIVUS 4 QL (120/30)
atazanavir oral capsule
150 mg, 300 mg
4 QL (30/30)
atazanavir oral capsule 200 mg 4 QL (60/30)
BARACLUDE ORAL
SOLUTION
4 QL (630/30)
BIKTARVY 5 NDS
CABENUVA 4
CIMDUO 4
COMPLERA 4 QL (30/30)
darunavir oral tablet 600 mg 5 QL (60/30); NDS
darunavir oral tablet 800 mg 5 QL (30/30); NDS
DELSTRIGO 4
DESCOVY 4 QL (30/30)
DOVATO 5 NDS
EDURANT 4 QL (30/30)
efavirenz oral capsule 200 mg 4 QL (120/30)
efavirenz oral capsule 50 mg 4 QL (180/30)
efavirenz oral tablet 4 QL (30/30)
efavirenz-emtricitabin-tenofov 5 QL (30/30); NDS
efavirenz-lamivu-tenofov disop
oral tablet 400-300-300 mg
4 QL (30/30)
efavirenz-lamivu-tenofov disop
oral tablet 600-300-300 mg
4
emtricitabine 3 QL (30/30)
emtricitabine-tenofovir (tdf)
oral tablet 100-150 mg,
167-250 mg, 200-300 mg
4 QL (30/30)
emtricitabine-tenofovir (tdf) oral
tablet 133-200 mg
5 QL (30/30); NDS
EMTRIVA ORAL SOLUTION 3 QL (680/28)
entecavir 4 QL (30/30)
EPCLUSA ORAL PELLETS IN
PACKET 150-37.5 MG
5 PA; QL (28/28);
NDS
Covered Drugs By Category
*$0 cost share for Paxlovid
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
11
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
EPCLUSA ORAL PELLETS IN
PACKET 200-50 MG
5 PA; QL (56/28);
NDS
EPCLUSA ORAL TABLET
200-50 MG
5 PA; QL (56/28);
NDS
EPCLUSA ORAL TABLET
400-100 MG
5 PA; QL (28/28);
NDS
etravirine 4 QL (60/30)
EVOTAZ 4 QL (30/30)
famciclovir 4 QL (60/30)
fosamprenavir 5 QL (120/30); NDS
FUZEON SUBCUTANEOUS
RECON SOLN
5 QL (60/30); NDS
HARVONI ORAL PELLETS IN
PACKET 33.75-150 MG
5 PA; QL (28/28);
NDS
HARVONI ORAL PELLETS IN
PACKET 45-200 MG
5 PA; QL (56/28);
NDS
HARVONI ORAL TABLET
45-200 MG
5 PA; QL (56/28);
NDS
HARVONI ORAL TABLET
90-400 MG
5 PA; QL (28/28);
NDS
INTELENCE ORAL TABLET
25 MG
4 QL (120/30)
ISENTRESS HD 5 NDS
ISENTRESS ORAL POWDER
IN PACKET
4 QL (60/30)
ISENTRESS ORAL TABLET 5 QL (120/30); NDS
ISENTRESS ORAL TABLET,
CHEWABLE 100 MG
5 QL (180/30); NDS
ISENTRESS ORAL TABLET,
CHEWABLE 25 MG
3 QL (180/30)
JULUCA 5 NDS
LAGEVRIO (EUA) 3 QL (40/180)
lamivudine oral solution 3 QL (900/30)
lamivudine oral tablet 100 mg,
300 mg
3 QL (30/30)
lamivudine oral tablet 150 mg 3 QL (60/30)
lamivudine-zidovudine 3 QL (60/30)
LEXIVA ORAL SUSPENSION 4 QL (1575/28)
lopinavir-ritonavir oral solution 4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
lopinavir-ritonavir oral tablet
100-25 mg
4 QL (300/30)
lopinavir-ritonavir oral tablet
200-50 mg
4 QL (120/30)
maraviroc oral tablet 150 mg 5 QL (60/30); NDS
maraviroc oral tablet 300 mg 5 QL (120/30); NDS
MAVYRET ORAL PELLETS IN
PACKET
5 PA; QL (168/28);
NDS
MAVYRET ORAL TABLET 5 PA; QL (84/28);
NDS
nevirapine oral suspension 4 QL (1200/30)
nevirapine oral tablet 3 QL (60/30)
nevirapine oral tablet extended
release 24 hr 100 mg
4 QL (90/30)
nevirapine oral tablet extended
release 24 hr 400 mg
4 QL (30/30)
NORVIR ORAL POWDER IN
PACKET
4
ODEFSEY 4 QL (30/30)
oseltamivir oral capsule 3
oseltamivir oral suspension for
reconstitution
4
PAXLOVID ORAL TABLETS,
DOSE PACK 150-100 MG
3 QL (20/180)
PAXLOVID ORAL TABLETS,
DOSE PACK 300 MG (150 MG
X 2)-100 MG
3 QL (30/180)
PIFELTRO 4
PREVYMIS 5 QL (30/30); NDS
PREZCOBIX 4 QL (30/30)
PREZISTA ORAL
SUSPENSION
5 QL (400/30); NDS
PREZISTA ORAL TABLET
150 MG
4 QL (240/30)
PREZISTA ORAL TABLET
75 MG
4 QL (480/30)
RETROVIR INTRAVENOUS 4
REYATAZ ORAL POWDER IN
PACKET
5 QL (240/30); NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
12
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ribavirin oral capsule 3
ribavirin oral tablet 200 mg 3
rimantadine 4
ritonavir 3 QL (360/30)
RUKOBIA 5 NDS
SELZENTRY ORAL
SOLUTION
5 NDS
SELZENTRY ORAL TABLET
25 MG
4
SELZENTRY ORAL TABLET
75 MG
5 NDS
STRIBILD 5 QL (30/30); NDS
SUNLENCA 5 NDS
SYMTUZA 4
tenofovir disoproxil fumarate 4 QL (30/30)
TIVICAY ORAL TABLET
10 MG
4 QL (60/30)
TIVICAY ORAL TABLET
25 MG, 50 MG
5 QL (60/30); NDS
TIVICAY PD 4 QL (180/30)
TRIUMEQ 4 QL (30/30)
TRIUMEQ PD 4 QL (300/30)
TRIZIVIR 5 QL (60/30); NDS
TROGARZO 5 NDS
valacyclovir oral tablet 1 gram 3 QL (120/30)
valacyclovir oral tablet 500 mg 3 QL (60/30)
valganciclovir oral recon soln 5 NDS
valganciclovir oral tablet 3
VEKLURY 5 QL (4/180); NDS
VEMLIDY 5 NDS
VIRACEPT ORAL TABLET
250 MG
4 QL (270/30)
VIRACEPT ORAL TABLET
625 MG
4 QL (120/30)
VIREAD ORAL POWDER 5 QL (240/30); NDS
VIREAD ORAL TABLET
150 MG, 200 MG, 250 MG
5 QL (30/30); NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
VOSEVI 5 PA; QL (28/28);
NDS
XOFLUZA ORAL TABLET
40 MG, 80 MG
4
zidovudine oral capsule 4 QL (180/30)
zidovudine oral syrup 4 QL (1680/28)
zidovudine oral tablet 2 QL (60/30)
CEPHALOSPORINS
cefaclor oral capsule 4
cefaclor oral suspension for
reconstitution 125 mg/5 ml,
250 mg/5 ml, 375 mg/5 ml
4
cefaclor oral tablet extended
release 12 hr
4
cefadroxil oral capsule 3
cefadroxil oral suspension for
reconstitution 250 mg/5 ml,
500 mg/5 ml
3
cefadroxil oral tablet 3
CEFAZOLIN IN DEXTROSE
(ISO-OS) INTRAVENOUS
PIGGYBACK 1 GRAM/50 ML,
2 GRAM/100 ML,
2 GRAM/50 ML
4
cefazolin injection recon soln
1 gram, 10 gram, 100 gram,
3 gram, 300 gram, 500 mg
4
CEFAZOLIN INJECTION
RECON SOLN 2 GRAM
4
cefazolin intravenous recon
soln 1 gram, 3 gram
4
CEFAZOLIN INTRAVENOUS
RECON SOLN 2 GRAM
4
cefdinir 4
CEFEPIME IN DEXTROSE 5% 4
CEFEPIME IN DEXTROSE,
ISO-OSM
4
cefepime injection 4
cefepime intravenous 4 PA
cexime 4
cefotetan injection 4 PA
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
13
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
cefoxitin 4 PA
CEFOXITIN IN DEXTROSE,
ISO-OSM
4 PA
cefpodoxime 4
cefprozil 3
ceftazidime 4 PA
ceftriaxone 4
ceftriaxone in dextrose, iso-os 4
cefuroxime axetil oral tablet 3
cefuroxime sodium injection
recon soln 750 mg
4 PA
cefuroxime sodium intravenous 4 PA
cephalexin oral capsule
250 mg, 500 mg
2
cephalexin oral suspension for
reconstitution
2
tazicef 4 PA
TEFLARO 4 PA
ERYTHROMYCINS / OTHER MACROLIDES
azithromycin intravenous 4 PA
AZITHROMYCIN ORAL
PACKET
3
azithromycin oral suspension
for reconstitution
4
azithromycin oral tablet 2
clarithromycin 4
DIFICID ORAL SUSPENSION
FOR RECONSTITUTION
5 QL (136/10); NDS
DIFICID ORAL TABLET 5 QL (20/10); NDS
erythrocin (as stearate) oral
tablet 250 mg
4
erythrocin intravenous recon
soln 500 mg
4 PA
erythromycin ethylsuccinate
oral suspension for
reconstitution 200 mg/5 ml
4
erythromycin oral capsule,
delayed release (dr/ec)
4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
erythromycin oral tablet 4
MISCELLANEOUS ANTIINFECTIVES
albendazole 5 NDS
amikacin injection solution
1,000 mg/4 ml, 500 mg/2 ml
4 PA
ARIKAYCE 4 PA; LA
atovaquone 4
atovaquone-proguanil 4
aztreonam 4 PA
bacitracin intramuscular 4
CAYSTON 5 PA; LA; QL (84/28);
NDS
chloramphenicol sod succinate 4
chloroquine phosphate 3
clindamycin hcl 2
CLINDAMYCIN IN 0.9%
SOD CHLOR
4 PA
CLINDAMYCIN IN 5%
DEXTROSE
4 PA
clindamycin palmitate hcl 4
clindamycin pediatric 4
clindamycin phosphate
injection
4 PA
COARTEM 4 QL (24/30)
colistin (colistimethate na) 4 PA
cycloserine 4
dapsone oral 3
daptomycin 5 NDS
DAPTOMYCIN IN 0.9%
SOD CHLOR
5 NDS
emverm 4
ertapenem 4
ethambutol 4
FIRVANQ 4 QL (450/10)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
14
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
gentamicin in nacl (iso-osm)
intravenous piggyback
100 mg/100 ml, 100 mg/50 ml,
120 mg/100 ml, 60 mg/50 ml,
80 mg/100 ml, 80 mg/50 ml
4 PA
gentamicin injection solution
40 mg/ml
4 PA
gentamicin sulfate (ped) (pf) 4 PA
hydroxychloroquine 3
imipenem-cilastatin 4
isoniazid oral solution 4
isoniazid oral tablet 2
ivermectin oral 3 PA
lincomycin 4 PA
linezolid in dextrose 5% 4 PA
linezolid oral suspension for
reconstitution
5 QL (1800/30); NDS
linezolid oral tablet 3 QL (60/30)
LINEZOLID-0.9% SODIUM
CHLORIDE
4 PA
meoquine 3
meropenem intravenous recon
soln 1 gram, 500 mg
4
MEROPENEM-0.9% SODIUM
CHLORIDE
4
METRO I.V. 4 PA
metronidazole in nacl (iso-os) 4 PA
metronidazole oral tablet 2
neomycin 2
nitazoxanide 5 QL (20/10); NDS
paromomycin 4
pentamidine inhalation 3 B/D PA; QL (1/28)
pentamidine injection 4
praziquantel 4
PRIFTIN 4
primaquine 4
pyrazinamide 4
pyrimethamine 5 PA; NDS
quinine sulfate 4 PA; QL (42/7)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
rifabutin 4
rifampin 4
SIRTURO 4 PA; LA
SIVEXTRO INTRAVENOUS 5 PA; QL (6/28); NDS
SIVEXTRO ORAL 5 QL (6/28); NDS
streptomycin 4 PA
tigecycline 5 PA; NDS
tobramycin in 0.225% nacl 5 B/D PA; QL
(280/28); NDS
tobramycin sulfate 4 PA
TRECATOR 3
VANCOMYCIN IN 0.9%
SODIUM CHL INTRAVENOUS
PIGGYBACK
4
VANCOMYCIN IN DEXTROSE
5% INTRAVENOUS
PIGGYBACK 1 GRAM/200 ML,
500 MG/100 ML,
750 MG/150 ML
4
vancomycin injection 4
vancomycin intravenous recon
soln 1,000 mg, 1.25 gram,
1.5 gram, 10 gram, 5 gram,
500 mg, 750 mg
4
vancomycin oral capsule
125 mg
4 PA; QL (40/10)
vancomycin oral capsule
250 mg
4 PA; QL (80/10)
vancomycin oral recon soln
25 mg/ml
4 QL (450/10)
VANCOMYCIN-DILUENT
COMBO NO.1
4
XIFAXAN ORAL TABLET
200 MG
4 PA; QL (9/30)
XIFAXAN ORAL TABLET
550 MG
5 PA; QL (90/30);
NDS
PENICILLINS
amoxicillin oral capsule 2
amoxicillin oral suspension for
reconstitution
2
amoxicillin oral tablet 2
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
15
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
amoxicillin oral tablet,
chewable 125 mg, 250 mg
2
amoxicillin-pot clavulanate oral
suspension for reconstitution
200-28.5 mg/5 ml,
400-57 mg/5 ml,
600-42.9 mg/5 ml
2
amoxicillin-pot clavulanate oral
suspension for reconstitution
250-62.5 mg/5 ml
4
amoxicillin-pot clavulanate oral
tablet
2
amoxicillin-pot clavulanate oral
tablet extended release 12 hr
4
amoxicillin-pot clavulanate oral
tablet, chewable 200-28.5 mg
2
amoxicillin-pot clavulanate oral
tablet, chewable 400-57 mg
4
ampicillin oral capsule 500 mg 2
ampicillin sodium 4 PA
ampicillin-sulbactam 4 PA
BICILLIN L-A 4 PA
dicloxacillin 2
EXTENCILLINE 4 PA
NAFCILLIN IN DEXTROSE
ISO-OSM INTRAVENOUS
PIGGYBACK 2 GRAM/100 ML
4 PA
nafcillin injection 4 PA
oxacillin 4 PA
penicillin g potassium 4 PA
penicillin v potassium 2
pzerpen-g 4 PA
piperacillin-tazobactam 4
QUINOLONES
ciprooxacin hcl oral tablet
100 mg
4
ciprooxacin hcl oral tablet
250 mg, 500 mg, 750 mg
2
ciprooxacin in 5% dextrose 4 PA
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ciprooxacin oral suspension,
microcapsule recon
500 mg/5 ml
4
levooxacin in d5w 4 PA
levooxacin oral solution 4
levooxacin oral tablet 2
moxioxacin oral 4
MOXIFLOXACIN-SOD.ACE,
SUL-WATER
4 PA
moxioxacin-sod.chloride (iso) 4 PA
SULFA'S / RELATED AGENTS
sulfadiazine 4
sulfamethoxazole-trimethoprim
intravenous
4 PA
sulfamethoxazole-trimethoprim
oral suspension
4
sulfamethoxazole-trimethoprim
oral tablet
2
TETRACYCLINES
doxy-100 4 PA
doxycycline hyclate
intravenous
4 PA
doxycycline hyclate oral
capsule
4
doxycycline hyclate oral tablet
100 mg, 20 mg
4
doxycycline monohydrate oral
capsule 100 mg, 50 mg
3
doxycycline monohydrate oral
suspension for reconstitution
4
doxycycline monohydrate oral
tablet
3
minocycline oral capsule 2
tetracycline oral capsule 4
URINARY TRACT AGENTS
methenamine hippurate 4
nitrofurantoin monohyd/m-cryst 3
trimethoprim 2
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
16
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
VANCOMYCIN
VANCOMYCIN IN
DEXTROSE 5%
INTRAVENOUS PIGGYBACK
1.25 GRAM/250 ML,
1.5 GRAM/300 ML
4
ANTINEOPLASTIC / IMMUNOSUPPRESSANT DRUGS
ADJUNCTIVE AGENTS
leucovorin calcium injection 4
leucovorin calcium oral tablet
10 mg, 15 mg, 25 mg
4
leucovorin calcium oral tablet
5 mg
3
mesna 4 B/D PA
MESNEX ORAL 5 NDS
XGEVA 5 PA; QL (1.7/28);
NDS
ANTINEOPLASTIC / IMMUNOSUPPRESSANT DRUGS
abiraterone oral tablet 250 mg 4 PA; QL (120/30)
abiraterone oral tablet 500 mg 4 PA; QL (60/30)
ABRAXANE 5 PA; NDS
ADCETRIS 4 PA
adstiladrin 5 PA; QL (4/90); NDS
AKEEGA 5 PA; QL (60/30);
NDS
ALECENSA 5 PA; QL (240/30);
NDS
ALIQOPA 5 PA; NDS
ALUNBRIG ORAL TABLET
180 MG, 90 MG
5 PA; QL (30/30);
NDS
ALUNBRIG ORAL TABLET
30 MG
5 PA; QL (60/30);
NDS
ALUNBRIG ORAL TABLETS,
DOSE PACK
5 PA; QL (60/365);
NDS
anastrozole 2
ANKTIVA 5 PA; NDS
arsenic trioxide 4 B/D PA
AUGTYRO 5 PA; QL (240/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
AYVAKIT 5 PA; LA; QL (30/30);
NDS
azacitidine 4 B/D PA
azathioprine oral tablet 50 mg 2 B/D PA
azathioprine sodium 4 B/D PA
BALVERSA 5 PA; LA; NDS
BAVENCIO 5 PA; NDS
BELEODAQ 4 B/D PA
bendamustine 5 B/D PA; NDS
BENDEKA 5 B/D PA; NDS
BESPONSA 5 PA; NDS
bexarotene 5 PA; NDS
bicalutamide 3
BLENREP 4 PA
bleomycin 4 B/D PA
BLINCYTO INTRAVENOUS
KIT
4 B/D PA
BORTEZOMIB INJECTION 5 PA; NDS
BOSULIF ORAL CAPSULE
100 MG
5 PA; QL (90/30);
NDS
BOSULIF ORAL CAPSULE
50 MG
5 PA; QL (30/30);
NDS
BOSULIF ORAL TABLET
100 MG
5 PA; QL (90/30);
NDS
BOSULIF ORAL TABLET
400 MG, 500 MG
5 PA; QL (30/30);
NDS
BRAFTOVI 5 PA; LA; QL
(180/30); NDS
BRUKINSA 5 PA; LA; NDS
busulfan 5 B/D PA; NDS
CABOMETYX 5 PA; LA; QL (30/30);
NDS
CALQUENCE 5 PA; LA; QL (60/30);
NDS
CALQUENCE
(ACALABRUTINIB MAL)
5 PA; LA; QL (60/30);
NDS
CAPRELSA ORAL TABLET
100 MG
5 PA; LA; QL (60/30);
NDS
CAPRELSA ORAL TABLET
300 MG
5 PA; LA; QL (30/30);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
17
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
carboplatin intravenous
solution
4 B/D PA
carmustine intravenous recon
soln 100 mg
4 B/D PA
cisplatin intravenous solution 4 B/D PA
cladribine 4 B/D PA
clofarabine 4 B/D PA
COLUMVI 5 PA; QL (30/21);
NDS
COMETRIQ ORAL CAPSULE
100 MG/DAY (80 MG
X1-20 MG X1)
5 PA; QL (56/28);
NDS
COMETRIQ ORAL CAPSULE
140 MG/DAY (80 MG
X1-20 MG X3)
5 PA; QL (112/28);
NDS
COMETRIQ ORAL CAPSULE
60 MG/DAY (20 MG X 3/DAY)
5 PA; QL (84/28);
NDS
COPIKTRA 5 PA; LA; QL (60/30);
NDS
COTELLIC 5 PA; LA; QL (63/28);
NDS
cyclophosphamide intravenous
recon soln
5 B/D PA; NDS
CYCLOPHOSPHAMIDE
INTRAVENOUS SOLUTION
5 B/D PA; NDS
cyclophosphamide oral capsule 3 B/D PA
cyclophosphamide oral tablet
25 mg
3 B/D PA
CYCLOPHOSPHAMIDE ORAL
TABLET 50 MG
3 B/D PA
cyclosporine intravenous 4 B/D PA
cyclosporine modied 4 B/D PA
cyclosporine oral capsule 4 B/D PA
CYRAMZA 5 PA; NDS
cytarabine 4 B/D PA
cytarabine (pf) 4 B/D PA
dacarbazine 4 B/D PA
dactinomycin 4 B/D PA
DANYELZA 4 PA
DARZALEX 5 PA; NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
DARZALEX FASPRO 5 PA; NDS
daunorubicin 4 B/D PA
DAURISMO ORAL TABLET
100 MG
5 PA; QL (30/30);
NDS
DAURISMO ORAL TABLET
25 MG
5 PA; QL (60/30);
NDS
decitabine 4 B/D PA
docetaxel 4 B/D PA
doxorubicin intravenous recon
soln 50 mg
4 B/D PA
doxorubicin intravenous
solution
4 B/D PA
doxorubicin, peg-liposomal 4 B/D PA
DROXIA 4
ELREXFIO 5 PA; NDS
ELZONRIS 5 PA; NDS
EMPLICITI 4 PA
ENHERTU 5 PA; NDS
ENVARSUS XR 4 B/D PA
epirubicin intravenous solution 4 B/D PA
EPKINLY 4 PA
ERBITUX 4 B/D PA
eribulin 5 PA; NDS
ERIVEDGE 5 PA; QL (30/30);
NDS
ERLEADA 5 PA; QL (120/30);
NDS
erlotinib oral tablet 100 mg,
150 mg
5 PA; QL (30/30);
NDS
erlotinib oral tablet 25 mg 5 PA; QL (60/30);
NDS
ETOPOPHOS 4 B/D PA
etoposide intravenous 3 B/D PA
everolimus (antineoplastic) oral
tablet
5 PA; QL (30/30);
NDS
everolimus (antineoplastic) oral
tablet for suspension 2 mg
5 PA; QL (150/30);
NDS
everolimus (antineoplastic) oral
tablet for suspension 3 mg,
5 mg
5 PA; QL (56/28);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
18
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
everolimus
(immunosuppressive) oral
tablet 0.25 mg
4 B/D PA
everolimus
(immunosuppressive) oral
tablet 0.5 mg, 0.75 mg, 1 mg
5 B/D PA; NDS
EVOMELA 5 PA; NDS
exemestane 4
FARYDAK 5 PA; QL (6/21); NDS
FIRMAGON KIT W DILUENT
SYRINGE
4 B/D PA
oxuridine 4 B/D PA
udarabine 4 B/D PA
uorouracil intravenous 4 B/D PA
FOLOTYN 5 B/D PA; NDS
FOTIVDA 5 PA; LA; QL (21/28);
NDS
FRUZAQLA ORAL CAPSULE
1 MG
5 PA; QL (84/28);
NDS
FRUZAQLA ORAL CAPSULE
5 MG
5 PA; QL (21/28);
NDS
fulvestrant 5 B/D PA; NDS
FYARRO 4 PA; LA
GAVRETO 5 PA; LA; QL
(120/30); NDS
GAZYVA 5 PA; NDS
getinib 5 PA; QL (30/30);
NDS
gemcitabine intravenous recon
soln
4 B/D PA
gemcitabine intravenous
solution 1 gram/26.3 ml
(38 mg/ml), 2 gram/52.6 ml
(38 mg/ml), 200 mg/5.26 ml
(38 mg/ml)
4 B/D PA
GEMCITABINE
INTRAVENOUS SOLUTION
100 MG/ML
4 B/D PA
gengraf 4 B/D PA
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
GILOTRIF 5 PA; QL (30/30);
NDS
GLEOSTINE 4
HALAVEN 5 PA; NDS
hydroxyurea 2
IBRANCE 5 PA; QL (21/28);
NDS
ICLUSIG 5 PA; QL (30/30);
NDS
idarubicin 4 B/D PA
IDHIFA 5 PA; LA; QL (30/30);
NDS
ifosfamide intravenous recon
soln 1 gram
4 B/D PA
IFOSFAMIDE INTRAVENOUS
RECON SOLN 3 GRAM
4 B/D PA
ifosfamide intravenous solution 4 B/D PA
imatinib oral tablet 100 mg 5 PA; QL (180/30);
NDS
imatinib oral tablet 400 mg 5 PA; QL (60/30);
NDS
IMBRUVICA ORAL CAPSULE
140 MG
5 PA; QL (120/30);
NDS
IMBRUVICA ORAL CAPSULE
70 MG
5 PA; QL (30/30);
NDS
IMBRUVICA ORAL
SUSPENSION
5 PA; QL (324/30);
NDS
IMBRUVICA ORAL TABLET
140 MG, 280 MG, 420 MG
5 PA; QL (30/30);
NDS
IMDELLTRA 4 PA
IMFINZI 5 PA; NDS
IMJUDO 5 PA; LA; NDS
INFUGEM 5 B/D PA; NDS
INLYTA ORAL TABLET 1 MG 5 PA; QL (180/30);
NDS
INLYTA ORAL TABLET 5 MG 5 PA; QL (120/30);
NDS
INQOVI 5 PA; QL (5/28); NDS
INREBIC 5 PA; LA; QL
(120/30); NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
19
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
irinotecan 4 B/D PA
IWILFIN 5 PA; LA; QL
(240/30); NDS
IXEMPRA 4 B/D PA
JAKAFI 5 PA; QL (60/30);
NDS
JAYPIRCA 5 PA; NDS
JEMPERLI 4 PA
JEVTANA 4 B/D PA
JYLAMVO 5 PA; NDS
KADCYLA 5 PA; NDS
KANJINTI 5 PA; NDS
KEYTRUDA 5 PA; NDS
KIMMTRAK 4 PA
KISQALI FEMARA CO-PACK
ORAL TABLET 200 MG/
DAY(200 MG X 1)-2.5 MG
5 PA; QL (49/28);
NDS
KISQALI FEMARA CO-PACK
ORAL TABLET 400 MG/
DAY(200 MG X 2)-2.5 MG
5 PA; QL (70/28);
NDS
KISQALI FEMARA CO-PACK
ORAL TABLET 600 MG/
DAY(200 MG X 3)-2.5 MG
5 PA; QL (91/28);
NDS
KISQALI ORAL TABLET
200 MG/DAY (200 MG X 1)
5 PA; QL (21/28);
NDS
KISQALI ORAL TABLET
400 MG/DAY (200 MG X 2)
5 PA; QL (42/28);
NDS
KISQALI ORAL TABLET
600 MG/DAY (200 MG X 3)
5 PA; QL (63/28);
NDS
KLISYRI 4 ST; QL (5/30)
KOSELUGO ORAL CAPSULE
10 MG
5 PA; QL (240/30);
NDS
KOSELUGO ORAL CAPSULE
25 MG
5 PA; QL (120/30);
NDS
KRAZATI 5 PA; QL (180/30);
NDS
KYPROLIS 5 B/D PA; NDS
lapatinib 5 PA; QL (180/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
lenalidomide 5 PA; QL (28/28);
NDS
LENVIMA ORAL CAPSULE
10 MG/DAY (10 MG X 1), 4 MG
5 PA; QL (30/30);
NDS
LENVIMA ORAL CAPSULE
12 MG/DAY (4 MG X 3),
18 MG/DAY (10 MG X 1-4 MG
X2), 24 MG/DAY (10 MG X
2-4 MG X 1)
5 PA; QL (90/30);
NDS
LENVIMA ORAL CAPSULE
14 MG/DAY (10 MG X 1-4 MG
X 1), 20 MG/DAY (10 MG X 2),
8 MG/DAY (4 MG X 2)
5 PA; QL (60/30);
NDS
letrozole 2
LEUKERAN 4
leuprolide (3 month) 4 PA
leuprolide subcutaneous kit 4 PA
LIBTAYO 5 PA; NDS
LONSURF ORAL TABLET
15-6.14 MG
5 PA; QL (100/28);
NDS
LONSURF ORAL TABLET
20-8.19 MG
5 PA; QL (80/28);
NDS
LOQTORZI 5 PA; NDS
LORBRENA ORAL TABLET
100 MG
5 PA; QL (30/30);
NDS
LORBRENA ORAL TABLET
25 MG
5 PA; QL (90/30);
NDS
LUMAKRAS ORAL TABLET
120 MG
5 PA; QL (240/30);
NDS
LUMAKRAS ORAL TABLET
320 MG
5 PA; QL (90/30);
NDS
LUNSUMIO 5 PA; LA; NDS
LUPRON DEPOT 5 PA; NDS
LUPRON DEPOT (3 MONTH) 4 PA
LUPRON DEPOT (4 MONTH) 4 PA
LUPRON DEPOT (6 MONTH) 4 PA
LUPRON DEPOT-
PED (3 MONTH)
INTRAMUSCULAR SYRINGE
KIT 11.25 MG
4 PA
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
20
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
LUPRON DEPOT-
PED (3 MONTH)
INTRAMUSCULAR SYRINGE
KIT 30 MG
5 PA; NDS
LUPRON DEPOT-PED
INTRAMUSCULAR KIT
5 PA; NDS
LUPRON DEPOT-PED
INTRAMUSCULAR SYRINGE
KIT
4 PA
LYNPARZA 5 PA; QL (120/30);
NDS
LYSODREN 5 NDS
LYTGOBI ORAL TABLET
12 MG/DAY (4 MG X 3)
5 PA; LA; QL (90/30);
NDS
LYTGOBI ORAL TABLET
16 MG/DAY (4 MG X 4)
5 PA; LA; QL
(120/30); NDS
LYTGOBI ORAL TABLET
20 MG/DAY (4 MG X 5)
5 PA; LA; QL
(150/30); NDS
MARGENZA 5 PA; NDS
MATULANE 5 NDS
megestrol oral suspension
400 mg/10 ml (10 ml),
400 mg/10 ml (40 mg/ml),
800 mg/20 ml (20 ml)
4 PA
megestrol oral tablet 20 mg 4 PA
megestrol oral tablet 40 mg 3 PA
MEKINIST ORAL RECON
SOLN
5 PA; QL (1350/30);
NDS
MEKINIST ORAL TABLET
0.5 MG
5 PA; QL (90/30);
NDS
MEKINIST ORAL TABLET
2 MG
5 PA; QL (30/30);
NDS
MEKTOVI 5 PA; LA; QL
(180/30); NDS
melphalan hcl 5 B/D PA; NDS
mercaptopurine 4
methotrexate sodium (pf) 4 B/D PA
methotrexate sodium injection 4 B/D PA
methotrexate sodium oral 3
mitomycin intravenous 4 B/D PA
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
mitoxantrone 4 B/D PA
MONJUVI 4 PA
MVASI 5 PA; NDS
mycophenolate mofetil (hcl) 4 B/D PA
mycophenolate mofetil oral
capsule
3 B/D PA
mycophenolate mofetil oral
suspension for reconstitution
5 B/D PA; NDS
mycophenolate mofetil oral
tablet
4 B/D PA
mycophenolate sodium 4 B/D PA
MYLOTARG 5 PA; NDS
nelarabine 4 B/D PA
NERLYNX 5 PA; LA; NDS
NEXAVAR 5 PA; QL (120/30);
NDS
nilutamide 5 NDS
NINLARO 5 PA; QL (3/28); NDS
NIPENT 4 B/D PA
NUBEQA 5 PA; LA; QL
(120/30); NDS
NULOJIX 5 B/D PA; NDS
octreotide acetate 4 PA
ODOMZO 5 PA; LA; QL (30/30);
NDS
OGIVRI 5 PA; NDS
OJEMDA ORAL TABLET
400 MG/WEEK (100 MG X 4)
5 PA; QL (16/28);
NDS
OJEMDA ORAL TABLET
500 MG/WEEK (100 MG X 5)
5 PA; QL (20/28);
NDS
OJEMDA ORAL TABLET
600 MG/WEEK (100 MG X 6)
5 PA; QL (24/28);
NDS
OJJAARA 5 PA; QL (30/30);
NDS
ONCASPAR 4 B/D PA
ONIVYDE 4 PA
ONUREG 4 PA; QL (14/28)
OPDIVO 5 PA; NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
21
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
OPDUALAG 4 PA
ORGOVYX 4 PA; LA; QL (30/28)
ORSERDU 5 PA; NDS
oxaliplatin 4 B/D PA
paclitaxel 4 B/D PA
PACLITAXEL PROTEIN-
BOUND
5 PA; NDS
PADCEV 4 PA
pazopanib 5 PA; QL (120/30);
NDS
PEMAZYRE 5 PA; LA; QL (14/21);
NDS
pemetrexed disodium
intravenous recon soln
5 PA; NDS
PERJETA 5 PA; NDS
PHESGO 5 PA; NDS
PIQRAY 5 PA; NDS
POLIVY 5 PA; NDS
POMALYST 5 PA; LA; QL (21/28);
NDS
PORTRAZZA 4 B/D PA
POTELIGEO 5 PA; NDS
PRALATREXATE 5 B/D PA; NDS
PROGRAF INTRAVENOUS 4 B/D PA
PROGRAF ORAL GRANULES
IN PACKET
4 B/D PA
PURIXAN 4
QINLOCK 5 PA; LA; QL (90/30);
NDS
RETEVMO ORAL CAPSULE
40 MG
5 PA; LA; QL
(180/30); NDS
RETEVMO ORAL CAPSULE
80 MG
5 PA; LA; QL
(120/30); NDS
REZLIDHIA 5 PA; QL (60/30);
NDS
REZUROCK 5 PA; LA; QL (30/30);
NDS
romidepsin intravenous recon
soln
5 PA; NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ROMIDEPSIN INTRAVENOUS
SOLUTION
5 PA; NDS
ROZLYTREK ORAL CAPSULE
100 MG
5 PA; QL (150/30);
NDS
ROZLYTREK ORAL CAPSULE
200 MG
5 PA; QL (90/30);
NDS
ROZLYTREK ORAL PELLETS
IN PACKET
5 PA; QL (360/30);
NDS
RUBRACA 5 PA; LA; QL
(120/30); NDS
RUXIENCE 5 PA; NDS
RYBREVANT 4 PA
RYDAPT 5 PA; QL (224/28);
NDS
RYLAZE 4 B/D PA
SANDIMMUNE ORAL
SOLUTION
4 B/D PA
SARCLISA 4 PA
SCEMBLIX ORAL TABLET
100 MG
5 PA; QL (120/30);
NDS
SCEMBLIX ORAL TABLET
20 MG
5 PA; QL (600/30);
NDS
SCEMBLIX ORAL TABLET
40 MG
5 PA; QL (300/30);
NDS
SIGNIFOR 5 PA; NDS
SIMULECT 5 B/D PA; NDS
sirolimus 4 B/D PA
SOLTAMOX 4
SOMATULINE DEPOT 5 PA; NDS
sorafenib 5 PA; QL (120/30);
NDS
SPRYCEL ORAL TABLET
100 MG, 140 MG, 50 MG,
80 MG
5 PA; QL (30/30);
NDS
SPRYCEL ORAL TABLET
20 MG, 70 MG
5 PA; QL (60/30);
NDS
STIVARGA 5 PA; QL (84/28);
NDS
sunitinib malate 5 PA; QL (30/30);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
22
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
TABLOID 4
TABRECTA 5 PA; NDS
tacrolimus oral capsule 4 B/D PA
TAFINLAR ORAL CAPSULE 5 PA; QL (120/30);
NDS
TAFINLAR ORAL TABLET
FOR SUSPENSION
5 PA; QL (840/28);
NDS
TAGRISSO 5 PA; LA; QL (30/30);
NDS
TALVEY 4 PA
TALZENNA ORAL CAPSULE
0.1 MG, 0.35 MG, 0.5 MG,
0.75 MG, 1 MG
5 PA; QL (30/30);
NDS
TALZENNA ORAL CAPSULE
0.25 MG
5 PA; QL (90/30);
NDS
tamoxifen 2
TASIGNA ORAL CAPSULE
150 MG, 200 MG
5 PA; QL (112/28);
NDS
TASIGNA ORAL CAPSULE
50 MG
5 PA; QL (120/30);
NDS
TAZVERIK 4 PA; LA
TECENTRIQ 5 PA; NDS
TECVAYLI 4 PA
TEMODAR INTRAVENOUS 4 B/D PA
temsirolimus 4 B/D PA
TEPMETKO 5 PA; LA; QL (60/30);
NDS
THALOMID ORAL CAPSULE
100 MG, 50 MG
5 PA; QL (28/28);
NDS
THALOMID ORAL CAPSULE
150 MG, 200 MG
5 PA; QL (56/28);
NDS
thiotepa 4 PA
TIBSOVO 5 PA; NDS
TIVDAK 4 PA
topotecan intravenous recon
soln
5 B/D PA; NDS
topotecan intravenous solution 4 B/D PA
toremifene 5 NDS
TRAZIMERA 5 PA; NDS
TREANDA 5 B/D PA; NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
TRELSTAR INTRAMUSCULAR
SUSPENSION FOR
RECONSTITUTION
4 PA
tretinoin (antineoplastic) 5 NDS
TRIPTODUR 4 PA; QL (1/168)
TRODELVY 4 PA
TRUQAP 5 PA; QL (64/28);
NDS
TRUXIMA 5 PA; NDS
TUKYSA ORAL TABLET
150 MG
5 PA; LA; QL
(120/30); NDS
TUKYSA ORAL TABLET
50 MG
5 PA; LA; QL
(300/30); NDS
TURALIO ORAL CAPSULE
125 MG
5 PA; LA; QL
(120/30); NDS
UNITUXIN 5 PA; NDS
valrubicin 4 B/D PA
VANFLYTA 5 PA; QL (56/28);
NDS
VECTIBIX 5 PA; NDS
VENCLEXTA ORAL TABLET
10 MG
4 PA; LA; QL (60/30)
VENCLEXTA ORAL TABLET
100 MG
5 PA; LA; QL
(120/30); NDS
VENCLEXTA ORAL TABLET
50 MG
5 PA; LA; QL (30/30);
NDS
VENCLEXTA STARTING PACK 5 PA; LA; QL
(84/365); NDS
VERZENIO 5 PA; LA; QL (60/30);
NDS
vinblastine 4 B/D PA
vincristine 4 B/D PA
vinorelbine 4 B/D PA
VITRAKVI ORAL CAPSULE
100 MG
5 PA; LA; QL (60/30);
NDS
VITRAKVI ORAL CAPSULE
25 MG
5 PA; LA; QL
(180/30); NDS
VITRAKVI ORAL SOLUTION 5 PA; LA; QL
(300/30); NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
23
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
VIZIMPRO 5 PA; QL (30/30);
NDS
VONJO 5 PA; QL (120/30);
NDS
VOTRIENT 5 PA; QL (120/30);
NDS
VYXEOS 5 B/D PA; NDS
WELIREG 5 PA; LA; QL (90/30);
NDS
XALKORI ORAL CAPSULE 5 PA; QL (60/30);
NDS
XALKORI ORAL PELLET
150 MG
5 PA; QL (180/30);
NDS
XALKORI ORAL PELLET
20 MG, 50 MG
5 PA; QL (120/30);
NDS
XATMEP 4 PA
XERMELO 5 PA; LA; QL (84/28);
NDS
XOSPATA 5 PA; LA; NDS
XPOVIO 5 PA; LA; NDS
XTANDI ORAL CAPSULE 5 PA; QL (120/30);
NDS
XTANDI ORAL TABLET 40 MG 5 PA; QL (120/30);
NDS
XTANDI ORAL TABLET 80 MG 5 PA; QL (60/30);
NDS
YERVOY 5 PA; NDS
YONDELIS 5 PA; NDS
ZALTRAP 4 B/D PA
ZANOSAR 4 B/D PA
ZEJULA ORAL TABLET 5 PA; LA; QL (30/30);
NDS
ZELBORAF 5 PA; QL (240/30);
NDS
ZEPZELCA 4 PA
ZIRABEV 5 PA; NDS
ZOLADEX 4 B/D PA
ZOLINZA 5 PA; QL (120/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ZYDELIG 5 PA; QL (60/30);
NDS
ZYKADIA 5 PA; QL (90/30);
NDS
ZYNLONTA 4 PA
ZYNYZ 5 PA; NDS
AUTONOMIC / CNS DRUGS, NEUROLOGY / PSYCH
ANTICONVULSANTS
APTIOM ORAL TABLET
200 MG
4 QL (180/30)
APTIOM ORAL TABLET
400 MG
4 QL (90/30)
APTIOM ORAL TABLET
600 MG, 800 MG
4 QL (60/30)
BRIVIACT INTRAVENOUS 4
BRIVIACT ORAL SOLUTION 4 QL (600/30)
BRIVIACT ORAL TABLET 4 QL (60/30)
carbamazepine oral capsule, er
multiphase 12 hr
4
carbamazepine oral
suspension 100 mg/5 ml
4
carbamazepine oral tablet 3
carbamazepine oral tablet
extended release 12 hr
4
carbamazepine oral tablet,
chewable
3
CELONTIN ORAL CAPSULE
300 MG
3
clobazam oral suspension 4 PA; QL (480/30)
clobazam oral tablet 10 mg 4 PA; QL (120/30)
clobazam oral tablet 20 mg 4 PA; QL (60/30)
clonazepam oral tablet 0.5 mg,
1 mg
2 QL (120/30)
clonazepam oral tablet 2 mg 2 QL (300/30)
clonazepam oral tablet,
disintegrating 0.125 mg,
0.25 mg
4 QL (90/30)
clonazepam oral tablet,
disintegrating 0.5 mg, 1 mg
4 QL (120/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
24
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
clonazepam oral tablet,
disintegrating 2 mg
4 QL (300/30)
DIACOMIT 5 LA; NDS
diazepam rectal 4
dilantin 4
divalproex oral capsule,
delayed rel sprinkle
4
divalproex oral tablet extended
release 24 hr
4
divalproex oral tablet, delayed
release (dr/ec)
3
EPIDIOLEX 5 PA; LA; NDS
epitol 3
EPRONTIA 4 PA
ethosuximide 4
felbamate 4
FINTEPLA 4 PA; LA; QL (360/30)
fosphenytoin 3
FYCOMPA ORAL
SUSPENSION
4 QL (720/30)
FYCOMPA ORAL TABLET
10 MG, 12 MG, 8 MG
4 QL (30/30)
FYCOMPA ORAL TABLET
2 MG, 4 MG, 6 MG
4 QL (60/30)
gabapentin oral capsule
100 mg, 300 mg
2 QL (360/30)
gabapentin oral capsule
400 mg
2 QL (270/30)
gabapentin oral solution 4 QL (2160/30)
gabapentin oral tablet 600 mg 2 QL (180/30)
gabapentin oral tablet 800 mg 2 QL (120/30)
lacosamide intravenous 4 QL (1200/30)
lacosamide oral solution 4 QL (1200/30)
lacosamide oral tablet 100 mg,
150 mg, 200 mg
3 QL (60/30)
lacosamide oral tablet 50 mg 3 QL (120/30)
lamotrigine oral tablet 2
lamotrigine oral tablet,
chewable dispersible
3
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
lamotrigine oral tablets, dose
pack
2
levetiracetam in nacl
(iso-os) intravenous
piggyback 1,000 mg/100 ml,
1,500 mg/100 ml,
500 mg/100 ml
4
levetiracetam intravenous 3
levetiracetam oral solution 3
levetiracetam oral tablet
1,000 mg, 750 mg
3
levetiracetam oral tablet
250 mg, 500 mg
2
levetiracetam oral tablet
extended release 24 hr
3
LIBERVANT 5 PA; QL (10/30);
NDS
methsuximide 3
MOTPOLY XR ORAL
CAPSULE, EXTENDED
RELEASE 24HR 100 MG
4 ST; QL (120/30)
MOTPOLY XR ORAL
CAPSULE, EXTENDED
RELEASE 24HR 150 MG,
200 MG
5 ST; QL (60/30);
NDS
NAYZILAM 4 PA; QL (10/30)
oxcarbazepine oral suspension 4
oxcarbazepine oral tablet 3
phenobarbital oral elixir 4 PA; QL (1500/30)
phenobarbital oral tablet 4 PA; QL (120/30)
phenobarbital sodium injection
solution
3
phenytoin oral suspension 2
phenytoin oral tablet, chewable 3
phenytoin sodium extended
oral capsule 100 mg, 200 mg
2
phenytoin sodium extended
oral capsule 300 mg
3
phenytoin sodium intravenous
solution
3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
25
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
pregabalin oral capsule
100 mg, 150 mg, 25 mg,
50 mg, 75 mg
4 QL (120/30)
pregabalin oral capsule 200 mg 4 QL (90/30)
pregabalin oral capsule
225 mg, 300 mg
4 QL (60/30)
pregabalin oral solution 3 QL (900/30)
primidone oral tablet 125 mg 4
primidone oral tablet 250 mg,
50 mg
2
roweepra oral tablet 500 mg 2
runamide oral suspension 5 PA; NDS
runamide oral tablet 3 PA
SPRITAM 4
subvenite 2
subvenite starter (blue) kit 2
subvenite starter (green) kit 2
subvenite starter (orange) kit 2
SYMPAZAN 5 PA; QL (60/30);
NDS
tiagabine 4
topiramate oral capsule,
sprinkle
3 PA
topiramate oral tablet 2 PA
valproate sodium 3
valproic acid 2
valproic acid (as sodium salt) 2
VALTOCO 4 PA; QL (10/30)
vigabatrin 5 PA; LA; QL
(180/30); NDS
vigadrone 5 PA; LA; QL
(180/30); NDS
vigpoder 5 PA; LA; QL
(180/30); NDS
XCOPRI MAINTENANCE
PACK ORAL TABLET 250MG/
DAY(150 MG X1-100MG
X1), 350 MG/DAY (200 MG
X1-150MG X1)
4 PA; QL (56/28)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
XCOPRI ORAL TABLET
100 MG
4 PA; QL (120/30)
XCOPRI ORAL TABLET
150 MG, 200 MG
4 PA; QL (60/30)
XCOPRI ORAL TABLET
25 MG
4 PA; QL (480/30)
XCOPRI ORAL TABLET
50 MG
4 PA; QL (240/30)
XCOPRI TITRATION PACK 4 PA; QL (56/365)
ZONISADE 5 PA; NDS
zonisamide oral capsule
100 mg
3 PA
zonisamide oral capsule
25 mg, 50 mg
2 PA
ZTALMY 4 PA; LA; QL
(1080/30)
ANTIPARKINSONISM AGENTS
benztropine injection 4
benztropine oral 2 PA
bromocriptine 4
carbidopa 4
carbidopa-levodopa oral tablet 2
carbidopa-levodopa oral tablet
extended release
3
carbidopa-levodopa oral tablet,
disintegrating
4
entacapone 4
GOCOVRI 4 ST
INBRIJA INHALATION
CAPSULE, W/INHALATION
DEVICE
5 PA; QL (300/30);
NDS
ONGENTYS 3
pramipexole oral tablet 2
rasagiline 4
ropinirole oral tablet 2
RYTARY 4 ST
selegiline hcl 3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
26
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
MIGRAINE / CLUSTER HEADACHE THERAPY
AJOVY AUTOINJECTOR 3 PA; QL (1.5/30)
AJOVY SYRINGE 3 PA; QL (1.5/30)
dihydroergotamine nasal 4 PA; QL (8/28)
ergotamine-caffeine 3
naratriptan 3 QL (18/28)
NURTEC ODT 3 PA; QL (16/30)
rizatriptan oral tablet 3 QL (36/28)
rizatriptan oral tablet,
disintegrating
4 QL (36/28)
sumatriptan nasal spray,
non-aerosol 20 mg/actuation
4 QL (18/28)
sumatriptan nasal spray,
non-aerosol 5 mg/actuation
4 QL (36/28)
sumatriptan succinate oral 2 QL (18/28)
SUMATRIPTAN SUCCINATE
SUBCUTANEOUS
CARTRIDGE
4 QL (8/28)
sumatriptan succinate
subcutaneous pen injector
4 QL (8/28)
sumatriptan succinate
subcutaneous solution
4 QL (8/28)
MISCELLANEOUS NEUROLOGICAL THERAPY
ADLARITY 4 ST; QL (4/28)
AUSTEDO ORAL TABLET
12 MG, 9 MG
5 PA; LA; QL
(120/30); NDS
AUSTEDO ORAL TABLET
6 MG
5 PA; LA; QL (60/30);
NDS
AUSTEDO XR ORAL TABLET
EXTENDED RELEASE 24 HR
12 MG
5 PA; LA; QL
(120/30); NDS
AUSTEDO XR ORAL TABLET
EXTENDED RELEASE 24 HR
24 MG
5 PA; LA; QL (60/30);
NDS
AUSTEDO XR ORAL TABLET
EXTENDED RELEASE 24 HR
30 MG, 36 MG, 42 MG, 48 MG
5 PA; QL (30/30);
NDS
AUSTEDO XR ORAL TABLET
EXTENDED RELEASE 24 HR
6 MG
5 PA; LA; QL
(240/30); NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
AUSTEDO XR TITRATION
KT(WK1-4) ORAL TABLET, EXT
REL 24HR DOSE PACK 6 MG
(14)-12 MG (14)-24 MG (14)
5 PA; QL (84/365);
NDS
dalfampridine 3 PA; QL (60/30)
donepezil oral tablet 10 mg 2 QL (60/30)
donepezil oral tablet 5 mg 2 QL (30/30)
donepezil oral tablet,
disintegrating 10 mg
2 QL (60/30)
donepezil oral tablet,
disintegrating 5 mg
2 QL (30/30)
galantamine oral capsule, ext
rel. pellets 24 hr
4 QL (30/30)
galantamine oral solution 4 QL (200/30)
galantamine oral tablet 3 QL (60/30)
glatiramer subcutaneous
syringe 20 mg/ml
4 PA; QL (30/30)
glatiramer subcutaneous
syringe 40 mg/ml
4 PA; QL (12/28)
glatopa subcutaneous syringe
20 mg/ml
4 PA; QL (30/30)
glatopa subcutaneous syringe
40 mg/ml
4 PA; QL (12/28)
INGREZZA 5 PA; LA; QL (30/30);
NDS
INGREZZA INITIATION
PK(TARDIV)
5 PA; LA; QL
(56/365); NDS
KESIMPTA PEN 5 PA; QL (1.2/28);
NDS
memantine oral solution 4 PA; QL (300/30)
memantine oral tablet 10 mg 3 PA; QL (60/30)
memantine oral tablet 5 mg 3 PA; QL (90/30)
MEMANTINE ORAL TABLETS,
DOSE PACK
3 PA; QL (98/365)
NAMZARIC 3 PA
NUEDEXTA 5 PA; NDS
OCREVUS 4 PA
RADICAVA 4 PA
rivastigmine 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
27
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
rivastigmine tartrate 4 QL (60/30)
tetrabenazine oral tablet
12.5 mg
4 PA; QL (240/30)
tetrabenazine oral tablet 25 mg 4 PA; QL (120/30)
VUMERITY 5 PA; QL (120/30);
NDS
ZEPOSIA 5 PA; QL (30/30);
NDS
ZEPOSIA STARTER KIT
(28-DAY)
5 PA; QL (56/365);
NDS
ZEPOSIA STARTER PACK
(7-DAY)
5 PA; QL (14/365);
NDS
MUSCLE RELAXANTS / ANTISPASMODIC THERAPY
baclofen oral tablet 10 mg,
20 mg, 5 mg
2
BACLOFEN ORAL TABLET
15 MG
3
cyclobenzaprine oral tablet
10 mg, 5 mg
3 PA
dantrolene oral 4
methocarbamol oral tablet
500 mg, 750 mg
3 PA
pyridostigmine bromide oral
tablet 60 mg
3
pyridostigmine bromide oral
tablet extended release
4
tizanidine oral tablet 2
NARCOTIC ANALGESICS
acetaminophen-codeine oral
solution 120-12 mg/5 ml
3 QL (4500/30); NDS
acetaminophen-codeine oral
tablet 300-15 mg, 300-30 mg
3 QL (360/30); NDS
acetaminophen-codeine oral
tablet 300-60 mg
3 QL (180/30); NDS
buprenorphine hcl injection 4 NDS
buprenorphine hcl sublingual 3 PA
endocet 3 QL (360/30); NDS
fentanyl citrate buccal lozenge
on a handle 1,200 mcg,
1,600 mcg, 400 mcg, 600 mcg,
800 mcg
5 PA; QL (120/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
fentanyl citrate buccal lozenge
on a handle 200 mcg
4 PA; QL (120/30);
NDS
fentanyl transdermal patch 72
hour 100 mcg/hr, 12 mcg/hr,
25 mcg/hr, 50 mcg/hr, 75 mcg/hr
4 QL (10/30); NDS
hydrocodone-acetaminophen
oral solution 7.5-325 mg/15 ml
4 QL (5550/30); NDS
hydrocodone-acetaminophen
oral tablet 10-325 mg,
5-325 mg, 7.5-325 mg
3 QL (360/30); NDS
hydrocodone-ibuprofen oral
tablet 7.5-200 mg
4 QL (50/30); NDS
hydromorphone oral liquid 4 QL (2400/30); NDS
hydromorphone oral tablet 4 QL (180/30); NDS
INFUMORPH P/F 4 B/D PA; NDS
methadone injection solution 4 NDS
methadone intensol 4 QL (90/30); NDS
methadone oral concentrate 4 QL (90/30); NDS
methadone oral solution
10 mg/5 ml
4 QL (600/30); NDS
methadone oral solution
5 mg/5 ml
4 QL (1200/30); NDS
methadone oral tablet 10 mg 3 QL (120/30); NDS
methadone oral tablet 5 mg 3 QL (240/30); NDS
morphine (pf) injection solution
0.5 mg/ml, 1 mg/ml
4 NDS
morphine concentrate oral
solution
4 QL (900/30); NDS
MORPHINE INJECTION
SOLUTION
4 NDS
MORPHINE INJECTION
SYRINGE 2 MG/ML, 4 MG/ML
4 NDS
morphine intravenous solution
10 mg/ml, 4 mg/ml, 8 mg/ml
4 NDS
MORPHINE INTRAVENOUS
SYRINGE 10 MG/ML, 2 MG/
ML, 4 MG/ML
4 NDS
morphine oral solution 4 QL (900/30); NDS
morphine oral tablet 3 QL (180/30); NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
28
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
morphine oral tablet extended
release
3 QL (120/30); NDS
oxycodone oral tablet 10 mg,
15 mg, 20 mg, 30 mg
3 QL (180/30); NDS
oxycodone oral tablet 5 mg 3 QL (360/30); NDS
oxycodone-acetaminophen oral
tablet 10-325 mg, 2.5-325 mg,
5-325 mg, 7.5-325 mg
3 QL (360/30); NDS
oxymorphone oral tablet
extended release 12 hr
4 QL (90/30); NDS
NON-NARCOTIC ANALGESICS
buprenorphine-naloxone
sublingual tablet 2-0.5 mg
2 QL (360/30)
buprenorphine-naloxone
sublingual tablet 8-2 mg
2 QL (90/30)
butorphanol nasal 4 QL (10/28); NDS
celecoxib 4 QL (60/30)
diclofenac potassium oral
tablet 50 mg
3
diclofenac sodium oral 2
diclofenac sodium topical drops 4 QL (300/28)
diclofenac sodium topical gel
1%
3 QL (1000/28)
diunisal 4
EC-NAPROXEN ORAL
TABLET, DELAYED RELEASE
(DR/EC) 375 MG
2
ec-naproxen oral tablet,
delayed release (dr/ec) 500 mg
3
urbiprofen oral tablet 100 mg 2
ibu 1
ibuprofen oral suspension 4
ibuprofen oral tablet 400 mg,
600 mg, 800 mg
1
KLOXXADO 3
meloxicam oral tablet 15 mg 1
meloxicam oral tablet 7.5 mg 1 QL (60/30)
nabumetone 2
naloxone injection solution 2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
naloxone injection syringe
1 mg/ml
2
naloxone nasal 3
naltrexone 3
naproxen oral suspension 4
naproxen oral tablet 1
naproxen oral tablet, delayed
release (dr/ec) 375 mg
2
naproxen oral tablet, delayed
release (dr/ec) 500 mg
3
naproxen sodium oral tablet
275 mg, 550 mg
4
oxaprozin oral tablet 4
sulindac 2
tramadol oral tablet 50 mg 2 QL (240/30); NDS
tramadol-acetaminophen 2 QL (240/30); NDS
VIVITROL 5 NDS
ZIMHI 4
ZUBSOLV SUBLINGUAL
TABLET 0.7-0.18 MG,
1.4-0.36 MG, 11.4-2.9 MG,
2.9-0.71 MG, 5.7-1.4 MG
3 QL (30/30); NDS
ZUBSOLV SUBLINGUAL
TABLET 8.6-2.1 MG
3 QL (60/30); NDS
PSYCHOTHERAPEUTIC DRUGS
ABILIFY ASIMTUFII
INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 720 MG/2.4 ML
4 QL (2.4/56)
ABILIFY ASIMTUFII
INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 960 MG/3.2 ML
4 QL (3.2/56)
ABILIFY MAINTENA 4 QL (1/28)
alprazolam oral tablet 0.25 mg,
0.5 mg, 1 mg
2 QL (120/30)
alprazolam oral tablet 2 mg 2 QL (150/30)
amitriptyline 4
amoxapine 3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
29
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
aripiprazole oral solution 4
aripiprazole oral tablet 10 mg,
15 mg, 2 mg, 5 mg
4 QL (60/30)
aripiprazole oral tablet 20 mg,
30 mg
4 QL (30/30)
aripiprazole oral tablet,
disintegrating
4 QL (60/30)
ARISTADA INITIO 4 QL (4.8/365)
ARISTADA INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 1,064 MG/3.9 ML
4 QL (3.9/56)
ARISTADA INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 441 MG/1.6 ML
4 QL (1.6/28)
ARISTADA INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 662 MG/2.4 ML
4 QL (2.4/28)
ARISTADA INTRAMUSCULAR
SUSPENSION, EXTENDED
REL SYRING 882 MG/3.2 ML
4 QL (3.2/28)
asenapine maleate sublingual
tablet 10 mg, 2.5 mg
4 QL (60/30)
asenapine maleate sublingual
tablet 5 mg
4 QL (90/30)
atomoxetine oral capsule
10 mg, 18 mg, 25 mg, 40 mg
4 QL (60/30)
atomoxetine oral capsule
100 mg, 60 mg, 80 mg
4 QL (30/30)
AUVELITY 4 ST; QL (60/30)
BELSOMRA 3 QL (30/30)
bupropion hcl oral tablet
100 mg
3 QL (120/30)
bupropion hcl oral tablet 75 mg 3 QL (180/30)
bupropion hcl oral tablet
extended release 24 hr 150 mg
3 QL (90/30)
bupropion hcl oral tablet
extended release 24 hr 300 mg
3 QL (30/30)
bupropion hcl oral tablet
sustained-release 12 hr
100 mg
3 QL (120/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
bupropion hcl oral tablet
sustained-release 12 hr
150 mg, 200 mg
3 QL (60/30)
buspirone 2
CAPLYTA 4 QL (30/30)
chlorpromazine 4
citalopram oral solution 4
citalopram oral tablet 10 mg,
20 mg
1 QL (60/30)
citalopram oral tablet 40 mg 1 QL (30/30)
clomipramine 4
clorazepate dipotassium oral
tablet 15 mg
4 QL (180/30)
clorazepate dipotassium oral
tablet 3.75 mg
4 QL (90/30)
clorazepate dipotassium oral
tablet 7.5 mg
4 QL (360/30)
clozapine oral tablet 100 mg,
200 mg
4
clozapine oral tablet 25 mg,
50 mg
3
clozapine oral tablet,
disintegrating
4
desipramine 4
desvenlafaxine succinate oral
tablet extended release 24 hr
100 mg
4 QL (120/30)
desvenlafaxine succinate oral
tablet extended release 24 hr
25 mg
4 QL (60/30)
desvenlafaxine succinate oral
tablet extended release 24 hr
50 mg
4 QL (90/30)
dexmethylphenidate oral tablet 3
dextroamphetamine sulfate
oral capsule, extended release
4
dextroamphetamine sulfate
oral tablet
4
dextroamphetamine-
amphetamine oral capsule,
extended release 24hr
4 QL (60/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
30
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
dextroamphetamine-
amphetamine oral tablet 10 mg
3 QL (180/30)
dextroamphetamine-
amphetamine oral tablet
12.5 mg, 30 mg, 7.5 mg
3 QL (60/30)
dextroamphetamine-
amphetamine oral tablet 15 mg
3 QL (120/30)
dextroamphetamine-
amphetamine oral tablet 20 mg
3 QL (90/30)
dextroamphetamine-
amphetamine oral tablet 5 mg
3 QL (360/30)
diazepam injection 2
diazepam intensol 3 QL (360/30)
diazepam oral concentrate 3 QL (360/30)
diazepam oral solution 4 QL (1800/30)
diazepam oral tablet 2 QL (180/30)
doxepin oral capsule 4
doxepin oral concentrate 4
doxepin oral tablet 4 QL (30/30)
duloxetine oral capsule,
delayed release (dr/ec) 20 mg,
60 mg
3 QL (60/30)
duloxetine oral capsule,
delayed release (dr/ec) 30 mg
3 QL (120/30)
EMSAM 4 QL (30/30)
escitalopram oxalate oral
solution
4 QL (600/30)
escitalopram oxalate oral tablet
10 mg, 5 mg
2 QL (60/30)
escitalopram oxalate oral tablet
20 mg
2 QL (30/30)
FANAPT ORAL TABLET 1 MG,
10 MG, 12 MG, 2 MG, 4 MG,
6 MG
4 PA; QL (60/30)
FANAPT ORAL TABLET 8 MG 4 PA; QL (90/30)
FANAPT ORAL TABLETS,
DOSE PACK
4 PA; QL (16/365)
FETZIMA ORAL CAPSULE,
EXT REL 24HR DOSE PACK
20 MG (2)- 40 MG (26)
4 ST; QL (56/365)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
FETZIMA ORAL CAPSULE,
EXTENDED RELEASE 24 HR
4 ST; QL (30/30)
uoxetine oral capsule 10 mg 2 QL (120/30)
uoxetine oral capsule 20 mg,
40 mg
2 QL (90/30)
uoxetine oral solution 2
uphenazine decanoate 4
uphenazine hcl injection 4
uphenazine hcl oral
concentrate
4
uphenazine hcl oral elixir 4
uphenazine hcl oral tablet 3
uvoxamine oral tablet 100 mg 3 QL (90/30)
uvoxamine oral tablet 25 mg 2 QL (90/30)
uvoxamine oral tablet 50 mg 2 QL (120/30)
guanfacine oral tablet extended
release 24 hr
4 QL (30/30)
haloperidol decanoate 4
haloperidol lactate injection 4
haloperidol lactate oral 2
haloperidol oral tablet 0.5 mg,
2 mg, 20 mg
2
haloperidol oral tablet 1 mg,
10 mg, 5 mg
3
imipramine hcl 4
INVEGA HAFYERA
INTRAMUSCULAR SYRINGE
1,092 MG/3.5 ML
4 QL (3.5/180)
INVEGA HAFYERA
INTRAMUSCULAR SYRINGE
1,560 MG/5 ML
4 QL (5/180)
INVEGA SUSTENNA
INTRAMUSCULAR SYRINGE
117 MG/0.75 ML
4 QL (0.75/28)
INVEGA SUSTENNA
INTRAMUSCULAR SYRINGE
156 MG/ML
4 QL (1/28)
INVEGA SUSTENNA
INTRAMUSCULAR SYRINGE
234 MG/1.5 ML
4 QL (1.5/28)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
31
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
INVEGA SUSTENNA
INTRAMUSCULAR SYRINGE
39 MG/0.25 ML
4 QL (0.25/28)
INVEGA SUSTENNA
INTRAMUSCULAR SYRINGE
78 MG/0.5 ML
4 QL (0.5/28)
INVEGA TRINZA
INTRAMUSCULAR SYRINGE
273 MG/0.88 ML
4 QL (0.88/90)
INVEGA TRINZA
INTRAMUSCULAR SYRINGE
410 MG/1.32 ML
4 QL (1.32/90)
INVEGA TRINZA
INTRAMUSCULAR SYRINGE
546 MG/1.75 ML
4 QL (1.75/90)
INVEGA TRINZA
INTRAMUSCULAR SYRINGE
819 MG/2.63 ML
4 QL (2.63/90)
lithium carbonate 2
lithium citrate 2
lorazepam injection solution 4
lorazepam injection syringe
2 mg/ml
4
lorazepam intensol 3 QL (150/30)
lorazepam oral concentrate 3 QL (150/30)
lorazepam oral syringe 3 QL (150/30)
lorazepam oral tablet 0.5 mg,
1 mg
2 QL (90/30)
lorazepam oral tablet 2 mg 2 QL (150/30)
loxapine succinate 4
lurasidone oral tablet 120 mg,
20 mg, 40 mg, 60 mg
4 QL (30/30)
lurasidone oral tablet 80 mg 4 QL (60/30)
MARPLAN 4 QL (180/30)
metadate er 4
methylphenidate hcl oral tablet 4 QL (90/30)
methylphenidate hcl oral tablet
extended release
4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
methylphenidate hcl oral tablet
extended release 24hr 18 mg,
18 mg (bx rating), 27 mg,
27 mg (bx rating), 36 mg,
36 mg (bx rating), 54 mg,
54 mg (bx rating)
4
mirtazapine oral tablet 2
mirtazapine oral tablet,
disintegrating
3 QL (30/30)
modanil oral tablet 100 mg 3 PA; QL (30/30)
modanil oral tablet 200 mg 3 PA; QL (60/30)
molindone oral tablet 10 mg,
25 mg
3
molindone oral tablet 5 mg 4
nefazodone 4
nortriptyline oral capsule 2
nortriptyline oral solution 3
NUPLAZID 4 PA; QL (30/30)
olanzapine intramuscular 4 QL (30/30)
olanzapine oral tablet 10 mg,
2.5 mg, 5 mg, 7.5 mg
4 QL (60/30)
olanzapine oral tablet 15 mg,
20 mg
4 QL (30/30)
olanzapine oral tablet,
disintegrating 10 mg, 5 mg
4 QL (60/30)
olanzapine oral tablet,
disintegrating 15 mg, 20 mg
4 QL (30/30)
paliperidone oral tablet
extended release 24hr 1.5 mg,
9 mg
4 PA; QL (30/30)
paliperidone oral tablet
extended release 24hr 3 mg,
6 mg
4 PA; QL (60/30)
paroxetine hcl oral suspension 4 QL (900/30)
paroxetine hcl oral tablet 10 mg 2 QL (180/30)
paroxetine hcl oral tablet
20 mg, 40 mg
2 QL (30/30)
paroxetine hcl oral tablet 30 mg 2 QL (60/30)
perphenazine 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
32
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
perphenazine-amitriptyline 4
PERSERIS 4 QL (1/28)
phenelzine 3
pimozide 4
protriptyline 4
quetiapine oral tablet 100 mg,
25 mg, 50 mg
2 QL (120/30)
quetiapine oral tablet 150 mg,
200 mg
2 QL (90/30)
quetiapine oral tablet 300 mg,
400 mg
2 QL (60/30)
QUILLICHEW ER ORAL
TABLET, CHEW, IR-ER.
BIPHASIC24HR 20 MG,
30 MG
4 PA; QL (60/30)
QUILLICHEW ER ORAL
TABLET, CHEW, IR-ER.
BIPHASIC24HR 40 MG
4 PA; QL (30/30)
REXULTI ORAL TABLET 4 QL (30/30)
RISPERDAL CONSTA 4 QL (2/28)
risperidone oral solution 4
risperidone oral tablet 0.25 mg,
0.5 mg, 4 mg
2 QL (120/30)
risperidone oral tablet 1 mg 2 QL (180/30)
risperidone oral tablet 2 mg 2 QL (90/30)
risperidone oral tablet 3 mg 2 QL (60/30)
risperidone oral tablet,
disintegrating 0.25 mg, 0.5 mg,
4 mg
4 QL (120/30)
risperidone oral tablet,
disintegrating 1 mg
4 QL (180/30)
risperidone oral tablet,
disintegrating 2 mg
4 QL (90/30)
risperidone oral tablet,
disintegrating 3 mg
4 QL (60/30)
SECUADO 4 QL (30/30)
sertraline oral concentrate 4
sertraline oral tablet 1 QL (60/30)
SODIUM OXYBATE 5 PA; LA; QL
(540/30); NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
SPRAVATO NASAL SPRAY,
NON-AEROSOL 56 MG
(28 MG X 2)
4 PA; QL (16/28)
SPRAVATO NASAL SPRAY,
NON-AEROSOL 84 MG
(28 MG X 3)
4 PA; QL (18/28)
tasimelteon 5 PA; QL (30/30);
NDS
thioridazine 4
thiothixene 4
tranylcypromine 4
trazodone 2
triuoperazine oral tablet 1 mg 3
triuoperazine oral tablet
10 mg, 2 mg, 5 mg
4
trimipramine 4
TRINTELLIX 4 ST; QL (30/30)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 100 MG/0.28 ML
4 QL (0.28/28)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 125 MG/0.35 ML
4 QL (0.35/28)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 150 MG/0.42 ML
4 QL (0.42/56)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 200 MG/0.56 ML
4 QL (0.56/56)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 250 MG/0.7 ML
4 QL (0.7/56)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 50 MG/0.14 ML
4 QL (0.14/28)
UZEDY SUBCUTANEOUS
SUSPENSION, EXTENDED
REL SYRING 75 MG/0.21 ML
4 QL (0.21/28)
venlafaxine oral capsule,
extended release 24hr 150 mg,
37.5 mg
2 QL (60/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
33
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
venlafaxine oral capsule,
extended release 24hr 75 mg
2 QL (90/30)
venlafaxine oral tablet 100 mg,
25 mg, 37.5 mg
2 QL (90/30)
venlafaxine oral tablet 50 mg,
75 mg
2 QL (120/30)
VERSACLOZ 4
vilazodone 4 QL (30/30)
VRAYLAR ORAL CAPSULE 4 QL (30/30)
ziprasidone hcl oral capsule
20 mg
4 QL (180/30)
ziprasidone hcl oral capsule
40 mg
4 QL (120/30)
ziprasidone hcl oral capsule
60 mg, 80 mg
4 QL (60/30)
ziprasidone mesylate 4 QL (6/30)
zolpidem oral tablet 2 QL (30/30)
ZURZUVAE 4 PA
ZYPREXA RELPREVV
INTRAMUSCULAR
SUSPENSION FOR
RECONSTITUTION 210 MG,
300 MG
4 PA; QL (2/28)
ZYPREXA RELPREVV
INTRAMUSCULAR
SUSPENSION FOR
RECONSTITUTION 405 MG
4 PA; QL (1/28)
CARDIOVASCULAR, HYPERTENSION / LIPIDS
ANTIARRHYTHMIC AGENTS
amiodarone intravenous
solution
4 B/D PA
amiodarone oral tablet 100 mg,
400 mg
4
amiodarone oral tablet 200 mg 2
dofetilide 4
ecainide 4
LIDOCAINE (PF)
INTRAVENOUS SOLUTION
4
lidocaine (pf) intravenous
syringe
4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
mexiletine 4
pacerone oral tablet 100 mg,
400 mg
4
pacerone oral tablet 200 mg 2
propafenone 4
quinidine sulfate oral tablet 2
sorine oral tablet 120 mg,
160 mg
2
sotalol af 2
sotalol oral 2
SOTYLIZE 4
ANTIHYPERTENSIVE THERAPY
acebutolol 2
amiloride 2
amiloride-hydrochlorothiazide 2
amlodipine 1
amlodipine-benazepril 1
amlodipine-valsartan 1
amlodipine-valsartan-hcthiazid 3
atenolol 1
atenolol-chlorthalidone 2
benazepril 1
benazepril-hydrochlorothiazide 1
betaxolol oral 3
bisoprolol fumarate 2
bisoprolol-hydrochlorothiazide 1
bumetanide injection 4
bumetanide oral tablet 0.5 mg,
1 mg
2
bumetanide oral tablet 2 mg 3
candesartan oral tablet 16 mg,
4 mg, 8 mg
3 QL (60/30)
candesartan oral tablet 32 mg 3 QL (30/30)
candesartan-hydrochlorothiazid 3
captopril 4
cartia xt 3
carvedilol 1
chlorothiazide sodium 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
34
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
chlorthalidone oral tablet
25 mg, 50 mg
2
clonidine 4 QL (4/28)
clonidine hcl oral tablet 2
diltiazem hcl intravenous 4
diltiazem hcl oral capsule, ext.
rel 24h degradable
3
diltiazem hcl oral capsule,
extended release 12 hr
3
diltiazem hcl oral capsule,
extended release 24 hr
120 mg, 180 mg, 240 mg,
300 mg, 420 mg
3
diltiazem hcl oral capsule,
extended release 24hr 120 mg,
180 mg, 240 mg, 300 mg
3
diltiazem hcl oral tablet 2
diltiazem hcl oral tablet
extended release 24 hr
120 mg, 180 mg, 240 mg,
300 mg, 360 mg
3
DILTIAZEM HCL ORAL
TABLET EXTENDED
RELEASE 24 HR 420 MG
3
dilt-xr 3
doxazosin oral tablet 1 mg,
2 mg, 4 mg
2 QL (30/30)
doxazosin oral tablet 8 mg 2 QL (60/30)
EDARBI 4
EDARBYCLOR 4
enalapril maleate oral tablet 1
enalapril-hydrochlorothiazide 1
ethacrynate sodium 4
felodipine 2
fosinopril 1
fosinopril-hydrochlorothiazide 1
furosemide injection solution 4
furosemide oral solution 10 mg/
ml, 40 mg/5 ml (8 mg/ml)
2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
FUROSEMIDE ORAL
SOLUTION 40 MG/4 ML
2
furosemide oral tablet 1
hydralazine injection 4
hydralazine oral 1
hydrochlorothiazide 1
indapamide 2
irbesartan 1 QL (30/30)
irbesartan-hydrochlorothiazide 1 QL (30/30)
isosorbide-hydralazine 3 QL (180/30)
KERENDIA 3 PA; QL (30/30)
labetalol oral 1
lisinopril 1
lisinopril-hydrochlorothiazide 1
losartan 1 QL (60/30)
losartan-hydrochlorothiazide
oral tablet 100-12.5 mg,
100-25 mg
1 QL (30/30)
losartan-hydrochlorothiazide
oral tablet 50-12.5 mg
1 QL (60/30)
matzim la 3
metolazone 3
metoprolol succinate 2
metoprolol ta-hydrochlorothiaz 3
metoprolol tartrate oral tablet
100 mg, 25 mg, 50 mg
1
metyrosine 5 PA; NDS
minoxidil oral 2
moexipril 1
nicardipine intravenous
solution
4
nicardipine oral 4
nifedipine oral tablet extended
release
3
nifedipine oral tablet extended
release 24hr
3
nimodipine 4
olmesartan 1
olmesartan-hydrochlorothiazide 3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
35
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ORENITRAM 4 PA
ORENITRAM MONTH
1 TITRATION KT
4 PA
ORENITRAM MONTH
2 TITRATION KT
4 PA
ORENITRAM MONTH
3 TITRATION KT
4 PA
perindopril erbumine 1
pindolol 3
prazosin 4
propranolol oral capsule,
extended release 24 hr
4
propranolol oral solution 4
propranolol oral tablet 2
quinapril 1
quinapril-hydrochlorothiazide 2
ramipril 1
spironolactone oral tablet 2
spironolacton-hydrochlorothiaz 2
telmisartan 1
terazosin oral capsule 1 mg,
2 mg, 5 mg
1 QL (30/30)
terazosin oral capsule 10 mg 1 QL (60/30)
tiadylt er 3
timolol maleate oral 4
torsemide oral 2
trandolapril 1
triamterene-hydrochlorothiazid 1
valsartan oral tablet 160 mg,
40 mg, 80 mg
1 QL (60/30)
valsartan oral tablet 320 mg 1 QL (30/30)
valsartan-hydrochlorothiazide 1 QL (30/30)
verapamil intravenous solution 4
verapamil oral capsule, 24 hr
er pellet ct
3
verapamil oral capsule, ext rel.
pellets 24 hr 120 mg, 180 mg,
240 mg
3
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
VERAPAMIL ORAL CAPSULE,
EXT REL. PELLETS 24 HR
360 MG
4
verapamil oral tablet 2
verapamil oral tablet extended
release
2
COAGULATION THERAPY
aminocaproic acid oral 4
BRILINTA 4 QL (60/30)
cilostazol 2
clopidogrel oral tablet 300 mg 4
clopidogrel oral tablet 75 mg 1 QL (30/30)
dipyridamole oral 3
DOPTELET (10 TAB PACK) 5 PA; LA; NDS
DOPTELET (15 TAB PACK) 5 PA; LA; NDS
DOPTELET (30 TAB PACK) 5 PA; LA; NDS
ELIQUIS 3
ELIQUIS DVT-PE TREAT 30D
START
3
enoxaparin 4
fondaparinux 4
HEPARIN (PORCINE) IN 5%
DEX
4
heparin (porcine) in nacl (pf)
intravenous parenteral solution
4
heparin (porcine) injection
solution
3
HEPARIN(PORCINE) IN
0.45% NACL INTRAVENOUS
PARENTERAL SOLUTION
25,000 UNIT/250 ML,
25,000 UNIT/500 ML
4
heparin, porcine (pf) injection
syringe 5,000 unit/0.5 ml
4
jantoven 1
pentoxifylline 2
prasugrel 3
PROMACTA ORAL POWDER
IN PACKET 12.5 MG
5 PA; QL (360/30);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
36
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
PROMACTA ORAL POWDER
IN PACKET 25 MG
5 PA; QL (180/30);
NDS
PROMACTA ORAL TABLET
12.5 MG, 25 MG, 50 MG
5 PA; LA; QL (30/30);
NDS
PROMACTA ORAL TABLET
75 MG
5 PA; LA; QL (60/30);
NDS
warfarin 1
XARELTO 3
XARELTO DVT-PE TREAT
30D START
3
LIPID/CHOLESTEROL LOWERING AGENTS
atorvastatin 1 QL (30/30)
cholestyramine (with sugar) 3
cholestyramine light 3
cholestyramine-aspartame 3
colestipol oral granules 4
colestipol oral packet 4
colestipol oral tablet 3
ezetimibe 2 QL (30/30)
ezetimibe-simvastatin 1 QL (30/30)
fenobrate micronized oral
capsule 134 mg, 200 mg,
67 mg
2
fenobrate nanocrystallized 2
fenobrate oral tablet 160 mg,
54 mg
2
fenobric acid (choline) 2
uvastatin oral capsule 20 mg 1 QL (30/30)
uvastatin oral capsule 40 mg 1 QL (60/30)
uvastatin oral tablet extended
release 24 hr
1 QL (30/30)
gembrozil 2
icosapent ethyl 4
lovastatin oral tablet 10 mg 1 QL (30/30)
lovastatin oral tablet 20 mg,
40 mg
1 QL (60/30)
NEXLETOL 3 PA; QL (30/30)
NEXLIZET 3 PA; QL (30/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
niacin oral tablet extended
release 24 hr
4
pitavastatin calcium 1 QL (30/30)
pravastatin 1 QL (30/30)
prevalite 3
REPATHA PUSHTRONEX 3 PA; QL (7/28)
REPATHA SURECLICK 3 PA; QL (6/28)
REPATHA SYRINGE 3 PA; QL (6/28)
rosuvastatin 1 QL (30/30)
simvastatin 1 QL (30/30)
MISCELLANEOUS CARDIOVASCULAR AGENTS
CORLANOR ORAL TABLET 4 PA; QL (60/30)
digoxin injection solution 4
digoxin oral solution 4
digoxin oral tablet 125 mcg
(0.125 mg), 250 mcg (0.25 mg)
3
digoxin oral tablet 62.5 mcg
(0.0625 mg)
4
ENTRESTO 3 QL (60/30)
LANOXIN PEDIATRIC 4
ranolazine 4 QL (60/30)
VERQUVO 3 PA; QL (30/30)
VYNDAQEL 4 PA
NITRATES
isosorbide dinitrate oral tablet
10 mg, 20 mg, 30 mg, 5 mg
4
isosorbide mononitrate 2
nitroglycerin intravenous 4 B/D PA
nitroglycerin sublingual 3
nitroglycerin transdermal patch
24 hour
2
nitroglycerin translingual 4
DERMATOLOGICALS/TOPICAL THERAPY
ANTIPSORIATIC / ANTISEBORRHEIC
acitretin 4 PA
calcipotriene scalp 3 QL (120/30)
calcipotriene topical cream 4 QL (120/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
37
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
calcipotriene topical ointment 4 QL (120/30)
selenium sulde topical lotion 2
SKYRIZI SUBCUTANEOUS
PEN INJECTOR
5 PA; QL (2/28); NDS
SKYRIZI SUBCUTANEOUS
SYRINGE 150 MG/ML
5 PA; QL (2/28); NDS
STELARA SUBCUTANEOUS
SOLUTION
5 PA; QL (0.5/28);
NDS
STELARA SUBCUTANEOUS
SYRINGE 45 MG/0.5 ML
5 PA; QL (0.5/28);
NDS
STELARA SUBCUTANEOUS
SYRINGE 90 MG/ML
5 PA; QL (1/28); NDS
TALTZ AUTOINJECTOR 5 PA; QL (4/28); NDS
TALTZ SYRINGE 5 PA; QL (4/28); NDS
MISCELLANEOUS DERMATOLOGICALS
ammonium lactate 3
DUPIXENT PEN
SUBCUTANEOUS PEN
INJECTOR 200 MG/1.14 ML
5 PA; QL (4.56/28);
NDS
DUPIXENT PEN
SUBCUTANEOUS PEN
INJECTOR 300 MG/2 ML
5 PA; QL (8/28); NDS
DUPIXENT SYRINGE
SUBCUTANEOUS SYRINGE
100 MG/0.67 ML
5 PA; QL (1.34/28);
NDS
DUPIXENT SYRINGE
SUBCUTANEOUS SYRINGE
200 MG/1.14 ML
5 PA; QL (4.56/28);
NDS
DUPIXENT SYRINGE
SUBCUTANEOUS SYRINGE
300 MG/2 ML
5 PA; QL (8/28); NDS
uorouracil topical cream 5% 3
uorouracil topical solution 3
glydo 3 QL (60/30)
imiquimod topical cream in
packet 5%
4
lidocaine (pf) injection solution 4
lidocaine hcl injection solution 4
lidocaine hcl mucous
membrane solution 4%
(40 mg/ml)
3
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
lidocaine topical adhesive
patch,medicated 5%
4 PA; QL (90/30)
lidocaine viscous 2
lidocaine-prilocaine topical
cream
4 QL (30/30)
methoxsalen 4
PANRETIN 5 NDS
podolox topical solution 4
REGRANEX 5 PA; NDS
SANTYL 4
SILVER SULFADIAZINE 3
SSD 3
tacrolimus topical 4 PA; QL (100/30)
VALCHLOR 5 PA; NDS
ZTLIDO 4 PA; QL (90/30)
THERAPY FOR ACNE
adapalene topical gel 0.3% 4 QL (45/30)
claravis 4
clindamycin phosphate topical
gel
4 QL (120/30)
clindamycin phosphate topical
gel, once daily
4 QL (120/30)
clindamycin phosphate topical
lotion
3 QL (120/30)
clindamycin phosphate topical
solution
4 QL (120/30)
clindamycin phosphate topical
swab
4 QL (60/30)
ery pads 4
erythromycin with ethanol
topical gel
4
erythromycin with ethanol
topical solution
3
erythromycin-benzoyl peroxide 4
isotretinoin oral capsule 10 mg,
20 mg, 30 mg, 40 mg
4
metronidazole topical 4
tazarotene topical cream 3 PA
tazarotene topical gel 4 PA
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
38
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
tretinoin microspheres topical
gel 0.1%
4 PA
tretinoin microspheres topical
gel with pump 0.1%
4 PA
tretinoin topical cream 4 PA
tretinoin topical gel 0.01% 3 PA
tretinoin topical gel 0.025%,
0.05%
4 PA
TOPICAL ANESTHETICS
lidocaine hcl laryngotracheal 3
lidocaine hcl mucous
membrane jelly in applicator
3 QL (60/30)
lidocaine hcl mucous
membrane solution 2%
2
TOPICAL ANTIBACTERIALS
gentamicin topical cream 4 QL (60/30)
gentamicin topical ointment 3
mupirocin 2 QL (44/30)
mupirocin calcium 4 QL (30/30)
sulfacetamide sodium (acne) 4
TOPICAL ANTIFUNGALS
ciclodan topical solution 4
ciclopirox topical cream 4 QL (90/28)
ciclopirox topical shampoo 4 QL (120/28)
ciclopirox topical solution 4 QL (6.6/28)
ciclopirox topical suspension 4 QL (60/28)
clotrimazole topical cream 3 QL (45/28)
clotrimazole topical solution 3 QL (30/28)
clotrimazole-betamethasone
topical cream
4 QL (45/28)
econazole 4 QL (85/28)
ketoconazole topical cream 2 QL (60/28)
ketoconazole topical shampoo 2 QL (120/28)
klayesta 3 QL (180/30)
nyamyc 3 QL (180/30)
nystatin topical cream 2 QL (30/28)
nystatin topical ointment 2 QL (30/28)
nystatin topical powder 3 QL (180/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
nystatin-triamcinolone 4 QL (60/28)
nystop 3 QL (180/30)
TOPICAL CORTICOSTEROIDS
ala-cort topical cream 1% 2
alclometasone 3
betamethasone dipropionate 4
betamethasone valerate topical
cream
3
betamethasone valerate topical
lotion
4
betamethasone valerate topical
ointment
3
betamethasone, augmented
topical cream
2
betamethasone, augmented
topical gel
4
betamethasone, augmented
topical lotion
4
betamethasone, augmented
topical ointment
4
desoximetasone topical cream 4
desoximetasone topical gel 4
desoximetasone topical
ointment
4
uocinolone and shower cap 4
uocinolone topical cream
0.01%
3
uocinolone topical cream
0.025%
4
uocinolone topical oil 4
uocinolone topical ointment 4
uocinolone topical solution 4
uocinonide topical cream
0.05%
3 QL (120/30)
uocinonide topical gel 4 QL (120/30)
uocinonide topical ointment 4 QL (120/30)
uocinonide topical solution 4 QL (120/30)
uticasone propionate topical
cream
4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
39
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
uticasone propionate topical
ointment
3
halobetasol propionate topical
cream
4
halobetasol propionate topical
ointment
4
hydrocortisone topical cream
1%, 2.5%
2
hydrocortisone topical lotion
2.5%
2
hydrocortisone topical ointment
1%, 2.5%
2
mometasone topical 2
triamcinolone acetonide topical
cream
2
triamcinolone acetonide topical
lotion
3
triamcinolone acetonide topical
ointment 0.025%, 0.1%, 0.5%
2
triderm topical cream 0.1% 2
TOPICAL SCABICIDES / PEDICULICIDES
malathion 4
permethrin 3
DIAGNOSTICS / MISCELLANEOUS AGENTS
IRRIGATING SOLUTIONS
LACTATED RINGERS
IRRIGATION
4
neomycin-polymyxin b gu 4
RINGER'S IRRIGATION 4
TIS-U-SOL PENTALYTE 4
MISCELLANEOUS AGENTS
acamprosate 4
anagrelide 3
carglumic acid 5 PA; NDS
CHEMET 4 PA
CLINIMIX 4.25%/D5W SULFIT
FREE
4 B/D PA
CUVRIOR 5 PA; QL (300/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
D10%-0.45% SODIUM
CHLORIDE
4
d2.5%-0.45% sodium chloride 4
d5% and 0.9% sodium chloride 4
d5%-0.45% sodium chloride 4
deferasirox oral tablet 180 mg,
360 mg
5 PA; NDS
deferasirox oral tablet 90 mg 4 PA
DEXTROSE 10% AND 0.2%
NACL
4
dextrose 10% in water (d10w) 4
DEXTROSE 25% IN WATER
(D25W)
4
dextrose 5% in water (d5w)
intravenous parenteral solution
4
DEXTROSE 5% IN WATER
(D5W) INTRAVENOUS
PIGGYBACK
4
DEXTROSE 5%-LACTATED
RINGERS
4
dextrose 5%-0.2% sod chloride 4
dextrose 5%-0.3% sod.chloride 4
DEXTROSE 50% IN WATER
(D50W) INTRAVENOUS
PARENTERAL SOLUTION
4
dextrose 50% in water (d50w)
intravenous syringe
4
DEXTROSE 70% IN WATER
(D70W)
4
disulram 4
droxidopa oral capsule 100 mg 4 PA; QL (90/30)
droxidopa oral capsule 200 mg,
300 mg
4 PA; QL (180/30)
ENDARI 5 PA; QL (180/30);
NDS
GLASSIA 5 PA; LA; NDS
INCRELEX 4 PA; LA
kionex (with sorbitol) 3
levocarnitine (with sugar) 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
40
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
levocarnitine oral solution
100 mg/ml
4
LEVOCARNITINE ORAL
TABLET
4
midodrine 4
nitisinone 5 NDS
pilocarpine hcl oral 4
PROLASTIN-C
INTRAVENOUS SOLUTION
5 PA; LA; NDS
REZDIFFRA 5 PA; QL (30/30);
NDS
riluzole 3
SODIUM CHLORIDE 0.9%
INTRAVENOUS
4
SODIUM CHLORIDE
IRRIGATION
4
sodium phenylbutyrate 5 PA; NDS
sodium polystyrene sulfonate
oral powder
3
sps (with sorbitol) oral 3
trientine oral capsule 250 mg 5 PA; QL (240/30);
NDS
TZIELD 4 PA; LA; QL (14/720)
VELPHORO 3
VELTASSA 4
WATER FOR IRRIGATION,
STERILE
4
XIAFLEX 4 PA
zoledronic acid-mannitol-
water intravenous piggyback
5 mg/100 ml
4 B/D PA
SMOKING DETERRENTS
bupropion hcl (smoking deter) 3 QL (60/30)
NICOTROL 4
varenicline 4
EAR, NOSE / THROAT MEDICATIONS
MISCELLANEOUS AGENTS
azelastine nasal spray,
non-aerosol 137 mcg (0.1%)
3 QL (60/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
chlorhexidine gluconate
mucous membrane
2
uoride (sodium) dental 2
ipratropium bromide nasal
spray, non-aerosol 21 mcg
(0.03%)
2 QL (30/30)
ipratropium bromide nasal
spray, non-aerosol 42 mcg
(0.06%)
3 QL (30/30)
oralone 4
periogard 2
sodium uoride 5000 dry
mouth
2
sodium uoride 5000 plus 2
sodium uoride-pot nitrate 2
triamcinolone acetonide dental 4
MISCELLANEOUS OTIC PREPARATIONS
acetic acid otic (ear) 3
ac otic oil 4
uocinolone acetonide oil 4
hydrocortisone-acetic acid 4
ooxacin otic (ear) 4
OTIC STEROID / ANTIBIOTIC
ciprooxacin-dexamethasone 3
neomycin-polymyxin-hc otic
(ear)
4
ENDOCRINE/DIABETES
ADRENAL HORMONES
cortisone 4
DEPO-MEDROL 4
dexamethasone intensol 4
dexamethasone oral elixir 3
dexamethasone oral solution 3
dexamethasone oral tablet 2
dexamethasone sodium phos
(pf) injection solution 10 mg/ml
4
dexamethasone sodium
phosphate injection solution
4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
41
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
udrocortisone 2
hydrocortisone oral 3
methylpred dp 2
methylprednisolone 2
methylprednisolone acetate 4
methylprednisolone sodium
succ injection recon soln
125 mg, 40 mg
4
methylprednisolone sodium
succ intravenous
4
prednisolone oral solution 4
prednisolone sodium
phosphate oral solution
15 mg/5 ml (3 mg/ml),
15 mg/5 ml (5 ml), 25 mg/5 ml
(5 mg/ml), 5 mg base/5 ml
(6.7 mg/5 ml)
4
prednisone intensol 4
prednisone oral solution 4
prednisone oral tablet 2
prednisone oral tablets, dose
pack
2
SOLU-CORTEF ACT-O-VIAL
(PF)
4
triamcinolone acetonide
injection suspension 40 mg/ml
4
ANTITHYROID AGENTS
methimazole oral tablet 10 mg,
5 mg
2
propylthiouracil 3
DIABETES THERAPY
acarbose oral tablet 100 mg 3 QL (90/30)
acarbose oral tablet 25 mg 3 QL (360/30)
acarbose oral tablet 50 mg 3 QL (180/30)
BAQSIMI 3
diazoxide 4
DROPLET MICRON PEN
NEEDLE
3 QL (200/30)
DROPLET PEN NEEDLE
NEEDLE 30 GAUGE X 5/16"
3 QL (200/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
DROPSAFE ALCOHOL PREP
PADS
3
DROPSAFE PEN NEEDLE
NEEDLE 31 GAUGE X 3/16"
3 QL (200/30)
glimepiride oral tablet 1 mg 1 QL (240/30)
glimepiride oral tablet 2 mg 1 QL (120/30)
glimepiride oral tablet 4 mg 1 QL (60/30)
glipizide oral tablet 10 mg 1 QL (120/30)
GLIPIZIDE ORAL TABLET
2.5 MG
3 QL (30/30)
glipizide oral tablet 5 mg 1 QL (240/30)
glipizide oral tablet extended
release 24hr 10 mg
1 QL (60/30)
glipizide oral tablet extended
release 24hr 2.5 mg
1 QL (240/30)
glipizide oral tablet extended
release 24hr 5 mg
1 QL (120/30)
glipizide-metformin oral tablet
2.5-250 mg
1 QL (240/30)
glipizide-metformin oral tablet
2.5-500 mg, 5-500 mg
1 QL (120/30)
GLUCAGON (HCL)
EMERGENCY KIT
3
glucagon emergency kit
(human)
3
GLYXAMBI 3 QL (30/30)
GVOKE 3
GVOKE HYPOPEN 1-PACK 3
GVOKE HYPOPEN 2-PACK 3
GVOKE PFS 1-PACK
SYRINGE SUBCUTANEOUS
SYRINGE 1 MG/0.2 ML
3
GVOKE PFS 2-PACK
SYRINGE SUBCUTANEOUS
SYRINGE 1 MG/0.2 ML
3
HUMALOG JUNIOR KWIKPEN
U-100
3
HUMALOG KWIKPEN
INSULIN
3
HUMALOG MIX
50-50 INSULIN U-100
3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
42
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
HUMALOG MIX
50-50 KWIKPEN
3
HUMALOG MIX
75-25 KWIKPEN
3
HUMALOG MIX 75-25(U-100)
INSULIN
3
HUMALOG U-100 INSULIN 3
HUMULIN
70/30 U-100 INSULIN
3
HUMULIN
70/30 U-100 KWIKPEN
3
HUMULIN N NPH INSULIN
KWIKPEN
3
HUMULIN N NPH
U-100 INSULIN
3
HUMULIN R REGULAR
U-100 INSULIN
3
HUMULIN R U-500 (CONC)
INSULIN
5 NDS
HUMULIN R U-500 (CONC)
KWIKPEN
5 NDS
INSULIN LISPRO 3
INSULIN LISPRO PROTAMIN-
LISPRO
3
INVOKAMET 3 QL (60/30)
INVOKAMET XR 3 QL (60/30)
INVOKANA 3 QL (30/30)
JANUMET 3 QL (60/30)
JANUMET XR ORAL TABLET,
ER MULTIPHASE 24 HR
100-1,000 MG
3 QL (30/30)
JANUMET XR ORAL TABLET,
ER MULTIPHASE 24 HR
50-1,000 MG, 50-500 MG
3 QL (60/30)
JANUVIA 3 QL (30/30)
JARDIANCE 3 QL (30/30)
JENTADUETO 3 QL (60/30)
JENTADUETO XR ORAL
TABLET, IR - ER, BIPHASIC
24HR 2.5-1,000 MG
3 QL (60/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
JENTADUETO XR ORAL
TABLET, IR - ER, BIPHASIC
24HR 5-1,000 MG
3 QL (30/30)
LANTUS SOLOSTAR
U-100 INSULIN
3
LANTUS U-100 INSULIN 3
LYUMJEV KWIKPEN
U-100 INSULIN
3
LYUMJEV KWIKPEN
U-200 INSULIN
3
LYUMJEV U-100 INSULIN 3
metformin oral solution 4 QL (765/30)
metformin oral tablet 1,000 mg 1 QL (75/30)
metformin oral tablet 500 mg 1 QL (150/30)
metformin oral tablet 850 mg 1 QL (90/30)
metformin oral tablet extended
release 24 hr 500 mg
1 QL (120/30)
metformin oral tablet extended
release 24 hr 750 mg
1 QL (60/30)
MOUNJARO 3 PA; QL (2/28)
nateglinide oral tablet 120 mg 3 QL (90/30)
nateglinide oral tablet 60 mg 3 QL (180/30)
OMNIPOD 5 G6 INTRO KIT
(GEN 5)
3 QL (1/365)
OMNIPOD 5 G6 PODS (GEN
5)
3 QL (20/30)
OMNIPOD CLASSIC PODS
(GEN 3)
3 QL (20/30)
OMNIPOD DASH INTRO KIT
(GEN 4)
3 QL (1/365)
OMNIPOD DASH PODS (GEN
4)
3 QL (20/30)
OMNIPOD GO PODS 3 QL (10/30)
OMNIPOD GO PODS
10 UNITS/DAY
3 QL (10/30)
OMNIPOD GO PODS
15 UNITS/DAY
3 QL (10/30)
OMNIPOD GO PODS
20 UNITS/DAY
3 QL (10/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
43
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
OMNIPOD GO PODS
25 UNITS/DAY
3 QL (10/30)
OMNIPOD GO PODS
30 UNITS/DAY
3 QL (10/30)
OMNIPOD GO PODS
40 UNITS/DAY
3 QL (10/30)
OZEMPIC SUBCUTANEOUS
PEN INJECTOR 0.25 MG OR
0.5 MG (2 MG/3 ML), 1 MG/
DOSE (4 MG/3 ML), 2 MG/
DOSE (8 MG/3 ML)
3 PA; QL (3/28)
PENTIPS 3 QL (200/30)
pioglitazone 1 QL (30/30)
repaglinide oral tablet 0.5 mg 4 QL (960/30)
repaglinide oral tablet 1 mg 4 QL (480/30)
repaglinide oral tablet 2 mg 4 QL (240/30)
RYBELSUS 3 PA; QL (30/30)
SOLIQUA 100/33 3 QL (15/25)
SYNJARDY 3 QL (60/30)
SYNJARDY XR ORAL
TABLET, IR - ER, BIPHASIC
24HR 10-1,000 MG,
12.5-1,000 MG, 5-1,000 MG
3 QL (60/30)
SYNJARDY XR ORAL
TABLET, IR - ER, BIPHASIC
24HR 25-1,000 MG
3 QL (30/30)
TOUJEO MAX
U-300 SOLOSTAR
3
TOUJEO SOLOSTAR
U-300 INSULIN
3
TRADJENTA 3 QL (30/30)
TRESIBA FLEXTOUCH U-100 3
TRESIBA FLEXTOUCH U-200 3
TRESIBA U-100 INSULIN 3
TRIJARDY XR ORAL TABLET,
IR - ER, BIPHASIC 24HR 10-5-
1,000 MG, 25-5-1,000 MG
3 QL (30/30)
TRIJARDY XR ORAL
TABLET, IR - ER, BIPHASIC
24HR 12.5-2.5-1,000 MG,
5-2.5-1,000 MG
3 QL (60/30)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
TRUEPLUS INSULIN 3 QL (200/30)
TRUEPLUS PEN NEEDLE 3 QL (200/30)
TRULICITY 3 PA; QL (2/28)
UNIFINE PENTIPS MAXFLOW 3 QL (200/30)
UNIFINE PENTIPS NEEDLE
29 GAUGE X 1/2", 31 GAUGE
X 1/4", 31 GAUGE X
3/16", 31 GAUGE X 5/16",
32 GAUGE X 1/4", 32 GAUGE
X 5/32", 33 GAUGE X 5/32"
3 QL (200/30)
UNIFINE PENTIPS PLUS 3 QL (200/30)
UNIFINE PENTIPS PLUS
MAXFLOW
3 QL (200/30)
UNIFINE SAFECONTROL 3 QL (200/30)
UNIFINE ULTRA PEN
NEEDLE
3 QL (200/30)
V-GO 20 3
V-GO 30 3
V-GO 40 3
XULTOPHY 100/3.6 3 QL (15/30)
MISCELLANEOUS HORMONES
ALDURAZYME 5 PA; NDS
cabergoline 3
calcitonin (salmon) nasal 3
calcitriol intravenous solution
1 mcg/ml
4
calcitriol oral capsule 2
calcitriol oral solution 3
CEREZYME INTRAVENOUS
RECON SOLN 400 UNIT
5 PA; NDS
CHORIONIC
GONADOTROPIN, HUMAN
INTRAMUSCULAR
4 PA
cinacalcet oral tablet 30 mg,
60 mg
4 QL (60/30)
cinacalcet oral tablet 90 mg 4 QL (120/30)
danazol 4
desmopressin injection 4
desmopressin nasal spray with
pump
4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
44
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
desmopressin nasal spray,
non-aerosol 10 mcg/spray
(0.1 ml)
4
desmopressin oral 3
doxercalciferol 4
ELAPRASE 5 PA; NDS
FABRAZYME 5 NDS
KORLYM 5 PA; QL (120/30);
NDS
LUMIZYME 5 PA; NDS
mifepristone oral tablet 300 mg 5 PA; QL (120/30);
NDS
miglustat 5 LA; NDS
NAGLAZYME 5 PA; NDS
pamidronate 4
paricalcitol oral 4
RAYALDEE 5 NDS
sapropterin 5 PA; NDS
SOMAVERT 5 PA; QL (30/30);
NDS
SYNAREL 4
testosterone cypionate 3
testosterone enanthate 4
testosterone transdermal gel 4 PA; QL (300/30)
testosterone transdermal gel in
metered-dose pump 12.5 mg/
1.25 gram (1%)
4 PA; QL (300/30)
testosterone transdermal gel
in packet 1% (25 mg/2.5gram),
1% (50 mg/5 gram)
4 PA; QL (300/30)
TOLVAPTAN ORAL TABLET
15 MG
5 PA; QL (120/30);
NDS
tolvaptan oral tablet 30 mg 5 PA; QL (60/30);
NDS
zoledronic acid intravenous
solution
4 B/D PA
zoledronic acid-mannitol-
water intravenous piggyback
4 mg/100 ml
4 B/D PA
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ZOLEDRONIC AC-MANNITOL-
0.9NACL
4 B/D PA
THYROID HORMONES
euthyrox 2
levothyroxine oral tablet 2
LEVOXYL ORAL TABLET
100 MCG, 112 MCG,
125 MCG, 137 MCG,
150 MCG, 175 MCG,
200 MCG, 25 MCG, 50 MCG,
75 MCG, 88 MCG
3
liothyronine oral 3
SYNTHROID 4
UNITHROID 4
GASTROENTEROLOGY
ANTIDIARRHEALS / ANTISPASMODICS
dicyclomine oral capsule 2
dicyclomine oral solution 4
dicyclomine oral tablet 2
diphenoxylate-atropine 4
glycopyrrolate (pf) 4
glycopyrrolate (pf) in water
injection
4
glycopyrrolate (pf) in
water intravenous syringe
0.4 mg/2 ml (0.2 mg/ml)
4
glycopyrrolate oral tablet 1 mg,
2 mg
4
loperamide oral capsule 2
MISCELLANEOUS GASTROINTESTINAL AGENTS
alosetron 4 PA
aprepitant 4 B/D PA
balsalazide 4
betaine 5 NDS
budesonide oral 4
CLENPIQ 4
compro 4
constulose 2
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
45
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
CORTIFOAM 4
cromolyn oral 3
dronabinol 4 B/D PA; QL (60/30)
enulose 2
GATTEX 30-VIAL 5 PA; NDS
GATTEX ONE-VIAL 5 PA; NDS
gavilyte-c 2
gavilyte-n 2
generlac 2
granisetron hcl oral 3 B/D PA
hydrocortisone rectal 3
hydrocortisone topical cream
with perineal applicator
2
lactulose oral solution 2
LINZESS 3 QL (30/30)
meclizine oral tablet 12.5 mg,
25 mg
2
mesalamine oral capsule,
extended release 24hr
4
mesalamine rectal enema 4
mesalamine with cleansing
wipe
4
metoclopramide hcl oral
solution
2
metoclopramide hcl oral tablet 2
MOVANTIK 4 QL (30/30)
nitroglycerin rectal 4
OCALIVA 4 PA; LA; QL (30/30)
ondansetron hcl (pf) 4
ondansetron hcl intravenous 4
ondansetron hcl oral solution 4 B/D PA
ondansetron hcl oral tablet
4 mg, 8 mg
2 B/D PA
ondansetron oral tablet,
disintegrating 4 mg, 8 mg
2 B/D PA
palonosetron intravenous
solution 0.25 mg/5 ml
4
peg 3350-electrolytes 2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
peg-electrolyte soln 2
prochlorperazine 4
prochlorperazine edisylate
injection solution 10 mg/2 ml
(5 mg/ml)
4
prochlorperazine maleate 2
procto-med hc 2
proctosol hc topical 2
proctozone-hc 2
RECTIV 4
REMICADE 5 PA; QL (20/30);
NDS
SANCUSO 5 NDS
scopolamine base 4 QL (10/30)
SKYRIZI INTRAVENOUS 5 PA; QL (30/180);
NDS
SKYRIZI SUBCUTANEOUS
WEARABLE INJECTOR
180 MG/1.2 ML (150 MG/ML)
5 PA; QL (1.2/56);
NDS
SKYRIZI SUBCUTANEOUS
WEARABLE INJECTOR
360 MG/2.4 ML (150 MG/ML)
5 PA; QL (2.4/56);
NDS
sodium, potassium, mag
sulfates oral recon soln
17.5-3.13-1.6 gram
3
SODIUM, POTASSIUM, MAG
SULFATES ORAL RECON
SOLN 17.5-3.13-1.6 GRAM
2 PACK (480ML)
3
SUCRAID 4 PA
SUFLAVE 4
sulfasalazine oral tablet 2
SULFASALAZINE ORAL
TABLET, DELAYED RELEASE
(DR/EC)
2
SUTAB 4
TRULANCE 4
ursodiol oral capsule 300 mg 3
ursodiol oral tablet 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
46
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ZENPEP ORAL CAPSULE,
DELAYED RELEASE (DR/EC)
10,000-32,000 -42,000 UNIT,
15,000-47,000 -63,000 UNIT,
20,000-63,000- 84,000 UNIT,
25,000-79,000- 105,000 UNIT,
3,000-10,000 -14,000-UNIT,
40,000-126,000- 168,000 UNIT,
5,000-17,000- 24,000 UNIT,
60,000-189,600- 252,600 UNIT
3
ULCER THERAPY
famotidine oral suspension for
reconstitution
4
famotidine oral tablet 20 mg 4
famotidine oral tablet 40 mg 3
misoprostol 3
omeprazole oral capsule,
delayed release (dr/ec)
2 QL (60/30)
pantoprazole oral tablet,
delayed release (dr/ec)
2 QL (60/30)
sucralfate oral tablet 2
TALICIA 4 QL (168/180)
IMMUNOLOGY, VACCINES / BIOTECHNOLOGY
BIOTECHNOLOGY DRUGS
ACTIMMUNE 5 PA; NDS
ARCALYST 5 PA; NDS
AVONEX 5 PA; QL (1/28); NDS
BESREMI 5 PA; LA; QL (2/28);
NDS
BETASERON
SUBCUTANEOUS KIT
5 PA; QL (14/28);
NDS
GENOTROPIN 5 PA; NDS
GENOTROPIN MINIQUICK 5 PA; NDS
NIVESTYM 5 PA; NDS
PEGASYS SUBCUTANEOUS
SOLUTION
5 PA; QL (4/28); NDS
PEGASYS SUBCUTANEOUS
SYRINGE
5 PA; QL (2/28); NDS
PLERIXAFOR 5 B/D PA; NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
PROCRIT 4 PA
RETACRIT 4 PA
ZIEXTENZO 4 PA
VACCINES / MISCELLANEOUS IMMUNOLOGICALS
ABRYSVO (PF) 3 PA; V; QL (1/365)
ACTHIB (PF) 3
ADACEL(TDAP ADOLESN/
ADULT)(PF)
3 V
AREXVY (PF) 3 PA; V; QL (1/365)
ATGAM 4 B/D PA
BCG VACCINE, LIVE (PF) 4 V
BEXSERO 3 V
BOOSTRIX TDAP 3 V
BOTOX 4 PA
DAPTACEL (DTAP
PEDIATRIC) (PF)
3
DENGVAXIA (PF) 3
ENGERIX-B (PF) 3 B/D PA; V
ENGERIX-B PEDIATRIC (PF) 3 B/D PA; V
fomepizole 5 NDS
GARDASIL 9 (PF) 4 V
HAVRIX (PF)
INTRAMUSCULAR SYRINGE
1,440 ELISA UNIT/ML
3 V
HAVRIX (PF)
INTRAMUSCULAR SYRINGE
720 ELISA UNIT/0.5 ML
3
HEPLISAV-B (PF) 3 B/D PA; V
HIBERIX (PF) 3
HIZENTRA SUBCUTANEOUS
SOLUTION
4 B/D PA
IMOVAX RABIES VACCINE
(PF)
4 V
INFANRIX (DTAP) (PF) 3
IPOL 3 V
IXCHIQ (PF) 3 V
IXIARO (PF) 4 V
JYNNEOS (PF) 3 V
KINRIX (PF) 3
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
47
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
MENACTRA (PF)
INTRAMUSCULAR SOLUTION
3 V
MENQUADFI (PF) 3 V
MENVEO A-C-Y-W-135-DIP
(PF)
3 V
M-M-R II (PF) 3 V
MRESVIA (PF) 3 PA; V; QL (1/365)
PANZYGA 5 B/D PA; NDS
PEDIARIX (PF) 3
PEDVAX HIB (PF) 3
PENBRAYA (PF) 3 V
PENTACEL (PF)
INTRAMUSCULAR KIT
15LF-48MCG-62DU
-10 MCG/0.5ML
3
PREHEVBRIO (PF) 3 B/D PA; V
PRIORIX (PF) 3 V
PROQUAD (PF) 3
QUADRACEL (PF) 3
RABAVERT (PF) 3 V
RECOMBIVAX HB (PF) 3 B/D PA; V
ROTARIX 3
ROTATEQ VACCINE 3
SHINGRIX (PF) 3 V; QL (2/999)
STAMARIL (PF) 4 V
TDVAX 3 V
TENIVAC (PF) 3 V
TETANUS, DIPHTHERIA TOX
PED (PF)
3
TICE BCG 4 B/D PA
TICOVAC INTRAMUSCULAR
SYRINGE 1.2 MCG/0.25 ML
3
TICOVAC INTRAMUSCULAR
SYRINGE 2.4 MCG/0.5 ML
3 V
TRUMENBA 3 V
TWINRIX (PF) 3 V
TYPHIM VI 3 V
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
VAQTA (PF)
INTRAMUSCULAR
SUSPENSION 25 UNIT/0.5 ML
3
VAQTA (PF)
INTRAMUSCULAR
SUSPENSION 50 UNIT/ML
3 V
VAQTA (PF)
INTRAMUSCULAR SYRINGE
25 UNIT/0.5 ML
3
VAQTA (PF)
INTRAMUSCULAR SYRINGE
50 UNIT/ML
3 V
VARIVAX (PF) 3 V
VARIZIG 4
YF-VAX (PF) 3 V
MISCELLANEOUS SUPPLIES
MISCELLANEOUS SUPPLIES
ALCOHOL PADS 3
ASSURE ID INSULIN SAFETY
SYRINGE 1 ML 29 GAUGE X
1/2"
3 QL (200/30)
BD SAFETYGLIDE INSULIN
SYRINGE SYRINGE 1 ML
31 GAUGE X 15/64"
3 QL (200/30)
BD ULTRA-FINE MICRO PEN
NEEDLE
3 QL (200/30)
BD ULTRA-FINE MINI PEN
NEEDLE
3 QL (200/30)
BD ULTRA-FINE NANO PEN
NEEDLE
3 QL (200/30)
BD ULTRA-FINE SHORT PEN
NEEDLE
3 QL (200/30)
GAUZE PAD TOPICAL
BANDAGE 2 X 2 "
3
INSULIN SYRINGE-NEEDLE
U-100 SYRINGE 0.3 ML
29 GAUGE, 1 ML 29 GAUGE
X 1/2", 1/2 ML 28 GAUGE
3 QL (200/30)
PEN NEEDLE, DIABETIC
NEEDLE 29 GAUGE X 1/2"
3 QL (200/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
48
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
TECHLITE INSULIN SYRINGE
SYRINGE 1 ML 30 GAUGE
X 1/2", 1 ML 31 GAUGE X
15/64", 1 ML 31 GAUGE X
5/16
3 QL (200/30)
TECHLITE INSULIN
SYR(HALF UNIT) SYRINGE
0.3 ML 31 GAUGE X 15/64",
0.3 ML 31 GAUGE X 5/16",
0.5 ML 30 GAUGE X 1/2",
0.5 ML 31 GAUGE X 15/64",
0.5 ML 31 GAUGE X 5/16"
3 QL (200/30)
TECHLITE PEN NEEDLE
NEEDLE 29 GAUGE X
1/2", 31 GAUGE X 3/16",
31 GAUGE X 5/16",
32 GAUGE X 1/4", 32 GAUGE
X 5/32"
3 QL (200/30)
MUSCULOSKELETAL / RHEUMATOLOGY
GOUT THERAPY
allopurinol oral tablet 100 mg,
300 mg
2
colchicine oral tablet 3 QL (120/30)
febuxostat 4 ST
MITIGARE 3 QL (120/30)
probenecid 3
probenecid-colchicine 3
OSTEOPOROSIS THERAPY
alendronate oral tablet 10 mg 1 QL (30/30)
alendronate oral tablet 35 mg,
70 mg
2 QL (4/28)
FORTEO 5 PA; QL (2.4/28);
NDS
ibandronate oral 3 QL (1/28)
PROLIA 4 QL (1/180)
raloxifene 3 QL (30/30)
TYMLOS 5 PA; QL (1.56/30);
NDS
OTHER RHEUMATOLOGICALS
ADALIMUMAB-ADAZ 5 PA; QL (1.6/28);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ADALIMUMAB-ADBM
SUBCUTANEOUS PEN
INJECTOR KIT (PREFERRED
NDCS STARTING WITH
00597)
5 PA; QL (4/28); NDS
ADALIMUMAB-ADBM
SUBCUTANEOUS SYRINGE
KIT 10 MG/0.2 ML,
20 MG/0.4 ML (PREFERRED
NDCS STARTING WITH
00597)
5 PA; QL (2/28); NDS
ADALIMUMAB-ADBM
SUBCUTANEOUS SYRINGE
KIT 40 MG/0.4 ML,
40 MG/0.8 ML (PREFERRED
NDCS STARTING WITH
00597)
5 PA; QL (4/28); NDS
ADALIMUMAB-ADBM(CF)
PEN CROHNS (PREFERRED
NDCS STARTING WITH
00597)
5 PA; QL (12/365);
NDS
ADALIMUMAB-ADBM(CF)
PEN PS-UV (PREFERRED
NDCS STARTING WITH
00597)
5 PA; QL (8/365);
NDS
BENLYSTA INTRAVENOUS 5 PA; NDS
CYLTEZO(CF) PEN 5 PA; QL (4/28); NDS
CYLTEZO(CF) PEN
CROHN'S-UC-HS
5 PA; QL (12/365);
NDS
CYLTEZO(CF) PEN
PSORIASIS-UV
5 PA; QL (8/365);
NDS
CYLTEZO(CF)
SUBCUTANEOUS SYRINGE
KIT 10 MG/0.2 ML,
20 MG/0.4 ML
5 PA; QL (2/28); NDS
CYLTEZO(CF)
SUBCUTANEOUS SYRINGE
KIT 40 MG/0.4 ML,
40 MG/0.8 ML
5 PA; QL (4/28); NDS
ENBREL MINI 5 PA; QL (8/28); NDS
ENBREL SUBCUTANEOUS
SOLUTION
5 PA; QL (8/28); NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
49
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
ENBREL SUBCUTANEOUS
SYRINGE
5 PA; QL (8/28); NDS
ENBREL SURECLICK 5 PA; QL (8/28); NDS
HUMIRA PEN (PREFERRED
NDCS STARTING WITH
00074)
5 PA; QL (4/28); NDS
HUMIRA SUBCUTANEOUS
SYRINGE KIT 40 MG/0.8 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (4/28); NDS
HUMIRA(CF) PEDI CROHNS
STARTER SUBCUTANEOUS
SYRINGE KIT 80 MG/0.8 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (6/365);
NDS
HUMIRA(CF) PEDI CROHNS
STARTER SUBCUTANEOUS
SYRINGE KIT
80 MG/0.8 ML-40 MG/0.4 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (4/365);
NDS
HUMIRA(CF) PEN CROHNS-
UC-HS (PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (6/365);
NDS
HUMIRA(CF) PEN PEDIATRIC
UC (PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (4/180);
NDS
HUMIRA(CF) PEN PSOR-
UV-ADOL HS (PREFERRED
NDCS STARTING WITH
00074)
5 PA; QL (6/365);
NDS
HUMIRA(CF) PEN
SUBCUTANEOUS PEN
INJECTOR KIT 40 MG/0.4 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (4/28); NDS
HUMIRA(CF) PEN
SUBCUTANEOUS PEN
INJECTOR KIT 80 MG/0.8 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (2/28); NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
HUMIRA(CF)
SUBCUTANEOUS SYRINGE
KIT 10 MG/0.1 ML,
20 MG/0.2 ML (PREFERRED
NDCS STARTING WITH
00074)
5 PA; QL (2/28); NDS
HUMIRA(CF)
SUBCUTANEOUS
SYRINGE KIT 40 MG/0.4 ML
(PREFERRED NDCS
STARTING WITH 00074)
5 PA; QL (4/28); NDS
HYRIMOZ PEN CROHN'S-UC
STARTER (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (4.8/365);
NDS
HYRIMOZ PEN PSORIASIS
STARTER (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (3.2/365);
NDS
HYRIMOZ(CF) PEDI CROHN
STARTER SUBCUTANEOUS
SYRINGE 80 MG/0.8 ML
(PREFERRED NDCS
STARTING WITH 61314)
5 PA; QL (3.2/365);
NDS
HYRIMOZ(CF) PEDI CROHN
STARTER SUBCUTANEOUS
SYRINGE 80 MG/0.8 ML-
40 MG/0.4 ML (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (2.4/365);
NDS
HYRIMOZ(CF) PEN
(PREFERRED NDCS
STARTING WITH 61314)
5 PA; QL (1.6/28);
NDS
HYRIMOZ(CF)
SUBCUTANEOUS SYRINGE
10 MG/0.1 ML (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (0.2/28);
NDS
HYRIMOZ(CF)
SUBCUTANEOUS SYRINGE
20 MG/0.2 ML (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (0.4/28);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
50
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
HYRIMOZ(CF)
SUBCUTANEOUS SYRINGE
40 MG/0.4 ML (PREFERRED
NDCS STARTING WITH
61314)
5 PA; QL (1.6/28);
NDS
leunomide 3 QL (30/30)
ORENCIA CLICKJECT 5 PA; QL (4/28); NDS
ORENCIA SUBCUTANEOUS
SYRINGE 125 MG/ML
5 PA; QL (4/28); NDS
ORENCIA SUBCUTANEOUS
SYRINGE 50 MG/0.4 ML
5 PA; QL (1.6/28);
NDS
ORENCIA SUBCUTANEOUS
SYRINGE 87.5 MG/0.7 ML
5 PA; QL (2.8/28);
NDS
OTEZLA 5 PA; QL (60/30);
NDS
OTEZLA STARTER ORAL
TABLETS, DOSE PACK 10 MG
(4)-20 MG (4)-30 MG (47)
5 PA; QL (110/365);
NDS
penicillamine 5 NDS
RINVOQ LQ 5 PA; QL (360/30);
NDS
RINVOQ ORAL TABLET
EXTENDED RELEASE 24 HR
15 MG, 30 MG
5 PA; QL (30/30);
NDS
RINVOQ ORAL TABLET
EXTENDED RELEASE 24 HR
45 MG
5 PA; QL (84/180);
NDS
OBSTETRICS / GYNECOLOGY
ESTROGENS / PROGESTINS
camila 4
deblitane 4
DEPO-SUBQ PROVERA 104 4
dotti 3 QL (8/28)
DUAVEE 4 PA
emzahh 4
errin 4
estradiol oral 2
estradiol transdermal patch
semiweekly
3 QL (8/28)
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
estradiol transdermal patch
weekly
3 QL (4/28)
estradiol vaginal 4
estradiol valerate 4
heather 4
incassia 4
jencycla 4
lyza 4
medroxyprogesterone
intramuscular
4
medroxyprogesterone oral 2
NORA-BE 4
norethindrone (contraceptive) 4
norethindrone acetate 4
PREMARIN INJECTION 4
PREMARIN ORAL 3
PREMARIN VAGINAL 3
PREMPRO 3
progesterone micronized 3
sharobel 4
yuvafem 4
MISCELLANEOUS OB/GYN
clindamycin phosphate vaginal 3
etonogestrel-ethinyl estradiol 4
metronidazole vaginal gel
0.75% (37.5mg/5 gram)
4
terconazole 4
tranexamic acid oral 3
VANDAZOLE 4
ORAL CONTRACEPTIVES / RELATED AGENTS
armelle 4
altavera (28) 4
alyacen 1/35 (28) 4
alyacen 7/7/7 (28) 4
amethia 4
amethyst (28) 4
apri 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
51
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
aranelle (28) 4
ashlyna 4
aubra eq 4
aurovela 1.5/30 (21) 4
aurovela 1/20 (21) 4
aurovela 24 fe 4
aurovela fe 1.5/30 (28) 4
aurovela fe 1-20 (28) 4
aviane 4
ayuna 4
azurette (28) 4
balziva (28) 4
blisovi 24 fe 4
blisovi fe 1.5/30 (28) 4
blisovi fe 1/20 (28) 4
briellyn 4
CAMRESE 4
CAMRESE LO 4
charlotte 24 fe 4
chateal eq (28) 4
cryselle (28) 4
cyred eq 4
dasetta 1/35 (28) 4
dasetta 7/7/7 (28) 4
daysee 4
desog-e. estradiol/e. estradiol 4
desogestrel-ethinyl estradiol 4
dolishale 4
drospirenone-e. estradiol-lm.
fa oral tablet 3-0.02-0.451 mg
(24) (4)
4
DROSPIRENONE-E.
ESTRADIOL-LM.FA ORAL
TABLET 3-0.03-0.451 MG (21)
(7)
4
drospirenone-ethinyl estradiol 4
elinest 4
enpresse 4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
enskyce 4
estarylla 4
ethynodiol diac-eth estradiol 4
falmina (28) 4
nzala 4
gemmily 4
hailey 4
hailey 24 fe 4
hailey fe 1.5/30 (28) 4
hailey fe 1/20 (28) 4
iclevia 4
isibloom 4
jaimiess 4
jasmiel (28) 4
JOLESSA 4
joyeaux 4
juleber 4
junel 1.5/30 (21) 4
junel 1/20 (21) 4
junel fe 1.5/30 (28) 4
junel fe 1/20 (28) 4
junel fe 24 4
kaitlib fe 4
kalliga 4
kariva (28) 4
kelnor 1/35 (28) 4
kelnor 1-50 (28) 4
kurvelo (28) 4
l norgest/e. estradiol-e. estrad 4
larin 1.5/30 (21) 4
larin 1/20 (21) 4
larin 24 fe 4
larin fe 1.5/30 (28) 4
larin fe 1/20 (28) 4
LAYOLIS FE 4
leena 28 4
lessina 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
52
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
levonest (28) 4
levonorgest-eth.estradiol-iron 4
levonorgestrel-ethinyl estrad 4
levonorg-eth estrad triphasic 4
levora-28 4
lojaimiess 4
loryna (28) 4
low-ogestrel (28) 4
lo-zumandimine (28) 4
lutera (28) 4
marlissa (28) 4
merzee 4
microgestin 1.5/30 (21) 4
microgestin 1/20 (21) 4
microgestin fe 1.5/30 (28) 4
microgestin fe 1/20 (28) 4
mili 4
mono-linyah 4
necon 0.5/35 (28) 4
nikki (28) 4
noreth-ethinyl estradiol-iron 4
norethindrone ac-eth estradiol
oral tablet 1-20 mg-mcg,
1.5-30 mg-mcg
4
norethindrone-e. estradiol-iron 4
norgestimate-ethinyl estradiol 4
nortrel 0.5/35 (28) 4
nortrel 1/35 (21) 4
nortrel 1/35 (28) 4
nortrel 7/7/7 (28) 4
nylia 1/35 (28) 4
nylia 7/7/7 (28) 4
nymyo 4
ocella 4
philith 4
pimtrea (28) 4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
portia 28 4
reclipsen (28) 4
RIVELSA 4
setlakin 4
simliya (28) 4
simpesse 4
sprintec (28) 4
sronyx 4
syeda 4
tarina 24 fe 4
tarina fe 1-20 eq (28) 4
tilia fe 4
tri-estarylla 4
tri-legest fe 4
tri-linyah 4
tri-lo-estarylla 4
tri-lo-marzia 4
tri-lo-mili 4
tri-lo-sprintec 4
tri-mili 4
tri-nymyo 4
tri-sprintec (28) 4
trivora (28) 4
tri-vylibra 4
tri-vylibra lo 4
turqoz (28) 4
TYBLUME 4
tydemy 4
velivet triphasic regimen (28) 4
vestura (28) 4
vienva 4
viorele (28) 4
volnea (28) 4
vyfemla (28) 4
vylibra 4
wera (28) 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
53
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
wymzya fe 4
zovia 1-35 (28) 4
zumandimine (28) 4
OPHTHALMOLOGY
ANTIBIOTICS
bacitracin ophthalmic (eye) 4
bacitracin-polymyxin b 2
BESIVANCE 4
ciprooxacin hcl ophthalmic
(eye)
2
erythromycin ophthalmic (eye) 2
gentamicin ophthalmic (eye)
drops
3
moxioxacin ophthalmic (eye) 3
NATACYN 4
neomycin-bacitracin-polymyxin 4
neomycin-polymyxin-gramicidin 3
ooxacin ophthalmic (eye) 2
polycin 2
polymyxin b sulf-trimethoprim 2
tobramycin ophthalmic (eye) 2
ANTIVIRALS
triuridine 3
zirgan 4
BETA-BLOCKERS
carteolol 2
levobunolol ophthalmic (eye)
drops 0.5%
2
timolol maleate ophthalmic
(eye) drops
2
timolol maleate ophthalmic
(eye) gel forming solution
4
MISCELLANEOUS OPHTHALMOLOGICS
atropine ophthalmic (eye)
drops 1%
3
azelastine ophthalmic (eye) 4
cromolyn ophthalmic (eye) 2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
cyclosporine ophthalmic (eye) 4
CYSTARAN 5 PA; NDS
EYLEA 4 PA; QL (0.1/28)
MIEBO (PF) 3 QL (3/30)
OXERVATE 4 PA; QL (112/56)
pilocarpine hcl ophthalmic
(eye) drops 1%, 2%, 4%
3
sulfacetamide sodium
ophthalmic (eye) drops
3
sulfacetamide-prednisolone 2
XDEMVY 4 PA; QL (10/42)
XIIDRA 3 QL (60/30)
NON-STEROIDAL ANTI-INFLAMMATORY AGENTS
diclofenac sodium ophthalmic
(eye)
2
urbiprofen sodium 3
KETOROLAC OPHTHALMIC
(EYE) DROPS 0.4%
3
ketorolac ophthalmic (eye)
drops 0.5%
2
ORAL DRUGS FOR GLAUCOMA
acetazolamide oral capsule,
extended release
4
acetazolamide oral tablet 3
acetazolamide sodium 4
methazolamide 4
OTHER GLAUCOMA DRUGS
brimonidine-timolol 4
dorzolamide 2
dorzolamide-timolol 2
latanoprost 1
LUMIGAN OPHTHALMIC
(EYE) DROPS 0.01%
3
RHOPRESSA 4 ST
ROCKLATAN 4 ST
SIMBRINZA 4
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
54
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
STEROID-ANTIBIOTIC COMBINATIONS
neomycin-bacitracin-poly-hc 3
neomycin-polymyxin
b-dexameth
2
neomycin-polymyxin-hc
ophthalmic (eye)
4
TOBRADEX ST 3
tobramycin-dexamethasone 3
STEROIDS
dexamethasone sodium
phosphate ophthalmic (eye)
3
diuprednate 3
EYSUVIS 4 QL (16.6/30)
FLUOROMETHOLONE 3
LOTEMAX OPHTHALMIC
(EYE) OINTMENT
4
LOTEMAX SM 4
loteprednol etabonate 4
PREDNISOLONE ACETATE 3
prednisolone sodium
phosphate ophthalmic (eye)
4
SYMPATHOMIMETICS
ALPHAGAN P OPHTHALMIC
(EYE) DROPS 0.1%
3
apraclonidine 4
brimonidine ophthalmic (eye)
drops 0.1%
3
brimonidine ophthalmic (eye)
drops 0.15%
4
brimonidine ophthalmic (eye)
drops 0.2%
2
RESPIRATORY AND ALLERGY
ANTIHISTAMINE / ANTIALLERGENIC AGENTS
desloratadine oral tablet 3 QL (30/30)
diphenhydramine hcl injection
solution 50 mg/ml
4
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
EPINEPHRINE INJECTION
AUTO-INJECTOR
0.15 MG/0.15 ML,
0.3 MG/0.3 ML
3 QL (2/30)
epinephrine injection auto-
injector 0.15 mg/0.3 ml,
0.3 mg/0.3 ml
3 QL (2/30)
epinephrine injection solution
1 mg/ml
4
hydroxyzine hcl oral tablet 4 PA
hydroxyzine pamoate 3 PA
levocetirizine oral tablet 2 QL (30/30)
promethazine oral syrup 4 PA
promethazine oral tablet 2 PA
PULMONARY AGENTS
acetylcysteine 4 B/D PA
ADEMPAS 5 PA; LA; QL (90/30);
NDS
ADVAIR HFA 3 QL (12/30)
albuterol sulfate inhalation
hfa aerosol inhaler 90 mcg/
actuation
3 QL (17/30)
albuterol sulfate inhalation
hfa aerosol inhaler 90 mcg/
actuation (nda020503)
3 QL (13.4/30)
albuterol sulfate inhalation
hfa aerosol inhaler 90 mcg/
actuation (nda020983)
3 QL (36/30)
albuterol sulfate inhalation
solution for nebulization
2 B/D PA
albuterol sulfate oral syrup 2
albuterol sulfate oral tablet 4
ambrisentan 5 PA; LA; QL (30/30);
NDS
ANORO ELLIPTA 3 QL (60/30)
arformoterol 4 B/D PA
ARNUITY ELLIPTA 3 QL (30/30)
ATROVENT HFA 4 QL (25.8/30)
BREO ELLIPTA 3 QL (60/30)
breyna 4 QL (10.3/30)
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
55
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
budesonide inhalation 4 B/D PA; QL
(120/30)
CINRYZE 5 PA; NDS
COMBIVENT RESPIMAT 4 QL (8/30)
cromolyn inhalation 4 B/D PA
unisolide 3 QL (50/30)
uticasone propionate nasal 2 QL (16/30)
icatibant 5 PA; QL (18/30);
NDS
INCRUSE ELLIPTA 3 QL (30/30)
ipratropium bromide inhalation 2 B/D PA
ipratropium-albuterol 2 B/D PA
KALYDECO 5 PA; QL (56/28);
NDS
montelukast oral granules in
packet
4 QL (30/30)
montelukast oral tablet 2 QL (30/30)
montelukast oral tablet,
chewable
2 QL (30/30)
NUCALA SUBCUTANEOUS
AUTO-INJECTOR
5 PA; LA; QL (3/28);
NDS
NUCALA SUBCUTANEOUS
SYRINGE 100 MG/ML
5 PA; LA; QL (3/28);
NDS
NUCALA SUBCUTANEOUS
SYRINGE 40 MG/0.4 ML
5 PA; LA; QL (0.4/28);
NDS
OFEV 5 PA; QL (60/30);
NDS
OPSUMIT 5 PA; NDS
ORKAMBI ORAL GRANULES
IN PACKET
5 PA; QL (56/28);
NDS
ORKAMBI ORAL TABLET 5 PA; QL (112/28);
NDS
pirfenidone oral capsule 5 PA; QL (270/30);
NDS
pirfenidone oral tablet 267 mg 5 PA; QL (270/30);
NDS
pirfenidone oral tablet 534 mg,
801 mg
5 PA; QL (90/30);
NDS
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
PULMOZYME 5 B/D PA; QL
(150/30); NDS
roumilast 4 PA; QL (30/30)
RYALTRIS 4 ST
sajazir 5 PA; QL (18/30);
NDS
SEREVENT DISKUS 3 QL (60/30)
sildenal (pulm. hypertension)
oral tablet
3 PA; QL (90/30)
terbutaline 4
theophylline oral tablet
extended release 12 hr
100 mg, 200 mg, 300 mg
4
theophylline oral tablet
extended release 12 hr 450 mg
2
theophylline oral tablet
extended release 24 hr 400 mg
2
theophylline oral tablet
extended release 24 hr 600 mg
3
TRELEGY ELLIPTA 3 QL (60/30)
TRIKAFTA ORAL GRANULES
IN PACKET, SEQUENTIAL
5 PA; QL (56/28);
NDS
TRIKAFTA ORAL TABLETS,
SEQUENTIAL
5 PA; QL (84/28);
NDS
TYVASO 4 B/D PA
TYVASO INSTITUTIONAL
START KIT
4 B/D PA
TYVASO REFILL KIT 4 B/D PA
TYVASO STARTER KIT 4 B/D PA
VENTAVIS 4 PA
VENTOLIN HFA 3 QL (36/30)
XOLAIR SUBCUTANEOUS
AUTO-INJECTOR 150 MG/ML,
300 MG/2 ML
5 PA; LA; QL (8/28);
NDS
XOLAIR SUBCUTANEOUS
AUTO-INJECTOR
75 MG/0.5 ML
5 PA; LA; QL (1/28);
NDS
XOLAIR SUBCUTANEOUS
RECON SOLN
5 PA; LA; QL (8/28);
NDS
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
56
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
XOLAIR SUBCUTANEOUS
SYRINGE 150 MG/ML,
300 MG/2 ML
5 PA; LA; QL (8/28);
NDS
XOLAIR SUBCUTANEOUS
SYRINGE 75 MG/0.5 ML
5 PA; LA; QL (1/28);
NDS
zarlukast 4 QL (60/30)
UROLOGICALS
ANTICHOLINERGICS / ANTISPASMODICS
GEMTESA 4 QL (30/30)
MYRBETRIQ ORAL TABLET
EXTENDED RELEASE 24 HR
3
oxybutynin chloride oral syrup 2
oxybutynin chloride oral tablet
5 mg
2
oxybutynin chloride oral tablet
extended release 24hr
4 QL (60/30)
tolterodine oral capsule,
extended release 24hr
4 ST
tolterodine oral tablet 4
BENIGN PROSTATIC HYPERPLASIA(BPH) THERAPY
alfuzosin 2
dutasteride 2
nasteride oral tablet 5 mg 2 QL (30/30)
tamsulosin 2 QL (60/30)
MISCELLANEOUS UROLOGICALS
bethanechol chloride 3
CYSTAGON 4 LA
ELMIRON 4
k-phos original 4
potassium citrate oral tablet
extended release
4
RENACIDIN 4
VITAMINS, HEMATINICS / ELECTROLYTES
ELECTROLYTES
calcium acetate (phosphat
bind)
3 QL (360/30)
klor-con 2
KLOR-CON 10 2
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
KLOR-CON 8 2
klor-con m10 2
klor-con m20 2
lactated ringers intravenous 4
magnesium sulfate in d5w
intravenous piggyback
1 gram/100 ml
4
magnesium sulfate in water 4
magnesium sulfate injection 4
POTASSIUM
CHLORID-D5-0.45% NACL
4
POTASSIUM CHLORIDE IN
0.9% NACL INTRAVENOUS
PARENTERAL SOLUTION
20 MEQ/L, 40 MEQ/L
4
potassium chloride in 5% dex
intravenous parenteral solution
10 meq/l
4
POTASSIUM CHLORIDE
IN 5% DEX INTRAVENOUS
PARENTERAL SOLUTION
20 MEQ/L
4
POTASSIUM CHLORIDE
IN LR-D5 INTRAVENOUS
PARENTERAL SOLUTION
20 MEQ/L
4
potassium chloride in water
intravenous piggyback
10 meq/100 ml, 10 meq/50 ml,
20 meq/100 ml, 20 meq/50 ml,
40 meq/100 ml
4
potassium chloride intravenous 4
potassium chloride oral
capsule, extended release
3
potassium chloride oral liquid 4
potassium chloride oral packet 2
potassium chloride oral tablet
extended release
2
Covered Drugs By Category
CAPITALIZED = BRAND NAME DRUG Lower case italic = Generic drug
You can nd information on what the symbols and abbreviations on this table mean by going to page 9.
57
September 2024
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
potassium chloride oral tablet,
er particles/crystals
2
potassium chloride-0.45% nacl 4
POTASSIUM
CHLORIDE-D5-0.2% NACL
INTRAVENOUS PARENTERAL
SOLUTION 20 MEQ/L
4
POTASSIUM
CHLORIDE-D5-0.9% NACL
4
RINGER'S INTRAVENOUS 4
sodium bicarbonate
intravenous syringe
4
sodium chloride 0.45%
intravenous
4
sodium chloride 3% hypertonic 4
SODIUM CHLORIDE 5%
HYPERTONIC
4
sodium chloride intravenous 4
MISCELLANEOUS NUTRITION PRODUCTS
CLINIMIX 5%/D15W
SULFITE FREE
4 B/D PA
CLINIMIX 4.25%/D10W
SULF FREE
4 B/D PA
CLINIMIX 5%-D20W
(SULFITE-FREE)
4 B/D PA
CLINIMIX 6%-D5W
(SULFITE-FREE)
4 B/D PA
CLINIMIX 8%-D10W
(SULFITE-FREE)
4 B/D PA
CLINIMIX 8%-D14W
(SULFITE-FREE)
4 B/D PA
CLINIMIX E 4.25%/D10W
SUL FREE
4 B/D PA
clinisol sf 15% 4 B/D PA
ELECTROLYTE-48 IN D5W 4
INTRALIPID INTRAVENOUS
EMULSION 20%, 30%
4 B/D PA
KABIVEN 4 B/D PA
PERIKABIVEN 4 B/D PA
plenamine 4 B/D PA
DRUG NAME
DRUG
TIER
REQUIREMENTS/
LIMITS
premasol 10% 4 B/D PA
PROSOL 20% 4 B/D PA
TRAVASOL 10% 4 B/D PA
TROPHAMINE 10% 4 B/D PA
VITAMINS / HEMATINICS
BAL-CARE DHA 3
C-NATE DHA 3
COMPLETE NATAL DHA 3
ELITE-OB 3
uoride (sodium) oral tablet 1
uoride (sodium) oral tablet,
chewable 1 mg (2.2 mg sod.
uoride)
1
FOLIVANE-OB 3
ludent uoride oral tablet,
chewable 1 mg (2.2 mg sod.
uoride)
1
M-NATAL PLUS 3
PNV-DHA 3
PNV-OMEGA 3
PNV-SELECT 3
PR NATAL 400 3
PR NATAL 400 EC 3
PR NATAL 430 3
PR NATAL 430 EC 3
PRENATAL PLUS (CALCIUM
CARB)
3
PRENATAL VITAMIN PLUS
LOW IRON
3
SE-NATAL 19 CHEWABLE 3
SE-NATAL-19 3
TARON-C DHA 3
TRINATAL RX 1 3
wescap-pn dha 3
wesnate dha 3
WESTAB PLUS 3
WESTGEL DHA 2
DRUG PAGE DRUG PAGE
58
September 2024
Covered Drugs Index
A
abacavir-lamivudine ........................................................................ 10
abacavir oral solution
...................................................................... 10
abacavir oral tablet .......................................................................... 10
ABELCET ........................................................................................... 10
ABILIFY ASIMTUFII INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 720 MG/2.4 ML ............................. 28
ABILIFY ASIMTUFII INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 960 MG/3.2 ML
............................. 28
ABILIFY MAINTENA ....................................................................... 28
abiraterone oral tablet 250 mg ..................................................... 16
abiraterone oral tablet 500 mg ..................................................... 16
ABRAXANE ....................................................................................... 16
ABRYSVO (PF) ................................................................................ 46
acamprosate
...................................................................................... 39
acarbose oral tablet 25 mg ........................................................... 41
acarbose oral tablet 50 mg ........................................................... 41
acarbose oral tablet 100 mg ......................................................... 41
acebutolol ........................................................................................... 33
acetaminophen-codeine oral solution 120-12 mg/5 ml ......... 27
acetaminophen-codeine oral tablet 300-15 mg, 300-30 mg
..... 27
acetaminophen-codeine oral tablet 300-60 mg ...................... 27
acetazolamide oral capsule, extended release ....................... 53
acetazolamide oral tablet ............................................................... 53
acetazolamide sodium .................................................................... 53
acetic acid otic (ear) ........................................................................ 40
acetylcysteine
................................................................................... 54
acitretin ............................................................................................... 36
ACTHIB (PF) ..................................................................................... 46
ACTIMMUNE .................................................................................... 46
acyclovir oral capsule ..................................................................... 10
acyclovir oral suspension 200 mg/5 ml ..................................... 10
acyclovir oral tablet
.......................................................................... 10
acyclovir sodium intravenous solution ....................................... 10
ADACEL(TDAP ADOLESN/ADULT)(PF) .................................. 46
ADALIMUMAB-ADAZ ..................................................................... 48
ADALIMUMAB-ADBM(CF) PEN CROHNS
(PREFERRED NDCS STARTING WITH 00597) .................... 48
ADALIMUMAB-ADBM(CF) PEN PS-UV
(PREFERRED NDCS STARTING WITH 00597) .................... 48
ADALIMUMAB-ADBM SUBCUTANEOUS PEN
INJECTOR KIT (PREFERRED NDCS STARTING
WITH 00597) ..................................................................................... 48
ADALIMUMAB-ADBM SUBCUTANEOUS SYRINGE
KIT 10 MG/0.2 ML, 20 MG/0.4 ML (PREFERRED
NDCS STARTING WITH 00597) ................................................. 48
ADALIMUMAB-ADBM SUBCUTANEOUS SYRINGE
KIT 40 MG/0.4 ML, 40 MG/0.8 ML (PREFERRED
NDCS STARTING WITH 00597) ................................................. 48
adapalene topical gel 0.3% ........................................................... 37
ADCETRIS ......................................................................................... 16
ADEMPAS .......................................................................................... 54
ADLARITY ......................................................................................... 26
adstiladrin ........................................................................................... 16
ADVAIR HFA ..................................................................................... 54
armelle .............................................................................................. 50
AJOVY AUTOINJECTOR .............................................................. 26
AJOVY SYRINGE ............................................................................ 26
AKEEGA ............................................................................................. 16
ala-cort topical cream 1% .............................................................. 38
albendazole ....................................................................................... 13
albuterol sulfate inhalation hfa aerosol inhaler 90 mcg/
actuation ............................................................................................. 54
albuterol sulfate inhalation hfa aerosol inhaler 90 mcg/
actuation (nda020503) ................................................................... 54
albuterol sulfate inhalation hfa aerosol inhaler 90 mcg/
actuation (nda020983) ................................................................... 54
albuterol sulfate inhalation solution for nebulization .............. 54
albuterol sulfate oral syrup ............................................................ 54
albuterol sulfate oral tablet ............................................................ 54
alclometasone ................................................................................... 38
ALCOHOL PADS ............................................................................. 47
ALDURAZYME ................................................................................. 43
ALECENSA........................................................................................ 16
alendronate oral tablet 10 mg ...................................................... 48
alendronate oral tablet 35 mg, 70 mg ........................................ 48
alfuzosin.............................................................................................. 56
ALIQOPA ............................................................................................ 16
allopurinol oral tablet 100 mg, 300 mg ...................................... 48
alosetron ............................................................................................. 44
ALPHAGAN P OPHTHALMIC (EYE) DROPS 0.1% ............. 54
alprazolam oral tablet 0.25 mg, 0.5 mg, 1 mg ......................... 28
Covered Drugs Index
DRUG PAGE DRUG PAGE
59
September 2024
alprazolam oral tablet 2 mg .......................................................... 28
altavera (28) ...................................................................................... 50
ALUNBRIG ORAL TABLET 30 MG ............................................ 16
ALUNBRIG ORAL TABLET 180 MG, 90 MG ........................... 16
ALUNBRIG ORAL TABLETS, DOSE PACK ............................ 16
alyacen 1/35 (28) ............................................................................. 50
alyacen 7/7/7 (28) ............................................................................ 50
amantadine hcl ................................................................................. 10
ambrisentan ....................................................................................... 54
amethia ............................................................................................... 50
amethyst (28) .................................................................................... 50
amikacin injection solution 1,000 mg/4 ml, 500 mg/2 ml ...... 13
amiloride ............................................................................................. 33
amiloride-hydrochlorothiazide ...................................................... 33
aminocaproic acid oral ................................................................... 35
amiodarone intravenous solution ................................................ 33
amiodarone oral tablet 100 mg, 400 mg ................................... 33
amiodarone oral tablet 200 mg .................................................... 33
amitriptyline........................................................................................ 28
amlodipine .......................................................................................... 33
amlodipine-benazepril .................................................................... 33
amlodipine-valsartan ....................................................................... 33
amlodipine-valsartan-hcthiazid .................................................... 33
ammonium lactate ........................................................................... 37
amoxapine ......................................................................................... 28
amoxicillin oral capsule .................................................................. 14
amoxicillin oral suspension for reconstitution .......................... 14
amoxicillin oral tablet ...................................................................... 14
amoxicillin oral tablet, chewable 125 mg, 250 mg ................. 15
amoxicillin-pot clavulanate oral suspension for
reconstitution 200-28.5 mg/5 ml, 400-57 mg/5 ml,
600-42.9 mg/5 ml ............................................................................. 15
amoxicillin-pot clavulanate oral suspension for
reconstitution 250-62.5 mg/5 ml .................................................. 15
amoxicillin-pot clavulanate oral tablet ........................................ 15
amoxicillin-pot clavulanate oral tablet, chewable
200-28.5 mg ...................................................................................... 15
amoxicillin-pot clavulanate oral tablet, chewable
400-57 mg .......................................................................................... 15
amoxicillin-pot clavulanate oral tablet extended
release 12 hr ..................................................................................... 15
amphotericin b .................................................................................. 10
amphotericin b liposome ................................................................ 10
ampicillin oral capsule 500 mg ..................................................... 15
ampicillin sodium .............................................................................. 15
ampicillin-sulbactam ........................................................................ 15
anagrelide .......................................................................................... 39
anastrozole ........................................................................................ 16
ANKTIVA ............................................................................................ 16
ANORO ELLIPTA ............................................................................. 54
apraclonidine ..................................................................................... 54
aprepitant ........................................................................................... 44
APRETUDE ....................................................................................... 10
apri ....................................................................................................... 50
APTIOM ORAL TABLET 200 MG ................................................ 23
APTIOM ORAL TABLET 400 MG ................................................ 23
APTIOM ORAL TABLET 600 MG, 800 MG .............................. 23
APTIVUS ............................................................................................ 10
aranelle (28) ...................................................................................... 51
ARCALYST ........................................................................................ 46
AREXVY (PF).................................................................................... 46
arformoterol ....................................................................................... 54
ARIKAYCE ......................................................................................... 13
aripiprazole oral solution ................................................................ 29
aripiprazole oral tablet 10 mg, 15 mg, 2 mg, 5 mg................. 29
aripiprazole oral tablet 20 mg, 30 mg ........................................ 29
aripiprazole oral tablet, disintegrating ........................................ 29
ARISTADA INITIO ............................................................................ 29
ARISTADA INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 1,064 MG/3.9 ML ......................... 29
ARISTADA INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 441 MG/1.6 ML ............................. 29
ARISTADA INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 662 MG/2.4 ML ............................. 29
ARISTADA INTRAMUSCULAR SUSPENSION,
EXTENDED REL SYRING 882 MG/3.2 ML ............................. 29
ARNUITY ELLIPTA.......................................................................... 54
arsenic trioxide.................................................................................. 16
asenapine maleate sublingual tablet 5 mg ............................... 29
asenapine maleate sublingual tablet 10 mg, 2.5 mg ............. 29
ashlyna ................................................................................................ 51
Covered Drugs Index
DRUG PAGE DRUG PAGE
60
September 2024
ASSURE ID INSULIN SAFETY SYRINGE 1 ML 29
GAUGE X 1/2" .................................................................................. 47
atazanavir oral capsule 150 mg, 300 mg .................................. 10
atazanavir oral capsule 200 mg ................................................... 10
atenolol ............................................................................................... 33
atenolol-chlorthalidone ................................................................... 33
ATGAM................................................................................................ 46
atomoxetine oral capsule 10 mg, 18 mg, 25 mg, 40 mg ...... 29
atomoxetine oral capsule 100 mg, 60 mg, 80 mg .................. 29
atorvastatin ........................................................................................ 36
atovaquone ........................................................................................ 13
atovaquone-proguanil ..................................................................... 13
atropine ophthalmic (eye) drops 1% .......................................... 53
ATROVENT HFA .............................................................................. 54
aubra eq.............................................................................................. 51
AUGTYRO ......................................................................................... 16
aurovela 1.5/30 (21) ........................................................................ 51
aurovela 1/20 (21)............................................................................ 51
aurovela 24 fe ................................................................................... 51
aurovela fe 1.5/30 (28) ................................................................... 51
aurovela fe 1-20 (28) ...................................................................... 51
AUSTEDO ORAL TABLET 6 MG ................................................ 26
AUSTEDO ORAL TABLET 12 MG, 9 MG ................................. 26
AUSTEDO XR ORAL TABLET EXTENDED RELEASE
24 HR 6 MG ....................................................................................... 26
AUSTEDO XR ORAL TABLET EXTENDED RELEASE
24 HR 12 MG .................................................................................... 26
AUSTEDO XR ORAL TABLET EXTENDED RELEASE
24 HR 24 MG .................................................................................... 26
AUSTEDO XR ORAL TABLET EXTENDED RELEASE
24 HR 30 MG, 36 MG, 42 MG, 48 MG ...................................... 26
AUSTEDO XR TITRATION KT(WK1-4) ORAL TABLET,
EXT REL 24HR DOSE PACK 6 MG (14)-12 MG
(14)-24 MG (14) ................................................................................ 26
AUVELITY .......................................................................................... 29
aviane .................................................................................................. 51
AVONEX ............................................................................................. 46
ayuna ................................................................................................... 51
AYVAKIT ............................................................................................. 16
azacitidine .......................................................................................... 16
azathioprine oral tablet 50 mg ...................................................... 16
azathioprine sodium ........................................................................ 16
azelastine nasal spray,
non-aerosol 137 mcg (0.1%) ........................................................ 40
azelastine ophthalmic (eye) .......................................................... 53
azithromycin intravenous ............................................................... 13
AZITHROMYCIN ORAL PACKET ............................................... 13
azithromycin oral suspension for reconstitution ...................... 13
azithromycin oral tablet .................................................................. 13
aztreonam .......................................................................................... 13
azurette (28) ...................................................................................... 51
B
bacitracin intramuscular ................................................................. 13
bacitracin ophthalmic (eye) ........................................................... 53
bacitracin-polymyxin b .................................................................... 53
baclofen oral tablet 10 mg, 20 mg, 5 mg .................................. 27
BACLOFEN ORAL TABLET 15 MG ........................................... 27
BAL-CARE DHA ............................................................................... 57
balsalazide ......................................................................................... 44
BALVERSA ........................................................................................ 16
balziva (28) ........................................................................................ 51
BAQSIMI ............................................................................................. 41
BARACLUDE ORAL SOLUTION ................................................ 10
BAVENCIO ......................................................................................... 16
BCG VACCINE, LIVE (PF) ............................................................ 46
BD SAFETYGLIDE INSULIN SYRINGE SYRINGE
1 ML 31 GAUGE X 15/64" ............................................................. 47
BD ULTRA-FINE MICRO PEN NEEDLE .................................. 47
BD ULTRA-FINE MINI PEN NEEDLE ....................................... 47
BD ULTRA-FINE NANO PEN NEEDLE .................................... 47
BD ULTRA-FINE SHORT PEN NEEDLE .................................. 47
BELEODAQ ....................................................................................... 16
BELSOMRA ....................................................................................... 29
benazepril ........................................................................................... 33
benazepril-hydrochlorothiazide .................................................... 33
bendamustine ................................................................................... 16
BENDEKA .......................................................................................... 16
BENLYSTA INTRAVENOUS ......................................................... 48
benztropine injection ....................................................................... 25
benztropine oral ................................................................................ 25
Covered Drugs Index
DRUG PAGE DRUG PAGE
61
September 2024
BESIVANCE ...................................................................................... 53
BESPONSA ....................................................................................... 16
BESREMI ........................................................................................... 46
betaine ................................................................................................ 44
betamethasone, augmented topical cream .............................. 38
betamethasone, augmented topical gel .................................... 38
betamethasone, augmented topical lotion ................................ 38
betamethasone, augmented topical ointment ......................... 38
betamethasone dipropionate ........................................................ 38
betamethasone valerate topical cream ..................................... 38
betamethasone valerate topical lotion ....................................... 38
betamethasone valerate topical ointment ................................. 38
BETASERON SUBCUTANEOUS KIT ....................................... 46
betaxolol oral ..................................................................................... 33
bethanechol chloride ....................................................................... 56
bexarotene ......................................................................................... 16
BEXSERO .......................................................................................... 46
bicalutamide ...................................................................................... 16
BICILLIN L-A ..................................................................................... 15
BIKTARVY .......................................................................................... 10
bisoprolol fumarate .......................................................................... 33
bisoprolol-hydrochlorothiazide ..................................................... 33
BLENREP .......................................................................................... 16
bleomycin ........................................................................................... 16
BLINCYTO INTRAVENOUS KIT ................................................. 16
blisovi 24 fe ........................................................................................ 51
blisovi fe 1.5/30 (28) ........................................................................ 51
blisovi fe 1/20 (28) ........................................................................... 51
BOOSTRIX TDAP ............................................................................ 46
BORTEZOMIB INJECTION .......................................................... 16
BOSULIF ORAL CAPSULE 50 MG ............................................ 16
BOSULIF ORAL CAPSULE 100 MG ......................................... 16
BOSULIF ORAL TABLET 100 MG .............................................. 16
BOSULIF ORAL TABLET 400 MG, 500 MG ............................ 16
BOTOX................................................................................................ 46
BRAFTOVI ......................................................................................... 16
BREO ELLIPTA ................................................................................ 54
breyna ................................................................................................. 54
briellyn ................................................................................................. 51
BRILINTA ........................................................................................... 35
brimonidine ophthalmic (eye) drops 0.1% ................................ 54
brimonidine ophthalmic (eye) drops 0.2% ................................ 54
brimonidine ophthalmic (eye) drops 0.15% .............................. 54
brimonidine-timolol .......................................................................... 53
BRIVIACT INTRAVENOUS ........................................................... 23
BRIVIACT ORAL SOLUTION ....................................................... 23
BRIVIACT ORAL TABLET ............................................................. 23
bromocriptine .................................................................................... 25
BRUKINSA ........................................................................................ 16
budesonide inhalation ..................................................................... 55
budesonide oral ................................................................................ 44
bumetanide injection ....................................................................... 33
bumetanide oral tablet 0.5 mg, 1 mg ......................................... 33
bumetanide oral tablet 2 mg ......................................................... 33
buprenorphine hcl injection ........................................................... 27
buprenorphine hcl sublingual ....................................................... 27
buprenorphine-naloxone sublingual tablet 2-0.5 mg ............. 28
buprenorphine-naloxone sublingual tablet 8-2 mg ................. 28
bupropion hcl oral tablet 75 mg ................................................... 29
bupropion hcl oral tablet 100 mg ................................................. 29
bupropion hcl oral tablet extended release 24 hr 150 mg ...... 29
bupropion hcl oral tablet extended release 24 hr 300 mg ...... 29
bupropion hcl oral tablet sustained-release 12 hr 100 mg...... 29
bupropion hcl oral tablet sustained-release 12 hr
150 mg, 200 mg ............................................................................... 29
bupropion hcl (smoking deter) ..................................................... 40
buspirone ............................................................................................ 29
busulfan .............................................................................................. 16
butorphanol nasal ............................................................................ 28
C
CABENUVA ....................................................................................... 10
cabergoline ........................................................................................ 43
CABOMETYX ................................................................................... 16
calcipotriene scalp ........................................................................... 36
calcipotriene topical cream ........................................................... 36
calcipotriene topical ointment ....................................................... 37
calcitonin (salmon) nasal ............................................................... 43
calcitriol intravenous solution 1 mcg/ml ..................................... 43
Covered Drugs Index
DRUG PAGE DRUG PAGE
62
September 2024
calcitriol oral capsule ...................................................................... 43
calcitriol oral solution ...................................................................... 43
calcium acetate (phosphat bind) ................................................. 56
CALQUENCE .................................................................................... 16
CALQUENCE (ACALABRUTINIB MAL) ................................... 16
camila .................................................................................................. 50
CAMRESE ......................................................................................... 51
CAMRESE LO .................................................................................. 51
candesartan-hydrochlorothiazid .................................................. 33
candesartan oral tablet 16 mg, 4 mg, 8 mg ............................. 33
candesartan oral tablet 32 mg ..................................................... 33
CAPLYTA............................................................................................ 29
CAPRELSA ORAL TABLET 100 MG ......................................... 16
CAPRELSA ORAL TABLET 300 MG ......................................... 16
captopril .............................................................................................. 33
carbamazepine oral capsule, er multiphase 12 hr ................. 23
carbamazepine oral suspension 100 mg/5 ml ......................... 23
carbamazepine oral tablet ............................................................. 23
carbamazepine oral tablet, chewable ........................................ 23
carbamazepine oral tablet extended release 12 hr................ 23
carbidopa ............................................................................................ 25
carbidopa-levodopa oral tablet .................................................... 25
carbidopa-levodopa oral tablet, disintegrating ........................ 25
carbidopa-levodopa oral tablet extended release .................. 25
carboplatin intravenous solution .................................................. 17
carglumic acid ................................................................................... 39
carmustine intravenous recon soln 100 mg ............................. 17
carteolol .............................................................................................. 53
cartia xt ............................................................................................... 33
carvedilol ............................................................................................ 33
caspofungin intravenous recon soln 50 mg ............................. 10
caspofungin intravenous recon soln 70 mg ............................. 10
CAYSTON .......................................................................................... 13
cefaclor oral capsule ....................................................................... 12
cefaclor oral suspension for reconstitution
125 mg/5 ml, 250 mg/5 ml, 375 mg/5 ml .................................. 12
cefaclor oral tablet extended release 12 hr .............................. 12
cefadroxil oral capsule .................................................................... 12
cefadroxil oral suspension for reconstitution
250 mg/5 ml, 500 mg/5 ml ............................................................. 12
cefadroxil oral tablet ........................................................................ 12
CEFAZOLIN IN DEXTROSE (ISO-OS) INTRAVENOUS
PIGGYBACK 1 GRAM/50 ML, 2 GRAM/100 ML,
2 GRAM/50 ML ................................................................................. 12
cefazolin injection recon soln 1 gram, 10 gram,
100 gram, 3 gram, 300 gram, 500 mg ....................................... 12
CEFAZOLIN INJECTION RECON SOLN 2 GRAM ............... 12
cefazolin intravenous recon soln 1 gram, 3 gram .................. 12
CEFAZOLIN INTRAVENOUS RECON SOLN 2 GRAM ....... 12
cefdinir ................................................................................................. 12
CEFEPIME IN DEXTROSE 5% ................................................... 12
CEFEPIME IN DEXTROSE, ISO-OSM ..................................... 12
cefepime injection ............................................................................ 12
cefepime intravenous...................................................................... 12
cexime ............................................................................................... 12
cefotetan injection ............................................................................ 12
cefoxitin ............................................................................................... 13
CEFOXITIN IN DEXTROSE, ISO-OSM .................................... 13
cefpodoxime ...................................................................................... 13
cefprozil .............................................................................................. 13
ceftazidime ......................................................................................... 13
ceftriaxone ......................................................................................... 13
ceftriaxone in dextrose, iso-os ..................................................... 13
cefuroxime axetil oral tablet .......................................................... 13
cefuroxime sodium injection recon soln 750 mg ..................... 13
cefuroxime sodium intravenous ................................................... 13
celecoxib ............................................................................................. 28
CELONTIN ORAL CAPSULE 300 MG ...................................... 23
cephalexin oral capsule 250 mg, 500 mg ................................. 13
cephalexin oral suspension for reconstitution ......................... 13
CEREZYME INTRAVENOUS RECON SOLN 400 UNIT ..... 43
charlotte 24 fe ................................................................................... 51
chateal eq (28) .................................................................................. 51
CHEMET ............................................................................................ 39
chloramphenicol sod succinate.................................................... 13
chlorhexidine gluconate mucous membrane ........................... 40
chloroquine phosphate ................................................................... 13
chlorothiazide sodium ..................................................................... 33
chlorpromazine ................................................................................. 29
chlorthalidone oral tablet 25 mg, 50 mg .................................... 34
Covered Drugs Index
DRUG PAGE DRUG PAGE
63
September 2024
cholestyramine-aspartame ............................................................ 36
cholestyramine light ........................................................................ 36
cholestyramine (with sugar) .......................................................... 36
CHORIONIC GONADOTROPIN, HUMAN
INTRAMUSCULAR ......................................................................... 43
ciclodan topical solution ................................................................. 38
ciclopirox topical cream .................................................................. 38
ciclopirox topical shampoo ............................................................ 38
ciclopirox topical solution ............................................................... 38
ciclopirox topical suspension ........................................................ 38
cilostazol ............................................................................................. 35
CIMDUO ............................................................................................. 10
cinacalcet oral tablet 30 mg, 60 mg ............................................ 43
cinacalcet oral tablet 90 mg .......................................................... 43
CINRYZE ............................................................................................ 55
ciprooxacin-dexamethasone ...................................................... 40
ciprooxacin hcl ophthalmic (eye) ............................................... 53
ciprooxacin hcl oral tablet 100 mg ............................................ 15
ciprooxacin hcl oral tablet 250 mg, 500 mg, 750 mg........... 15
ciprooxacin in 5% dextrose ......................................................... 15
ciprooxacin oral suspension, microcapsule recon
500 mg/5 ml ....................................................................................... 15
cisplatin intravenous solution ....................................................... 17
citalopram oral solution .................................................................. 29
citalopram oral tablet 10 mg, 20 mg ........................................... 29
citalopram oral tablet 40 mg ......................................................... 29
cladribine ............................................................................................ 17
claravis ................................................................................................ 37
clarithromycin .................................................................................... 13
CLENPIQ ............................................................................................ 44
clindamycin hcl ................................................................................. 13
CLINDAMYCIN IN 0.9%
SOD CHLOR ..................................................................................... 13
CLINDAMYCIN IN 5% DEXTROSE ........................................... 13
clindamycin palmitate hcl ............................................................... 13
clindamycin pediatric ...................................................................... 13
clindamycin phosphate injection .................................................. 13
clindamycin phosphate topical gel .............................................. 37
clindamycin phosphate topical gel, once daily ........................ 37
clindamycin phosphate topical lotion ......................................... 37
clindamycin phosphate topical solution ..................................... 37
clindamycin phosphate topical swab .......................................... 37
clindamycin phosphate vaginal .................................................... 50
CLINIMIX 4.25%/D5W SULFIT FREE ....................................... 39
CLINIMIX 4.25%/D10W
SULF FREE ....................................................................................... 57
CLINIMIX 5%/D15W
SULFITE FREE ................................................................................ 57
CLINIMIX 5%-D20W (SULFITE-FREE) .................................... 57
CLINIMIX 6%-D5W
(SULFITE-FREE) ............................................................................. 57
CLINIMIX 8%-D10W (SULFITE-FREE) .................................... 57
CLINIMIX 8%-D14W
(SULFITE-FREE) ............................................................................. 57
CLINIMIX E 4.25%/D10W
SUL FREE .......................................................................................... 57
clinisol sf 15% ................................................................................... 57
clobazam oral suspension ............................................................. 23
clobazam oral tablet 10 mg ........................................................... 23
clobazam oral tablet 20 mg ........................................................... 23
clofarabine ......................................................................................... 17
clomipramine ..................................................................................... 29
clonazepam oral tablet 0.5 mg, 1 mg ......................................... 23
clonazepam oral tablet 2 mg ........................................................ 23
clonazepam oral tablet, disintegrating 0.5 mg, 1 mg ............. 23
clonazepam oral tablet, disintegrating 0.125 mg, 0.25 mg ..... 23
clonazepam oral tablet, disintegrating 2 mg ............................ 24
clonidine.............................................................................................. 34
clonidine hcl oral tablet ................................................................... 34
clopidogrel oral tablet 75 mg ........................................................ 35
clopidogrel oral tablet 300 mg ...................................................... 35
clorazepate dipotassium oral tablet 3.75 mg ........................... 29
clorazepate dipotassium oral tablet 7.5 mg ............................. 29
clorazepate dipotassium oral tablet 15 mg ............................... 29
clotrimazole-betamethasone topical cream ............................. 38
clotrimazole mucous membrane ................................................. 10
clotrimazole topical cream ............................................................. 38
clotrimazole topical solution .......................................................... 38
clozapine oral tablet 25 mg, 50 mg ............................................. 29
clozapine oral tablet 100 mg, 200 mg ........................................ 29
clozapine oral tablet, disintegrating ............................................ 29
Covered Drugs Index
DRUG PAGE DRUG PAGE
64
September 2024
C-NATE DHA .................................................................................... 57
COARTEM ......................................................................................... 13
colchicine oral tablet ....................................................................... 48
colestipol oral granules .................................................................. 36
colestipol oral packet ...................................................................... 36
colestipol oral tablet ........................................................................ 36
colistin (colistimethate na) ............................................................. 13
COLUMVI ........................................................................................... 17
COMBIVENT RESPIMAT .............................................................. 55
COMETRIQ ORAL CAPSULE 60 MG/DAY
(20 MG X 3/DAY) ............................................................................. 17
COMETRIQ ORAL CAPSULE 100 MG/DAY
(80 MG X1-20 MG X1) ................................................................... 17
COMETRIQ ORAL CAPSULE 140 MG/DAY
(80 MG X1-20 MG X3) ................................................................... 17
COMPLERA ...................................................................................... 10
COMPLETE NATAL DHA .............................................................. 57
compro ................................................................................................ 44
constulose .......................................................................................... 44
COPIKTRA ........................................................................................ 17
CORLANOR ORAL TABLET ........................................................ 36
CORTIFOAM ..................................................................................... 45
cortisone ............................................................................................. 40
COTELLIC ......................................................................................... 17
CRESEMBA ORAL .......................................................................... 10
cromolyn inhalation ......................................................................... 55
cromolyn ophthalmic (eye) ............................................................ 53
cromolyn oral ..................................................................................... 45
cryselle (28) ....................................................................................... 51
CUVRIOR ........................................................................................... 39
cyclobenzaprine oral tablet 10 mg, 5 mg .................................. 27
cyclophosphamide intravenous recon soln .............................. 17
CYCLOPHOSPHAMIDE INTRAVENOUS SOLUTION ........ 17
cyclophosphamide oral capsule .................................................. 17
cyclophosphamide oral tablet 25 mg ......................................... 17
CYCLOPHOSPHAMIDE ORAL TABLET 50 MG .................... 17
cycloserine ......................................................................................... 13
cyclosporine intravenous ............................................................... 17
cyclosporine modied ..................................................................... 17
cyclosporine ophthalmic (eye) ..................................................... 53
cyclosporine oral capsule .............................................................. 17
CYLTEZO(CF) PEN ........................................................................ 48
CYLTEZO(CF) PEN CROHN'S-UC-HS .................................... 48
CYLTEZO(CF) PEN PSORIASIS-UV ........................................ 48
CYLTEZO(CF) SUBCUTANEOUS SYRINGE KIT
10 MG/0.2 ML, 20 MG/0.4 ML ..................................................... 48
CYLTEZO(CF) SUBCUTANEOUS SYRINGE KIT
40 MG/0.4 ML, 40 MG/0.8 ML ..................................................... 48
CYRAMZA ......................................................................................... 17
cyred eq .............................................................................................. 51
CYSTAGON ....................................................................................... 56
CYSTARAN ....................................................................................... 53
cytarabine ........................................................................................... 17
cytarabine (pf) ................................................................................... 17
D
d2.5%-0.45% sodium chloride ..................................................... 39
d5%-0.45% sodium chloride ......................................................... 39
d5% and 0.9% sodium chloride ................................................... 39
D10%-0.45% SODIUM CHLORIDE ........................................... 39
dacarbazine ....................................................................................... 17
dactinomycin ..................................................................................... 17
dalfampridine ..................................................................................... 26
danazol ............................................................................................... 43
dantrolene oral .................................................................................. 27
DANYELZA ........................................................................................ 17
dapsone oral ...................................................................................... 13
DAPTACEL (DTAP PEDIATRIC) (PF) ........................................ 46
daptomycin ........................................................................................ 13
DAPTOMYCIN IN 0.9%
SOD CHLOR ..................................................................................... 13
darunavir oral tablet 600 mg ......................................................... 10
darunavir oral tablet 800 mg ......................................................... 10
DARZALEX ........................................................................................ 17
DARZALEX FASPRO ..................................................................... 17
dasetta 1/35 (28) .............................................................................. 51
dasetta 7/7/7 (28) ............................................................................. 51
daunorubicin ...................................................................................... 17
DAURISMO ORAL TABLET 25 MG ........................................... 17
DAURISMO ORAL TABLET 100 MG ......................................... 17
Covered Drugs Index
DRUG PAGE DRUG PAGE
65
September 2024
daysee ................................................................................................. 51
deblitane ............................................................................................. 50
decitabine ........................................................................................... 17
deferasirox oral tablet 90 mg ........................................................ 39
deferasirox oral tablet 180 mg, 360 mg ..................................... 39
DELSTRIGO ...................................................................................... 10
DENGVAXIA (PF) ............................................................................ 46
DEPO-MEDROL .............................................................................. 40
DEPO-SUBQ PROVERA 104 ...................................................... 50
DESCOVY ......................................................................................... 10
desipramine ....................................................................................... 29
desloratadine oral tablet ................................................................ 54
desmopressin injection ................................................................... 43
desmopressin nasal spray, non-aerosol
10 mcg/spray (0.1 ml) ..................................................................... 44
desmopressin nasal spray with pump........................................ 43
desmopressin oral ........................................................................... 44
desog-e. estradiol/e. estradiol ...................................................... 51
desogestrel-ethinyl estradiol ......................................................... 51
desoximetasone topical cream .................................................... 38
desoximetasone topical gel .......................................................... 38
desoximetasone topical ointment ................................................ 38
desvenlafaxine succinate oral tablet extended
release 24 hr 25 mg ........................................................................ 29
desvenlafaxine succinate oral tablet extended
release 24 hr 50 mg ........................................................................ 29
desvenlafaxine succinate oral tablet extended
release 24 hr 100 mg ...................................................................... 29
dexamethasone intensol ................................................................ 40
dexamethasone oral elixir ............................................................. 40
dexamethasone oral solution ....................................................... 40
dexamethasone oral tablet ............................................................ 40
dexamethasone sodium phos (pf) injection
solution 10 mg/ml ............................................................................. 40
dexamethasone sodium phosphate injection solution .......... 40
dexamethasone sodium phosphate ophthalmic (eye) .......... 54
dexmethylphenidate oral tablet .................................................... 29
dextroamphetamine-amphetamine oral capsule,
extended release 24hr .................................................................... 29
dextroamphetamine-amphetamine oral tablet 5 mg .............. 30
dextroamphetamine-amphetamine oral tablet 10 mg ........... 30
dextroamphetamine-amphetamine oral tablet
12.5 mg, 30 mg, 7.5 mg ................................................................. 30
dextroamphetamine-amphetamine oral tablet 15 mg ........... 30
dextroamphetamine-amphetamine oral tablet 20 mg ........... 30
dextroamphetamine sulfate oral capsule, extended release .... 29
dextroamphetamine sulfate oral tablet ...................................... 29
dextrose 5%-0.2% sod chloride ................................................... 39
dextrose 5%-0.3% sod.chloride ................................................... 39
dextrose 5% in water (d5w) intravenous parenteral solution .... 39
DEXTROSE 5% IN WATER (D5W) INTRAVENOUS
PIGGYBACK ..................................................................................... 39
DEXTROSE 5%-LACTATED RINGERS ................................... 39
DEXTROSE 10% AND 0.2% NACL ........................................... 39
dextrose 10% in water (d10w) ..................................................... 39
DEXTROSE 25% IN WATER (D25W) ....................................... 39
DEXTROSE 50% IN WATER (D50W) INTRAVENOUS
PARENTERAL SOLUTION ........................................................... 39
dextrose 50% in water (d50w) intravenous syringe ............... 39
DEXTROSE 70% IN WATER (D70W) ....................................... 39
DIACOMIT ......................................................................................... 24
diazepam injection ........................................................................... 30
diazepam intensol ............................................................................ 30
diazepam oral concentrate ............................................................ 30
diazepam oral solution ................................................................... 30
diazepam oral tablet ........................................................................ 30
diazepam rectal ................................................................................ 24
diazoxide ............................................................................................ 41
diclofenac potassium oral tablet 50 mg ..................................... 28
diclofenac sodium ophthalmic (eye) ........................................... 53
diclofenac sodium oral .................................................................... 28
diclofenac sodium topical drops .................................................. 28
diclofenac sodium topical gel 1% ................................................ 28
dicloxacillin ......................................................................................... 15
dicyclomine oral capsule................................................................ 44
dicyclomine oral solution................................................................ 44
dicyclomine oral tablet .................................................................... 44
DIFICID ORAL SUSPENSION FOR RECONSTITUTION ... 13
DIFICID ORAL TABLET ................................................................. 13
diunisal .............................................................................................. 28
diuprednate ...................................................................................... 54
Covered Drugs Index
DRUG PAGE DRUG PAGE
66
September 2024
digoxin injection solution ................................................................ 36
digoxin oral solution ........................................................................ 36
digoxin oral tablet 62.5 mcg (0.0625 mg) ................................. 36
digoxin oral tablet 125 mcg (0.125 mg), 250 mcg (0.25 mg) .... 36
dihydroergotamine nasal ............................................................... 26
dilantin ................................................................................................. 24
diltiazem hcl intravenous ............................................................... 34
diltiazem hcl oral capsule, extended release 12 hr ................ 34
diltiazem hcl oral capsule, extended release 24hr
120 mg, 180 mg, 240 mg, 300 mg .............................................. 34
diltiazem hcl oral capsule, extended release 24 hr
120 mg, 180 mg, 240 mg, 300 mg, 420 mg ............................. 34
diltiazem hcl oral capsule, ext. rel 24h degradable ................ 34
diltiazem hcl oral tablet ................................................................... 34
diltiazem hcl oral tablet extended release 24 hr 120 mg,
180 mg, 240 mg, 300 mg, 360 mg .............................................. 34
DILTIAZEM HCL ORAL TABLET EXTENDED RELEASE
24 HR 420 MG .................................................................................. 34
dilt-xr .................................................................................................... 34
diphenhydramine hcl injection solution 50 mg/ml ................... 54
diphenoxylate-atropine ................................................................... 44
dipyridamole oral .............................................................................. 35
disulram ............................................................................................ 39
divalproex oral capsule, delayed rel sprinkle ........................... 24
divalproex oral tablet, delayed release (dr/ec) ........................ 24
divalproex oral tablet extended release 24 hr ......................... 24
docetaxel ............................................................................................ 17
dofetilide ............................................................................................. 33
dolishale.............................................................................................. 51
donepezil oral tablet 5 mg ............................................................. 26
donepezil oral tablet 10 mg ........................................................... 26
donepezil oral tablet, disintegrating 5 mg ................................. 26
donepezil oral tablet, disintegrating 10 mg ............................... 26
DOPTELET (10 TAB PACK) ......................................................... 35
DOPTELET (15 TAB PACK) ......................................................... 35
DOPTELET (30 TAB PACK) ......................................................... 35
dorzolamide ....................................................................................... 53
dorzolamide-timolol ......................................................................... 53
dotti ...................................................................................................... 50
DOVATO ............................................................................................. 10
doxazosin oral tablet 1 mg, 2 mg, 4 mg .................................... 34
doxazosin oral tablet 8 mg ............................................................ 34
doxepin oral capsule ....................................................................... 30
doxepin oral concentrate ............................................................... 30
doxepin oral tablet ........................................................................... 30
doxercalciferol ................................................................................... 44
doxorubicin intravenous recon soln 50 mg ............................... 17
doxorubicin intravenous solution ................................................. 17
doxorubicin, peg-liposomal ........................................................... 17
doxy-100 ............................................................................................. 15
doxycycline hyclate intravenous .................................................. 15
doxycycline hyclate oral capsule ................................................. 15
doxycycline hyclate oral tablet 100 mg, 20 mg ....................... 15
doxycycline monohydrate oral capsule 100 mg, 50 mg ....... 15
doxycycline monohydrate oral suspension for
reconstitution ..................................................................................... 15
doxycycline monohydrate oral tablet .......................................... 15
dronabinol .......................................................................................... 45
DROPLET MICRON PEN NEEDLE ........................................... 41
DROPLET PEN NEEDLE NEEDLE 30 GAUGE X 5/16" .......... 41
DROPSAFE ALCOHOL PREP PADS ........................................ 41
DROPSAFE PEN NEEDLE NEEDLE 31 GAUGE X 3/16" ...... 41
drospirenone-e. estradiol-lm.fa oral tablet
3-0.02-0.451 mg (24) (4)................................................................ 51
DROSPIRENONE-E. ESTRADIOL-LM.FA ORAL
TABLET 3-0.03-0.451 MG (21) (7) ............................................. 51
drospirenone-ethinyl estradiol ...................................................... 51
DROXIA .............................................................................................. 17
droxidopa oral capsule 100 mg.................................................... 39
droxidopa oral capsule 200 mg, 300 mg ................................... 39
DUAVEE ............................................................................................. 50
duloxetine oral capsule, delayed release (dr/ec) 20 mg,
60 mg ................................................................................................... 30
duloxetine oral capsule, delayed release (dr/ec) 30 mg ....... 30
DUPIXENT PEN SUBCUTANEOUS PEN INJECTOR
200 MG/1.14 ML .............................................................................. 37
DUPIXENT PEN SUBCUTANEOUS PEN INJECTOR
300 MG/2 ML .................................................................................... 37
DUPIXENT SYRINGE SUBCUTANEOUS SYRINGE
100 MG/0.67 ML .............................................................................. 37
Covered Drugs Index
DRUG PAGE DRUG PAGE
67
September 2024
DUPIXENT SYRINGE SUBCUTANEOUS SYRINGE
200 MG/1.14 ML .............................................................................. 37
DUPIXENT SYRINGE SUBCUTANEOUS SYRINGE
300 MG/2 ML .................................................................................... 37
dutasteride ......................................................................................... 56
E
EC-NAPROXEN ORAL TABLET, DELAYED RELEASE
(DR/EC) 375 MG .............................................................................. 28
ec-naproxen oral tablet, delayed release (dr/ec)
500 mg ................................................................................................ 28
econazole ........................................................................................... 38
EDARBI .............................................................................................. 34
EDARBYCLOR ................................................................................. 34
EDURANT .......................................................................................... 10
efavirenz-emtricitabin-tenofov ...................................................... 10
efavirenz-lamivu-tenofov disop oral tablet 400-300-300 mg ..... 10
efavirenz-lamivu-tenofov disop oral tablet 600-300-300 mg ..... 10
efavirenz oral capsule 50 mg ....................................................... 10
efavirenz oral capsule 200 mg ..................................................... 10
efavirenz oral tablet ......................................................................... 10
ELAPRASE ........................................................................................ 44
ELECTROLYTE-48 IN D5W ......................................................... 57
elinest .................................................................................................. 51
ELIQUIS.............................................................................................. 35
ELIQUIS DVT-PE TREAT 30D START ...................................... 35
ELITE-OB ........................................................................................... 57
ELMIRON ........................................................................................... 56
ELREXFIO ......................................................................................... 17
ELZONRIS ......................................................................................... 17
EMPLICITI ......................................................................................... 17
EMSAM ............................................................................................... 30
emtricitabine ...................................................................................... 10
emtricitabine-tenofovir (tdf) oral tablet 100-150 mg,
167-250 mg, 200-300 mg .............................................................. 10
emtricitabine-tenofovir (tdf) oral tablet 133-200 mg ............... 10
EMTRIVA ORAL SOLUTION ........................................................ 10
emverm ............................................................................................... 13
emzahh ............................................................................................... 50
enalapril-hydrochlorothiazide ....................................................... 34
enalapril maleate oral tablet.......................................................... 34
ENBREL MINI ................................................................................... 48
ENBREL SUBCUTANEOUS SOLUTION ................................. 48
ENBREL SUBCUTANEOUS SYRINGE .................................... 49
ENBREL SURECLICK .................................................................... 49
ENDARI .............................................................................................. 39
endocet ............................................................................................... 27
ENGERIX-B PEDIATRIC (PF) ..................................................... 46
ENGERIX-B (PF) ............................................................................. 46
ENHERTU .......................................................................................... 17
enoxaparin ......................................................................................... 35
enpresse ............................................................................................. 51
enskyce ............................................................................................... 51
entacapone ........................................................................................ 25
entecavir ............................................................................................. 10
ENTRESTO ....................................................................................... 36
enulose ............................................................................................... 45
ENVARSUS XR ................................................................................ 17
EPCLUSA ORAL PELLETS IN PACKET 150-37.5 MG ........ 10
EPCLUSA ORAL PELLETS IN PACKET 200-50 MG ........... 11
EPCLUSA ORAL TABLET 200-50 MG ...................................... 11
EPCLUSA ORAL TABLET 400-100 MG .................................... 11
EPIDIOLEX ........................................................................................ 24
epinephrine injection auto-injector 0.15 mg/0.3 ml,
0.3 mg/0.3 ml .................................................................................... 54
EPINEPHRINE INJECTION AUTO-INJECTOR
0.15 MG/0.15 ML, 0.3 MG/0.3 ML .............................................. 54
epinephrine injection solution 1 mg/ml ...................................... 54
epirubicin intravenous solution .................................................... 17
epitol .................................................................................................... 24
EPKINLY ............................................................................................. 17
EPRONTIA ........................................................................................ 24
ERBITUX ............................................................................................ 17
ergotamine-caffeine ........................................................................ 26
eribulin ................................................................................................. 17
ERIVEDGE ........................................................................................ 17
ERLEADA .......................................................................................... 17
erlotinib oral tablet 25 mg .............................................................. 17
erlotinib oral tablet 100 mg, 150 mg ........................................... 17
errin ...................................................................................................... 50
Covered Drugs Index
DRUG PAGE DRUG PAGE
68
September 2024
ertapenem .......................................................................................... 13
ery pads .............................................................................................. 37
erythrocin (as stearate) oral tablet 250 mg .............................. 13
erythrocin intravenous recon soln 500 mg ............................... 13
erythromycin-benzoyl peroxide .................................................... 37
erythromycin ethylsuccinate oral suspension for
reconstitution 200 mg/5 ml ............................................................ 13
erythromycin ophthalmic (eye) ..................................................... 53
erythromycin oral capsule, delayed release (dr/ec) ............... 13
erythromycin oral tablet .................................................................. 13
erythromycin with ethanol topical gel ......................................... 37
erythromycin with ethanol topical solution ................................ 37
escitalopram oxalate oral solution .............................................. 30
escitalopram oxalate oral tablet 10 mg, 5 mg .......................... 30
escitalopram oxalate oral tablet 20 mg ...................................... 30
estarylla .............................................................................................. 51
estradiol oral ...................................................................................... 50
estradiol transdermal patch semiweekly ................................... 50
estradiol transdermal patch weekly ............................................ 50
estradiol vaginal ............................................................................... 50
estradiol valerate .............................................................................. 50
ethacrynate sodium ......................................................................... 34
ethambutol ......................................................................................... 13
ethosuximide ..................................................................................... 24
ethynodiol diac-eth estradiol ......................................................... 51
etonogestrel-ethinyl estradiol ....................................................... 50
ETOPOPHOS ................................................................................... 17
etoposide intravenous .................................................................... 17
etravirine ............................................................................................. 11
euthyrox .............................................................................................. 44
everolimus (antineoplastic) oral tablet ....................................... 17
everolimus (antineoplastic) oral tablet for suspension 2 mg ..... 17
everolimus (antineoplastic) oral tablet for suspension
3 mg, 5 mg ......................................................................................... 17
everolimus (immunosuppressive) oral tablet 0.5 mg,
0.75 mg, 1 mg ................................................................................... 18
everolimus (immunosuppressive) oral tablet 0.25 mg .......... 18
EVOMELA .......................................................................................... 18
EVOTAZ .............................................................................................. 11
exemestane ....................................................................................... 18
EXTENCILLINE ................................................................................ 15
EYLEA ................................................................................................. 53
EYSUVIS ............................................................................................ 54
ezetimibe ............................................................................................ 36
ezetimibe-simvastatin ..................................................................... 36
F
FABRAZYME .................................................................................... 44
falmina (28) ........................................................................................ 51
famciclovir .......................................................................................... 11
famotidine oral suspension for reconstitution .......................... 46
famotidine oral tablet 20 mg ......................................................... 46
famotidine oral tablet 40 mg ......................................................... 46
FANAPT ORAL TABLET 1 MG, 10 MG, 12 MG, 2 MG,
4 MG, 6 MG ....................................................................................... 30
FANAPT ORAL TABLET 8 MG .................................................... 30
FANAPT ORAL TABLETS, DOSE PACK .................................. 30
FARYDAK .......................................................................................... 18
febuxostat ........................................................................................... 48
felbamate ............................................................................................ 24
felodipine ............................................................................................ 34
fenobrate micronized oral capsule 134 mg, 200 mg,
67 mg ................................................................................................... 36
fenobrate nanocrystallized .......................................................... 36
fenobrate oral tablet 160 mg, 54 mg ........................................ 36
fenobric acid (choline) .................................................................. 36
fentanyl citrate buccal lozenge on a handle 1,200 mcg,
1,600 mcg, 400 mcg, 600 mcg, 800 mcg.................................. 27
fentanyl citrate buccal lozenge on a handle 200 mcg ........... 27
fentanyl transdermal patch 72 hour 100 mcg/hr,
12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr ........................... 27
FETZIMA ORAL CAPSULE, EXTENDED RELEASE
24 HR .................................................................................................. 30
FETZIMA ORAL CAPSULE, EXT REL 24HR DOSE
PACK 20 MG (2)- 40 MG (26) ...................................................... 30
nasteride oral tablet 5 mg ............................................................ 56
FINTEPLA .......................................................................................... 24
nzala .................................................................................................. 51
FIRMAGON KIT W DILUENT SYRINGE .................................. 18
FIRVANQ ............................................................................................ 13
ac otic oil .......................................................................................... 40
Covered Drugs Index
DRUG PAGE DRUG PAGE
69
September 2024
ecainide ............................................................................................ 33
oxuridine ........................................................................................... 18
uconazole in nacl (iso-osm) ........................................................ 10
uconazole oral suspension for reconstitution ........................ 10
uconazole oral tablet ..................................................................... 10
ucytosine .......................................................................................... 10
udarabine ......................................................................................... 18
udrocortisone .................................................................................. 41
unisolide ........................................................................................... 55
uocinolone acetonide oil .............................................................. 40
uocinolone and shower cap ........................................................ 38
uocinolone topical cream 0.01% ............................................... 38
uocinolone topical cream 0.025% ............................................. 38
uocinolone topical oil .................................................................... 38
uocinolone topical ointment ........................................................ 38
uocinolone topical solution .......................................................... 38
uocinonide topical cream 0.05% ............................................... 38
uocinonide topical gel ................................................................... 38
uocinonide topical ointment ........................................................ 38
uocinonide topical solution .......................................................... 38
uoride (sodium) dental ................................................................. 40
uoride (sodium) oral tablet .......................................................... 57
uoride (sodium) oral tablet, chewable 1 mg
(2.2 mg sod. uoride) ...................................................................... 57
FLUOROMETHOLONE ................................................................. 54
uorouracil intravenous .................................................................. 18
uorouracil topical cream 5% ....................................................... 37
uorouracil topical solution ............................................................ 37
uoxetine oral capsule 10 mg ...................................................... 30
uoxetine oral capsule 20 mg, 40 mg ........................................ 30
uoxetine oral solution .................................................................... 30
uphenazine decanoate ................................................................. 30
uphenazine hcl injection .............................................................. 30
uphenazine hcl oral concentrate ............................................... 30
uphenazine hcl oral elixir ............................................................. 30
uphenazine hcl oral tablet ........................................................... 30
urbiprofen oral tablet 100 mg ..................................................... 28
urbiprofen sodium .......................................................................... 53
uticasone propionate nasal ......................................................... 55
uticasone propionate topical cream ......................................... 38
uticasone propionate topical ointment ..................................... 39
uvastatin oral capsule 20 mg ..................................................... 36
uvastatin oral capsule 40 mg ..................................................... 36
uvastatin oral tablet extended release 24 hr .......................... 36
uvoxamine oral tablet 25 mg ...................................................... 30
uvoxamine oral tablet 50 mg ...................................................... 30
uvoxamine oral tablet 100 mg .................................................... 30
FOLIVANE-OB .................................................................................. 57
FOLOTYN .......................................................................................... 18
fomepizole .......................................................................................... 46
fondaparinux ...................................................................................... 35
FORTEO ............................................................................................. 48
fosamprenavir ................................................................................... 11
fosinopril ............................................................................................. 34
fosinopril-hydrochlorothiazide ...................................................... 34
fosphenytoin ...................................................................................... 24
FOTIVDA ............................................................................................ 18
FRUZAQLA ORAL CAPSULE 1 MG .......................................... 18
FRUZAQLA ORAL CAPSULE 5 MG .......................................... 18
fulvestrant ........................................................................................... 18
furosemide injection solution ........................................................ 34
furosemide oral solution 10 mg/ml, 40 mg/5 ml (8 mg/ml)...... 34
FUROSEMIDE ORAL SOLUTION 40 MG/4 ML ..................... 34
furosemide oral tablet ..................................................................... 34
FUZEON SUBCUTANEOUS RECON SOLN .......................... 11
FYARRO ............................................................................................. 18
FYCOMPA ORAL SUSPENSION ............................................... 24
FYCOMPA ORAL TABLET 2 MG, 4 MG, 6 MG ...................... 24
FYCOMPA ORAL TABLET 10 MG, 12 MG, 8 MG ................. 24
G
gabapentin oral capsule 100 mg, 300 mg ................................ 24
gabapentin oral capsule 400 mg ................................................. 24
gabapentin oral solution ................................................................. 24
gabapentin oral tablet 600 mg ..................................................... 24
gabapentin oral tablet 800 mg ..................................................... 24
galantamine oral capsule, ext rel. pellets 24 hr ...................... 26
galantamine oral solution ............................................................... 26
galantamine oral tablet ................................................................... 26
Covered Drugs Index
DRUG PAGE DRUG PAGE
70
September 2024
GARDASIL 9 (PF) ............................................................................ 46
GATTEX 30-VIAL ............................................................................. 45
GATTEX ONE-VIAL ........................................................................ 45
GAUZE PAD TOPICAL BANDAGE 2 X 2 " .............................. 47
gavilyte-c ............................................................................................ 45
gavilyte-n ............................................................................................ 45
GAVRETO .......................................................................................... 18
GAZYVA ............................................................................................. 18
getinib ................................................................................................ 18
gemcitabine intravenous recon soln ........................................... 18
gemcitabine intravenous solution 1 gram/26.3 ml
(38 mg/ml), 2 gram/52.6 ml (38 mg/ml), 200 mg/
5.26 ml (38 mg/ml) ........................................................................... 18
GEMCITABINE INTRAVENOUS SOLUTION
100 MG/ML ........................................................................................ 18
gembrozil .......................................................................................... 36
gemmily .............................................................................................. 51
GEMTESA ......................................................................................... 56
generlac .............................................................................................. 45
gengraf ................................................................................................ 18
GENOTROPIN.................................................................................. 46
GENOTROPIN MINIQUICK .......................................................... 46
gentamicin injection solution 40 mg/ml ...................................... 14
gentamicin in nacl (iso-osm) intravenous piggyback
100 mg/100 ml, 100 mg/50 ml, 120 mg/100 ml,
60 mg/50 ml, 80 mg/100 ml, 80 mg/50 ml ................................ 14
gentamicin ophthalmic (eye) drops ............................................. 53
gentamicin sulfate (ped) (pf) ......................................................... 14
gentamicin topical cream ............................................................... 38
gentamicin topical ointment .......................................................... 38
GILOTRIF ........................................................................................... 18
GLASSIA ............................................................................................ 39
glatiramer subcutaneous syringe 20 mg/ml ............................. 26
glatiramer subcutaneous syringe 40 mg/ml ............................. 26
glatopa subcutaneous syringe 20 mg/ml .................................. 26
glatopa subcutaneous syringe 40 mg/ml .................................. 26
GLEOSTINE ...................................................................................... 18
glimepiride oral tablet 1 mg ........................................................... 41
glimepiride oral tablet 2 mg ........................................................... 41
glimepiride oral tablet 4 mg ........................................................... 41
glipizide-metformin oral tablet 2.5-250 mg ............................... 41
glipizide-metformin oral tablet 2.5-500 mg, 5-500 mg........... 41
GLIPIZIDE ORAL TABLET 2.5 MG ............................................ 41
glipizide oral tablet 5 mg ................................................................ 41
glipizide oral tablet 10 mg .............................................................. 41
glipizide oral tablet extended release 24hr 2.5 mg ................ 41
glipizide oral tablet extended release 24hr 5 mg .................... 41
glipizide oral tablet extended release 24hr 10 mg ................. 41
glucagon emergency kit (human) ................................................ 41
GLUCAGON (HCL) EMERGENCY KIT .................................... 41
glycopyrrolate oral tablet 1 mg, 2 mg ......................................... 44
glycopyrrolate (pf) ............................................................................ 44
glycopyrrolate (pf) in water injection ........................................... 44
glycopyrrolate (pf) in water intravenous syringe
0.4 mg/2 ml (0.2 mg/ml) ................................................................. 44
glydo .................................................................................................... 37
GLYXAMBI ......................................................................................... 41
GOCOVRI .......................................................................................... 25
granisetron hcl oral .......................................................................... 45
griseofulvin microsize ..................................................................... 10
griseofulvin ultramicrosize ............................................................. 10
guanfacine oral tablet extended release 24 hr ........................ 30
GVOKE ............................................................................................... 41
GVOKE HYPOPEN 1-PACK ........................................................ 41
GVOKE HYPOPEN 2-PACK ........................................................ 41
GVOKE PFS 1-PACK SYRINGE SUBCUTANEOUS
SYRINGE 1 MG/0.2 ML ................................................................. 41
GVOKE PFS 2-PACK SYRINGE SUBCUTANEOUS
SYRINGE 1 MG/0.2 ML ................................................................. 41
H
hailey ................................................................................................... 51
hailey 24 fe ........................................................................................ 51
hailey fe 1.5/30 (28) ........................................................................ 51
hailey fe 1/20 (28) ............................................................................ 51
HALAVEN ........................................................................................... 18
halobetasol propionate topical cream ........................................ 39
halobetasol propionate topical ointment ................................... 39
haloperidol decanoate .................................................................... 30
haloperidol lactate injection .......................................................... 30
haloperidol lactate oral ................................................................... 30
Covered Drugs Index
DRUG PAGE DRUG PAGE
71
September 2024
haloperidol oral tablet 0.5 mg, 2 mg, 20 mg ............................ 30
haloperidol oral tablet 1 mg, 10 mg, 5 mg ................................ 30
HARVONI ORAL PELLETS IN PACKET 33.75-150 MG ...... 11
HARVONI ORAL PELLETS IN PACKET 45-200 MG ............ 11
HARVONI ORAL TABLET 45-200 MG ...................................... 11
HARVONI ORAL TABLET 90-400 MG ...................................... 11
HAVRIX (PF) INTRAMUSCULAR SYRINGE 1,440
ELISA UNIT/ML ................................................................................ 46
HAVRIX (PF) INTRAMUSCULAR SYRINGE 720 ELISA
UNIT/0.5 ML ...................................................................................... 46
heather ................................................................................................ 50
HEPARIN(PORCINE) IN 0.45% NACL INTRAVENOUS
PARENTERAL SOLUTION 25,000 UNIT/250 ML,
25,000 UNIT/500 ML ...................................................................... 35
HEPARIN (PORCINE) IN 5% DEX ............................................. 35
heparin (porcine) injection solution ............................................. 35
heparin (porcine) in nacl (pf) intravenous parenteral
solution ................................................................................................ 35
heparin, porcine (pf) injection syringe 5,000 unit/0.5 ml ....... 35
HEPLISAV-B (PF) ............................................................................ 46
HIBERIX (PF) .................................................................................... 46
HIZENTRA SUBCUTANEOUS SOLUTION ............................. 46
HUMALOG JUNIOR KWIKPEN U-100 ..................................... 41
HUMALOG KWIKPEN INSULIN ................................................. 41
HUMALOG MIX 50-50 INSULIN U-100 .................................... 41
HUMALOG MIX 50-50 KWIKPEN............................................... 42
HUMALOG MIX 75-25 KWIKPEN............................................... 42
HUMALOG MIX 75-25(U-100)INSULIN .................................... 42
HUMALOG U-100 INSULIN .......................................................... 42
HUMIRA(CF) PEDI CROHNS STARTER
SUBCUTANEOUS SYRINGE KIT
80 MG/0.8 ML-40 MG/0.4 ML (PREFERRED
NDCS STARTING WITH 00074) ................................................. 49
HUMIRA(CF) PEDI CROHNS STARTER
SUBCUTANEOUS SYRINGE KIT 80 MG/0.8 ML
(PREFERRED NDCS STARTING WITH 00074) .................... 49
HUMIRA(CF) PEN CROHNS-UC-HS
(PREFERRED NDCS STARTING WITH 00074) .................... 49
HUMIRA(CF) PEN PEDIATRIC UC
(PREFERRED NDCS STARTING WITH 00074) .................... 49
HUMIRA(CF) PEN PSOR-UV-ADOL HS
(PREFERRED NDCS STARTING WITH 00074) .................... 49
HUMIRA(CF) PEN SUBCUTANEOUS PEN
INJECTOR KIT 40 MG/0.4 ML (PREFERRED
NDCS STARTING WITH 00074) ................................................. 49
HUMIRA(CF) PEN SUBCUTANEOUS PEN
INJECTOR KIT 80 MG/0.8 ML (PREFERRED
NDCS STARTING WITH 00074) ................................................. 49
HUMIRA(CF) SUBCUTANEOUS SYRINGE KIT
10 MG/0.1 ML, 20 MG/0.2 ML (PREFERRED NDCS
STARTING WITH 00074) .............................................................. 49
HUMIRA(CF) SUBCUTANEOUS SYRINGE KIT
40 MG/0.4 ML (PREFERRED NDCS STARTING WITH
00074) ................................................................................................. 49
HUMIRA PEN (PREFERRED NDCS STARTING WITH
00074) ................................................................................................. 49
HUMIRA SUBCUTANEOUS SYRINGE KIT
40 MG/0.8 ML (PREFERRED NDCS STARTING
WITH 00074) ..................................................................................... 49
HUMULIN 70/30 U-100 INSULIN ................................................ 42
HUMULIN 70/30 U-100 KWIKPEN ............................................. 42
HUMULIN N NPH INSULIN KWIKPEN ..................................... 42
HUMULIN N NPH U-100 INSULIN ............................................. 42
HUMULIN R REGULAR U-100 INSULIN ................................. 42
HUMULIN R U-500 (CONC) INSULIN ....................................... 42
HUMULIN R U-500 (CONC) KWIKPEN .................................... 42
hydralazine injection ....................................................................... 34
hydralazine oral ................................................................................ 34
hydrochlorothiazide ......................................................................... 34
hydrocodone-acetaminophen oral solution
7.5-325 mg/15 ml ............................................................................. 27
hydrocodone-acetaminophen oral tablet 10-325 mg,
5-325 mg, 7.5-325 mg .................................................................... 27
hydrocodone-ibuprofen oral tablet 7.5-200 mg ....................... 27
hydrocortisone-acetic acid ............................................................ 40
hydrocortisone oral .......................................................................... 41
hydrocortisone rectal ...................................................................... 45
hydrocortisone topical cream 1%, 2.5% .................................... 39
hydrocortisone topical cream with perineal applicator .......... 45
hydrocortisone topical lotion 2.5% .............................................. 39
hydrocortisone topical ointment 1%, 2.5% ............................... 39
hydromorphone oral liquid ............................................................. 27
hydromorphone oral tablet ............................................................ 27
hydroxychloroquine ......................................................................... 14
Covered Drugs Index
DRUG PAGE DRUG PAGE
72
September 2024
hydroxyurea ....................................................................................... 18
hydroxyzine hcl oral tablet ............................................................. 54
hydroxyzine pamoate...................................................................... 54
HYRIMOZ(CF) PEDI CROHN STARTER
SUBCUTANEOUS SYRINGE 80 MG/0.8 ML-
40 MG/0.4 ML (PREFERRED NDCS STARTING
WITH 61314) ..................................................................................... 49
HYRIMOZ(CF) PEDI CROHN STARTER
SUBCUTANEOUS SYRINGE 80 MG/0.8 ML
(PREFERRED NDCS STARTING WITH 61314) .................... 49
HYRIMOZ(CF) PEN (PREFERRED NDCS
STARTING WITH 61314) .............................................................. 49
HYRIMOZ(CF) SUBCUTANEOUS SYRINGE
10 MG/0.1 ML (PREFERRED NDCS STARTING
WITH 61314) ..................................................................................... 49
HYRIMOZ(CF) SUBCUTANEOUS SYRINGE
20 MG/0.2 ML (PREFERRED NDCS STARTING
WITH 61314) ..................................................................................... 49
HYRIMOZ(CF) SUBCUTANEOUS SYRINGE
40 MG/0.4 ML (PREFERRED NDCS STARTING
WITH 61314) ..................................................................................... 50
HYRIMOZ PEN CROHN'S-UC STARTER
(PREFERRED NDCS STARTING WITH 61314) .................... 49
HYRIMOZ PEN PSORIASIS STARTER
(PREFERRED NDCS STARTING WITH 61314) .................... 49
I
ibandronate oral ............................................................................... 48
IBRANCE ........................................................................................... 18
ibu ......................................................................................................... 28
ibuprofen oral suspension ............................................................. 28
ibuprofen oral tablet 400 mg, 600 mg, 800 mg ....................... 28
icatibant .............................................................................................. 55
iclevia ................................................................................................... 51
ICLUSIG ............................................................................................. 18
icosapent ethyl .................................................................................. 36
idarubicin ............................................................................................ 18
IDHIFA ................................................................................................. 18
ifosfamide intravenous recon soln 1 gram ................................ 18
IFOSFAMIDE INTRAVENOUS RECON SOLN 3 GRAM ..... 18
ifosfamide intravenous solution ................................................... 18
imatinib oral tablet 100 mg ............................................................ 18
imatinib oral tablet 400 mg ............................................................ 18
IMBRUVICA ORAL CAPSULE 70 MG....................................... 18
IMBRUVICA ORAL CAPSULE 140 MG .................................... 18
IMBRUVICA ORAL SUSPENSION............................................. 18
IMBRUVICA ORAL TABLET 140 MG, 280 MG, 420 MG ....... 18
IMDELLTRA ....................................................................................... 18
IMFINZI ............................................................................................... 18
imipenem-cilastatin .......................................................................... 14
imipramine hcl ................................................................................... 30
imiquimod topical cream in packet 5% ...................................... 37
IMJUDO .............................................................................................. 18
IMOVAX RABIES VACCINE (PF) ............................................... 46
INBRIJA INHALATION CAPSULE, W/INHALATION
DEVICE .............................................................................................. 25
incassia ............................................................................................... 50
INCRELEX ......................................................................................... 39
INCRUSE ELLIPTA ......................................................................... 55
indapamide ........................................................................................ 34
INFANRIX (DTAP) (PF) .................................................................. 46
INFUGEM ........................................................................................... 18
INFUMORPH P/F............................................................................. 27
INGREZZA ......................................................................................... 26
INGREZZA INITIATION PK(TARDIV) ........................................ 26
INLYTA ORAL TABLET 1 MG ....................................................... 18
INLYTA ORAL TABLET 5 MG ....................................................... 18
INQOVI ............................................................................................... 18
INREBIC ............................................................................................. 18
INSULIN LISPRO ............................................................................ 42
INSULIN LISPRO PROTAMIN-LISPRO .................................... 42
INSULIN SYRINGE-NEEDLE U-100 SYRINGE
0.3 ML 29 GAUGE, 1 ML 29 GAUGE X 1/2",
1/2 ML 28 GAUGE ........................................................................... 47
INTELENCE ORAL TABLET 25 MG .......................................... 11
INTRALIPID INTRAVENOUS EMULSION 20%, 30% .......... 57
INVEGA HAFYERA INTRAMUSCULAR SYRINGE
1,092 MG/3.5 ML ............................................................................. 30
INVEGA HAFYERA INTRAMUSCULAR SYRINGE
1,560 MG/5 ML ................................................................................. 30
INVEGA SUSTENNA INTRAMUSCULAR SYRINGE
39 MG/0.25 ML ................................................................................. 31
Covered Drugs Index
DRUG PAGE DRUG PAGE
73
September 2024
INVEGA SUSTENNA INTRAMUSCULAR SYRINGE
78 MG/0.5 ML ................................................................................... 31
INVEGA SUSTENNA INTRAMUSCULAR SYRINGE
117 MG/0.75 ML ............................................................................... 30
INVEGA SUSTENNA INTRAMUSCULAR SYRINGE
156 MG/ML ........................................................................................ 30
INVEGA SUSTENNA INTRAMUSCULAR SYRINGE
234 MG/1.5 ML ................................................................................. 30
INVEGA TRINZA INTRAMUSCULAR SYRINGE
273 MG/0.88 ML .............................................................................. 31
INVEGA TRINZA INTRAMUSCULAR SYRINGE
410 MG/1.32 ML .............................................................................. 31
INVEGA TRINZA INTRAMUSCULAR SYRINGE
546 MG/1.75 ML .............................................................................. 31
INVEGA TRINZA INTRAMUSCULAR SYRINGE
819 MG/2.63 ML .............................................................................. 31
INVOKAMET ..................................................................................... 42
INVOKAMET XR .............................................................................. 42
INVOKANA ........................................................................................ 42
IPOL ..................................................................................................... 46
ipratropium-albuterol ....................................................................... 55
ipratropium bromide inhalation .................................................... 55
ipratropium bromide nasal spray, non-aerosol
21 mcg (0.03%) ................................................................................ 40
ipratropium bromide nasal spray, non-aerosol
42 mcg (0.06%) ................................................................................ 40
irbesartan ........................................................................................... 34
irbesartan-hydrochlorothiazide .................................................... 34
irinotecan ............................................................................................ 19
ISENTRESS HD ............................................................................... 11
ISENTRESS ORAL POWDER IN PACKET ............................. 11
ISENTRESS ORAL TABLET ........................................................ 11
ISENTRESS ORAL TABLET, CHEWABLE 25 MG ................ 11
ISENTRESS ORAL TABLET, CHEWABLE 100 MG .............. 11
isibloom ............................................................................................... 51
isoniazid oral solution ..................................................................... 14
isoniazid oral tablet .......................................................................... 14
isosorbide dinitrate oral tablet 10 mg, 20 mg,
30 mg, 5 mg ....................................................................................... 36
isosorbide-hydralazine ................................................................... 34
isosorbide mononitrate ................................................................... 36
isotretinoin oral capsule 10 mg, 20 mg, 30 mg,
40 mg ................................................................................................... 37
itraconazole oral capsule ............................................................... 10
itraconazole oral solution ............................................................... 10
ivermectin oral .................................................................................. 14
IWILFIN ............................................................................................... 19
IXCHIQ (PF) ...................................................................................... 46
IXEMPRA ........................................................................................... 19
IXIARO (PF) ...................................................................................... 46
J
jaimiess ............................................................................................... 51
JAKAFI ................................................................................................ 19
jantoven .............................................................................................. 35
JANUMET .......................................................................................... 42
JANUMET XR ORAL TABLET, ER MULTIPHASE
24 HR 50-1,000 MG, 50-500 MG ................................................ 42
JANUMET XR ORAL TABLET, ER MULTIPHASE
24 HR 100-1,000 MG...................................................................... 42
JANUVIA ............................................................................................ 42
JARDIANCE ...................................................................................... 42
jasmiel (28) ........................................................................................ 51
JAYPIRCA .......................................................................................... 19
JEMPERLI ......................................................................................... 19
jencycla ............................................................................................... 50
JENTADUETO .................................................................................. 42
JENTADUETO XR ORAL TABLET, IR - ER,
BIPHASIC 24HR 2.5-1,000 MG ................................................... 42
JENTADUETO XR ORAL TABLET, IR - ER,
BIPHASIC 24HR 5-1,000 MG ...................................................... 42
JEVTANA ........................................................................................... 19
JOLESSA ........................................................................................... 51
joyeaux ................................................................................................ 51
juleber .................................................................................................. 51
JULUCA .............................................................................................. 11
junel 1.5/30 (21) ............................................................................... 51
junel 1/20 (21) ................................................................................... 51
junel fe 1.5/30 (28) ........................................................................... 51
junel fe 1/20 (28) .............................................................................. 51
junel fe 24 ........................................................................................... 51
Covered Drugs Index
DRUG PAGE DRUG PAGE
74
September 2024
JYLAMVO .......................................................................................... 19
JYNNEOS (PF) ................................................................................. 46
K
KABIVEN ............................................................................................ 57
KADCYLA .......................................................................................... 19
kaitlib fe ............................................................................................... 51
kalliga .................................................................................................. 51
KALYDECO ....................................................................................... 55
KANJINTI ........................................................................................... 19
kariva (28) .......................................................................................... 51
kelnor 1/35 (28) ................................................................................ 51
kelnor 1-50 (28) ................................................................................ 51
KERENDIA ........................................................................................ 34
KESIMPTA PEN ............................................................................... 26
ketoconazole oral ............................................................................. 10
ketoconazole topical cream .......................................................... 38
ketoconazole topical shampoo .................................................... 38
KETOROLAC OPHTHALMIC (EYE) DROPS 0.4% .............. 53
ketorolac ophthalmic (eye) drops 0.5% ..................................... 53
KEYTRUDA ....................................................................................... 19
KIMMTRAK ........................................................................................ 19
KINRIX (PF) ....................................................................................... 46
kionex (with sorbitol) ....................................................................... 39
KISQALI FEMARA CO-PACK ORAL TABLET 200 MG/
DAY(200 MG X 1)-2.5 MG ............................................................ 19
KISQALI FEMARA CO-PACK ORAL TABLET 400 MG/
DAY(200 MG X 2)-2.5 MG ............................................................ 19
KISQALI FEMARA CO-PACK ORAL TABLET 600 MG/
DAY(200 MG X 3)-2.5 MG ............................................................ 19
KISQALI ORAL TABLET 200 MG/DAY (200 MG X 1) ........... 19
KISQALI ORAL TABLET 400 MG/DAY (200 MG X 2) ........... 19
KISQALI ORAL TABLET 600 MG/DAY (200 MG X 3) ........... 19
klayesta ............................................................................................... 38
KLISYRI .............................................................................................. 19
klor-con ............................................................................................... 56
KLOR-CON 8 .................................................................................... 56
KLOR-CON 10 .................................................................................. 56
klor-con m10 ...................................................................................... 56
klor-con m20 ...................................................................................... 56
KLOXXADO ....................................................................................... 28
KORLYM ............................................................................................. 44
KOSELUGO ORAL CAPSULE 10 MG ...................................... 19
KOSELUGO ORAL CAPSULE 25 MG ...................................... 19
k-phos original .................................................................................. 56
KRAZATI ............................................................................................. 19
kurvelo (28) ........................................................................................ 51
KYPROLIS ......................................................................................... 19
L
labetalol oral ...................................................................................... 34
lacosamide intravenous ................................................................. 24
lacosamide oral solution ................................................................ 24
lacosamide oral tablet 50 mg ....................................................... 24
lacosamide oral tablet 100 mg, 150 mg, 200 mg ................... 24
lactated ringers intravenous.......................................................... 56
LACTATED RINGERS IRRIGATION .......................................... 39
lactulose oral solution ..................................................................... 45
LAGEVRIO (EUA)............................................................................ 11
lamivudine oral solution ................................................................. 11
lamivudine oral tablet 100 mg, 300 mg ..................................... 11
lamivudine oral tablet 150 mg ...................................................... 11
lamivudine-zidovudine .................................................................... 11
lamotrigine oral tablet ..................................................................... 24
lamotrigine oral tablet, chewable dispersible ........................... 24
lamotrigine oral tablets, dose pack ............................................. 24
LANOXIN PEDIATRIC .................................................................... 36
LANTUS SOLOSTAR U-100 INSULIN ...................................... 42
LANTUS U-100 INSULIN .............................................................. 42
lapatinib .............................................................................................. 19
larin 1.5/30 (21) ................................................................................ 51
larin 1/20 (21) .................................................................................... 51
larin 24 fe ............................................................................................ 51
larin fe 1.5/30 (28)............................................................................ 51
larin fe 1/20 (28) ............................................................................... 51
latanoprost ......................................................................................... 53
LAYOLIS FE ...................................................................................... 51
leena 28 .............................................................................................. 51
leunomide ........................................................................................ 50
Covered Drugs Index
DRUG PAGE DRUG PAGE
75
September 2024
lenalidomide ...................................................................................... 19
LENVIMA ORAL CAPSULE 10 MG/DAY (10 MG X 1),
4 MG .................................................................................................... 19
LENVIMA ORAL CAPSULE 12 MG/DAY (4 MG X 3),
18 MG/DAY (10 MG X 1-4 MG X2), 24 MG/DAY
(10 MG X 2-4 MG X 1) ................................................................... 19
LENVIMA ORAL CAPSULE 14 MG/DAY (10 MG X
1-4 MG X 1), 20 MG/DAY (10 MG X 2), 8 MG/DAY
(4 MG X 2) ......................................................................................... 19
lessina ................................................................................................. 51
letrozole .............................................................................................. 19
leucovorin calcium injection .......................................................... 16
leucovorin calcium oral tablet 5 mg ............................................ 16
leucovorin calcium oral tablet 10 mg, 15 mg, 25 mg ............. 16
LEUKERAN ....................................................................................... 19
leuprolide (3 month) ........................................................................ 19
leuprolide subcutaneous kit .......................................................... 19
levetiracetam in nacl (iso-os) intravenous piggyback
1,000 mg/100 ml, 1,500 mg/100 ml, 500 mg/100 ml ............. 24
levetiracetam intravenous ............................................................. 24
levetiracetam oral solution ............................................................ 24
levetiracetam oral tablet 1,000 mg, 750 mg ............................. 24
levetiracetam oral tablet 250 mg, 500 mg ................................ 24
levetiracetam oral tablet extended release 24 hr ................... 24
levobunolol ophthalmic (eye) drops 0.5% ................................. 53
levocarnitine oral solution 100 mg/ml ........................................ 40
LEVOCARNITINE ORAL TABLET .............................................. 40
levocarnitine (with sugar) ............................................................... 39
levocetirizine oral tablet ................................................................. 54
levooxacin in d5w .......................................................................... 15
levooxacin oral solution................................................................ 15
levooxacin oral tablet .................................................................... 15
levonest (28) ...................................................................................... 52
levonorgest-eth.estradiol-iron ....................................................... 52
levonorgestrel-ethinyl estrad ........................................................ 52
levonorg-eth estrad triphasic ........................................................ 52
levora-28 ............................................................................................. 52
levothyroxine oral tablet ................................................................. 44
LEVOXYL ORAL TABLET 100 MCG, 112 MCG,
125 MCG, 137 MCG, 150 MCG, 175 MCG, 200 MCG,
25 MCG, 50 MCG, 75 MCG, 88 MCG ....................................... 44
LEXIVA ORAL SUSPENSION ...................................................... 11
LIBERVANT ....................................................................................... 24
LIBTAYO ............................................................................................. 19
lidocaine hcl injection solution ...................................................... 37
lidocaine hcl laryngotracheal ........................................................ 38
lidocaine hcl mucous membrane jelly in applicator ................ 38
lidocaine hcl mucous membrane solution 2% ......................... 38
lidocaine hcl mucous membrane solution 4%
(40 mg/ml) .......................................................................................... 37
lidocaine (pf) injection solution ..................................................... 37
LIDOCAINE (PF) INTRAVENOUS SOLUTION ...................... 33
lidocaine (pf) intravenous syringe ............................................... 33
lidocaine-prilocaine topical cream ............................................... 37
lidocaine topical adhesive patch,medicated 5% ..................... 37
lidocaine viscous .............................................................................. 37
lincomycin .......................................................................................... 14
LINEZOLID-0.9% SODIUM CHLORIDE ................................... 14
linezolid in dextrose 5% ................................................................. 14
linezolid oral suspension for reconstitution .............................. 14
linezolid oral tablet ........................................................................... 14
LINZESS ............................................................................................. 45
liothyronine oral ................................................................................ 44
lisinopril ............................................................................................... 34
lisinopril-hydrochlorothiazide ........................................................ 34
lithium carbonate .............................................................................. 31
lithium citrate ..................................................................................... 31
l norgest/e. estradiol-e. estrad ..................................................... 51
lojaimiess ............................................................................................ 52
LONSURF ORAL TABLET 15-6.14 MG .................................... 19
LONSURF ORAL TABLET 20-8.19 MG .................................... 19
loperamide oral capsule ................................................................. 44
lopinavir-ritonavir oral solution ..................................................... 11
lopinavir-ritonavir oral tablet 100-25 mg .................................... 11
lopinavir-ritonavir oral tablet 200-50 mg .................................... 11
LOQTORZI ......................................................................................... 19
lorazepam injection solution ......................................................... 31
lorazepam injection syringe 2 mg/ml .......................................... 31
lorazepam intensol .......................................................................... 31
lorazepam oral concentrate .......................................................... 31
lorazepam oral syringe ................................................................... 31
Covered Drugs Index
DRUG PAGE DRUG PAGE
76
September 2024
lorazepam oral tablet 0.5 mg, 1 mg ............................................ 31
lorazepam oral tablet 2 mg ........................................................... 31
LORBRENA ORAL TABLET 25 MG ........................................... 19
LORBRENA ORAL TABLET 100 MG ......................................... 19
loryna (28) .......................................................................................... 52
losartan ............................................................................................... 34
losartan-hydrochlorothiazide oral tablet 50-12.5 mg ............. 34
losartan-hydrochlorothiazide oral tablet 100-12.5 mg,
100-25 mg .......................................................................................... 34
LOTEMAX OPHTHALMIC (EYE) OINTMENT ........................ 54
LOTEMAX SM .................................................................................. 54
loteprednol etabonate ..................................................................... 54
lovastatin oral tablet 10 mg ........................................................... 36
lovastatin oral tablet 20 mg, 40 mg ............................................. 36
low-ogestrel (28) .............................................................................. 52
loxapine succinate ........................................................................... 31
lo-zumandimine (28) ....................................................................... 52
ludent uoride oral tablet, chewable 1 mg (2.2 mg sod.
uoride) ............................................................................................... 57
LUMAKRAS ORAL TABLET 120 MG ........................................ 19
LUMAKRAS ORAL TABLET 320 MG ........................................ 19
LUMIGAN OPHTHALMIC (EYE) DROPS 0.01% ................... 53
LUMIZYME ........................................................................................ 44
LUNSUMIO ........................................................................................ 19
LUPRON DEPOT ............................................................................ 19
LUPRON DEPOT (3 MONTH) ..................................................... 19
LUPRON DEPOT (4 MONTH) ..................................................... 19
LUPRON DEPOT (6 MONTH) ..................................................... 19
LUPRON DEPOT-PED (3 MONTH) INTRAMUSCULAR
SYRINGE KIT 11.25 MG ............................................................... 19
LUPRON DEPOT-PED (3 MONTH) INTRAMUSCULAR
SYRINGE KIT 30 MG ..................................................................... 20
LUPRON DEPOT-PED INTRAMUSCULAR KIT .................... 20
LUPRON DEPOT-PED INTRAMUSCULAR SYRINGE
KIT ........................................................................................................ 20
lurasidone oral tablet 80 mg ......................................................... 31
lurasidone oral tablet 120 mg, 20 mg, 40 mg, 60 mg ............ 31
lutera (28) ........................................................................................... 52
LYNPARZA ........................................................................................ 20
LYSODREN ....................................................................................... 20
LYTGOBI ORAL TABLET 12 MG/DAY (4 MG X 3) ................ 20
LYTGOBI ORAL TABLET 16 MG/DAY (4 MG X 4) ................ 20
LYTGOBI ORAL TABLET 20 MG/DAY (4 MG X 5) ................ 20
LYUMJEV KWIKPEN U-100 INSULIN ....................................... 42
LYUMJEV KWIKPEN U-200 INSULIN ....................................... 42
LYUMJEV U-100 INSULIN ............................................................ 42
lyza ....................................................................................................... 50
M
magnesium sulfate in d5w intravenous piggyback
1 gram/100 ml ................................................................................... 56
magnesium sulfate injection ......................................................... 56
magnesium sulfate in water .......................................................... 56
malathion ............................................................................................ 39
maraviroc oral tablet 150 mg ........................................................ 11
maraviroc oral tablet 300 mg ........................................................ 11
MARGENZA ...................................................................................... 20
marlissa (28) ...................................................................................... 52
MARPLAN .......................................................................................... 31
MATULANE ....................................................................................... 20
matzim la ............................................................................................ 34
MAVYRET ORAL PELLETS IN PACKET ................................. 11
MAVYRET ORAL TABLET ............................................................ 11
meclizine oral tablet 12.5 mg, 25 mg ......................................... 45
medroxyprogesterone intramuscular ......................................... 50
medroxyprogesterone oral ............................................................ 50
meoquine ......................................................................................... 14
megestrol oral suspension 400 mg/10 ml (10 ml),
400 mg/10 ml (40 mg/ml), 800 mg/20 ml (20 ml) ................... 20
megestrol oral tablet 20 mg .......................................................... 20
megestrol oral tablet 40 mg .......................................................... 20
MEKINIST ORAL RECON SOLN ................................................ 20
MEKINIST ORAL TABLET 0.5 MG ............................................. 20
MEKINIST ORAL TABLET 2 MG ................................................. 20
MEKTOVI ........................................................................................... 20
meloxicam oral tablet 7.5 mg ....................................................... 28
meloxicam oral tablet 15 mg ......................................................... 28
melphalan hcl .................................................................................... 20
memantine oral solution ................................................................. 26
memantine oral tablet 5 mg .......................................................... 26
memantine oral tablet 10 mg ........................................................ 26
Covered Drugs Index
DRUG PAGE DRUG PAGE
77
September 2024
MEMANTINE ORAL TABLETS, DOSE PACK ......................... 26
MENACTRA (PF) INTRAMUSCULAR SOLUTION ............... 47
MENQUADFI (PF) ........................................................................... 47
MENVEO A-C-Y-W-135-DIP (PF) ............................................... 47
mercaptopurine ................................................................................. 20
MEROPENEM-0.9% SODIUM CHLORIDE ............................. 14
meropenem intravenous recon soln 1 gram, 500 mg ........... 14
merzee ................................................................................................ 52
mesalamine oral capsule, extended release 24hr ................. 45
mesalamine rectal enema ............................................................. 45
mesalamine with cleansing wipe ................................................. 45
mesna .................................................................................................. 16
MESNEX ORAL ............................................................................... 16
metadate er........................................................................................ 31
metformin oral solution ................................................................... 42
metformin oral tablet 1,000 mg .................................................... 42
metformin oral tablet 500 mg ........................................................ 42
metformin oral tablet 850 mg ........................................................ 42
metformin oral tablet extended release 24 hr 500 mg .......... 42
metformin oral tablet extended release 24 hr 750 mg .......... 42
methadone injection solution ........................................................ 27
methadone intensol ......................................................................... 27
methadone oral concentrate ......................................................... 27
methadone oral solution 5 mg/5 ml ............................................ 27
methadone oral solution 10 mg/5 ml .......................................... 27
methadone oral tablet 5 mg .......................................................... 27
methadone oral tablet 10 mg ........................................................ 27
methazolamide ................................................................................. 53
methenamine hippurate ................................................................. 15
methimazole oral tablet 10 mg, 5 mg ......................................... 41
methocarbamol oral tablet 500 mg, 750 mg ............................ 27
methotrexate sodium injection ..................................................... 20
methotrexate sodium oral .............................................................. 20
methotrexate sodium (pf) ............................................................... 20
methoxsalen ...................................................................................... 37
methsuximide .................................................................................... 24
methylphenidate hcl oral tablet .................................................... 31
methylphenidate hcl oral tablet extended release .................. 31
methylphenidate hcl oral tablet extended release 24hr
18 mg, 18 mg (bx rating), 27 mg, 27 mg (bx rating),
36 mg, 36 mg (bx rating), 54 mg, 54 mg (bx rating) .............. 31
methylpred dp ................................................................................... 41
methylprednisolone ......................................................................... 41
methylprednisolone acetate .......................................................... 41
methylprednisolone sodium succ injection recon soln
125 mg, 40 mg .................................................................................. 41
methylprednisolone sodium succ intravenous ........................ 41
metoclopramide hcl oral solution ................................................. 45
metoclopramide hcl oral tablet ..................................................... 45
metolazone ........................................................................................ 34
metoprolol succinate ....................................................................... 34
metoprolol ta-hydrochlorothiaz .................................................... 34
metoprolol tartrate oral tablet 100 mg, 25 mg, 50 mg ........... 34
METRO I.V. ........................................................................................ 14
metronidazole in nacl (iso-os) ...................................................... 14
metronidazole oral tablet ............................................................... 14
metronidazole topical ...................................................................... 37
metronidazole vaginal gel 0.75% (37.5mg/5 gram) ............... 50
metyrosine ......................................................................................... 34
mexiletine ........................................................................................... 33
microgestin 1.5/30 (21) .................................................................. 52
microgestin 1/20 (21) ...................................................................... 52
microgestin fe 1.5/30 (28) .............................................................. 52
microgestin fe 1/20 (28) ................................................................. 52
midodrine ............................................................................................ 40
MIEBO (PF) ....................................................................................... 53
mifepristone oral tablet 300 mg ................................................... 44
miglustat ............................................................................................. 44
mili ........................................................................................................ 52
minocycline oral capsule................................................................ 15
minoxidil oral ..................................................................................... 34
mirtazapine oral tablet .................................................................... 31
mirtazapine oral tablet, disintegrating ........................................ 31
misoprostol ........................................................................................ 46
MITIGARE .......................................................................................... 48
mitomycin intravenous .................................................................... 20
mitoxantrone ...................................................................................... 20
M-M-R II (PF) .................................................................................... 47
Covered Drugs Index
DRUG PAGE DRUG PAGE
78
September 2024
M-NATAL PLUS ................................................................................ 57
modanil oral tablet 100 mg.......................................................... 31
modanil oral tablet 200 mg.......................................................... 31
moexipril ............................................................................................. 34
molindone oral tablet 5 mg ............................................................ 31
molindone oral tablet 10 mg, 25 mg ........................................... 31
mometasone topical ........................................................................ 39
MONJUVI ........................................................................................... 20
mono-linyah ....................................................................................... 52
montelukast oral granules in packet ........................................... 55
montelukast oral tablet ................................................................... 55
montelukast oral tablet, chewable .............................................. 55
morphine concentrate oral solution ............................................ 27
MORPHINE INJECTION SOLUTION ........................................ 27
MORPHINE INJECTION SYRINGE 2 MG/ML,
4 MG/ML ............................................................................................. 27
morphine intravenous solution 10 mg/ml, 4 mg/ml,
8 mg/ml ............................................................................................... 27
MORPHINE INTRAVENOUS SYRINGE 10 MG/ML,
2 MG/ML, 4 MG/ML ......................................................................... 27
morphine oral solution .................................................................... 27
morphine oral tablet ........................................................................ 27
morphine oral tablet extended release ...................................... 28
morphine (pf) injection solution 0.5 mg/ml, 1 mg/ml .............. 27
MOTPOLY XR ORAL CAPSULE, EXTENDED
RELEASE 24HR 100 MG .............................................................. 24
MOTPOLY XR ORAL CAPSULE, EXTENDED
RELEASE 24HR 150 MG, 200 MG ............................................ 24
MOUNJARO ...................................................................................... 42
MOVANTIK ........................................................................................ 45
moxioxacin ophthalmic (eye) ...................................................... 53
moxioxacin oral .............................................................................. 15
MOXIFLOXACIN-SOD.ACE, SUL-WATER .............................. 15
moxioxacin-sod.chloride (iso)..................................................... 15
MRESVIA (PF) .................................................................................. 47
mupirocin ............................................................................................ 38
mupirocin calcium ............................................................................ 38
MVASI ................................................................................................. 20
mycophenolate mofetil (hcl) .......................................................... 20
mycophenolate mofetil oral capsule ........................................... 20
mycophenolate mofetil oral suspension for reconstitution ... 20
mycophenolate mofetil oral tablet ............................................... 20
mycophenolate sodium .................................................................. 20
MYLOTARG ....................................................................................... 20
MYRBETRIQ ORAL TABLET EXTENDED RELEASE
24 HR .................................................................................................. 56
N
nabumetone ....................................................................................... 28
NAFCILLIN IN DEXTROSE ISO-OSM INTRAVENOUS
PIGGYBACK 2 GRAM/100 ML .................................................... 15
nafcillin injection ............................................................................... 15
NAGLAZYME .................................................................................... 44
naloxone injection solution ............................................................ 28
naloxone injection syringe 1 mg/ml ............................................ 28
naloxone nasal.................................................................................. 28
naltrexone .......................................................................................... 28
NAMZARIC ........................................................................................ 26
naproxen oral suspension ............................................................. 28
naproxen oral tablet ........................................................................ 28
naproxen oral tablet, delayed release (dr/ec) 375 mg .......... 28
naproxen oral tablet, delayed release (dr/ec) 500 mg .......... 28
naproxen sodium oral tablet 275 mg, 550 mg ......................... 28
naratriptan .......................................................................................... 26
NATACYN ........................................................................................... 53
nateglinide oral tablet 60 mg ........................................................ 42
nateglinide oral tablet 120 mg ...................................................... 42
NAYZILAM ......................................................................................... 24
necon 0.5/35 (28) ............................................................................. 52
nefazodone ........................................................................................ 31
nelarabine .......................................................................................... 20
neomycin ............................................................................................ 14
neomycin-bacitracin-poly-hc ......................................................... 54
neomycin-bacitracin-polymyxin.................................................... 53
neomycin-polymyxin b-dexameth ............................................... 54
neomycin-polymyxin b gu .............................................................. 39
neomycin-polymyxin-gramicidin .................................................. 53
neomycin-polymyxin-hc ophthalmic (eye) ................................ 54
neomycin-polymyxin-hc otic (ear) ............................................... 40
NERLYNX .......................................................................................... 20
nevirapine oral suspension ........................................................... 11
Covered Drugs Index
DRUG PAGE DRUG PAGE
79
September 2024
nevirapine oral tablet ...................................................................... 11
nevirapine oral tablet extended release 24 hr 100 mg.......... 11
nevirapine oral tablet extended release 24 hr 400 mg.......... 11
NEXAVAR ........................................................................................... 20
NEXLETOL ........................................................................................ 36
NEXLIZET .......................................................................................... 36
niacin oral tablet extended release 24 hr .................................. 36
nicardipine intravenous solution .................................................. 34
nicardipine oral ................................................................................. 34
NICOTROL ........................................................................................ 40
nifedipine oral tablet extended release ...................................... 34
nifedipine oral tablet extended release 24hr ............................ 34
nikki (28) ............................................................................................. 52
nilutamide ........................................................................................... 20
nimodipine .......................................................................................... 34
NINLARO ........................................................................................... 20
NIPENT ............................................................................................... 20
nitazoxanide ...................................................................................... 14
nitisinone ............................................................................................ 40
nitrofurantoin monohyd/m-cryst ................................................... 15
nitroglycerin intravenous ................................................................ 36
nitroglycerin rectal............................................................................ 45
nitroglycerin sublingual ................................................................... 36
nitroglycerin transdermal patch 24 hour .................................... 36
nitroglycerin translingual ................................................................ 36
NIVESTYM ........................................................................................ 46
NORA-BE ........................................................................................... 50
noreth-ethinyl estradiol-iron .......................................................... 52
norethindrone acetate ..................................................................... 50
norethindrone ac-eth estradiol oral tablet 1-20 mg-mcg,
1.5-30 mg-mcg.................................................................................. 52
norethindrone (contraceptive) ...................................................... 50
norethindrone-e. estradiol-iron ..................................................... 52
norgestimate-ethinyl estradiol ...................................................... 52
nortrel 0.5/35 (28) ............................................................................ 52
nortrel 1/35 (21) ................................................................................ 52
nortrel 1/35 (28) ................................................................................ 52
nortrel 7/7/7 (28) ............................................................................... 52
nortriptyline oral capsule ................................................................ 31
nortriptyline oral solution ................................................................ 31
NORVIR ORAL POWDER IN PACKET ..................................... 11
NUBEQA ............................................................................................ 20
NUCALA SUBCUTANEOUS AUTO-INJECTOR ..................... 55
NUCALA SUBCUTANEOUS SYRINGE 40 MG/0.4 ML ....... 55
NUCALA SUBCUTANEOUS SYRINGE 100 MG/ML ............ 55
NUEDEXTA ....................................................................................... 26
NULOJIX ............................................................................................ 20
NUPLAZID ......................................................................................... 31
NURTEC ODT .................................................................................. 26
nyamyc ................................................................................................ 38
nylia 1/35 (28) ................................................................................... 52
nylia 7/7/7 (28) .................................................................................. 52
nymyo .................................................................................................. 52
nystatin oral ....................................................................................... 10
nystatin topical cream ..................................................................... 38
nystatin topical ointment ................................................................ 38
nystatin topical powder ................................................................... 38
nystatin-triamcinolone ..................................................................... 38
nystop .................................................................................................. 38
O
OCALIVA ............................................................................................ 45
ocella ................................................................................................... 52
OCREVUS ......................................................................................... 26
octreotide acetate ............................................................................ 20
ODEFSEY .......................................................................................... 11
ODOMZO ........................................................................................... 20
OFEV ................................................................................................... 55
ooxacin ophthalmic (eye) ............................................................ 53
ooxacin otic (ear) ........................................................................... 40
OGIVRI ............................................................................................... 20
OJEMDA ORAL TABLET 400 MG/WEEK (100 MG X 4) ..... 20
OJEMDA ORAL TABLET 500 MG/WEEK (100 MG X 5) ..... 20
OJEMDA ORAL TABLET 600 MG/WEEK (100 MG X 6) ..... 20
OJJAARA ........................................................................................... 20
olanzapine intramuscular ............................................................... 31
olanzapine oral tablet 10 mg, 2.5 mg, 5 mg, 7.5 mg ............. 31
olanzapine oral tablet 15 mg, 20 mg .......................................... 31
olanzapine oral tablet, disintegrating 10 mg, 5 mg ................ 31
Covered Drugs Index
DRUG PAGE DRUG PAGE
80
September 2024
olanzapine oral tablet, disintegrating 15 mg, 20 mg .............. 31
olmesartan ......................................................................................... 34
olmesartan-hydrochlorothiazide .................................................. 34
omeprazole oral capsule, delayed release (dr/ec) ................. 46
OMNIPOD 5 G6 INTRO KIT (GEN 5) ........................................ 42
OMNIPOD 5 G6 PODS (GEN 5) ................................................. 42
OMNIPOD CLASSIC PODS (GEN 3) ........................................ 42
OMNIPOD DASH INTRO KIT (GEN 4) ..................................... 42
OMNIPOD DASH PODS (GEN 4) .............................................. 42
OMNIPOD GO PODS ..................................................................... 42
OMNIPOD GO PODS 10 UNITS/DAY ....................................... 42
OMNIPOD GO PODS 15 UNITS/DAY ....................................... 42
OMNIPOD GO PODS 20 UNITS/DAY ....................................... 42
OMNIPOD GO PODS 25 UNITS/DAY ....................................... 43
OMNIPOD GO PODS 30 UNITS/DAY ....................................... 43
OMNIPOD GO PODS 40 UNITS/DAY ....................................... 43
ONCASPAR ....................................................................................... 20
ondansetron hcl intravenous ........................................................ 45
ondansetron hcl oral solution ....................................................... 45
ondansetron hcl oral tablet 4 mg, 8 mg ..................................... 45
ondansetron hcl (pf) ........................................................................ 45
ondansetron oral tablet, disintegrating 4 mg, 8 mg................ 45
ONGENTYS ...................................................................................... 25
ONIVYDE ........................................................................................... 20
ONUREG ............................................................................................ 20
OPDIVO .............................................................................................. 20
OPDUALAG ....................................................................................... 21
OPSUMIT ........................................................................................... 55
oralone ................................................................................................ 40
ORENCIA CLICKJECT .................................................................. 50
ORENCIA SUBCUTANEOUS SYRINGE 50 MG/0.4 ML ..... 50
ORENCIA SUBCUTANEOUS SYRINGE 87.5 MG/0.7 ML ...... 50
ORENCIA SUBCUTANEOUS SYRINGE 125 MG/ML .......... 50
ORENITRAM ..................................................................................... 35
ORENITRAM MONTH 1 TITRATION KT .................................. 35
ORENITRAM MONTH 2 TITRATION KT .................................. 35
ORENITRAM MONTH 3 TITRATION KT .................................. 35
ORGOVYX ......................................................................................... 21
ORKAMBI ORAL GRANULES IN PACKET ............................. 55
ORKAMBI ORAL TABLET ............................................................. 55
ORSERDU ......................................................................................... 21
oseltamivir oral capsule ................................................................. 11
oseltamivir oral suspension for reconstitution ......................... 11
OTEZLA .............................................................................................. 50
OTEZLA STARTER ORAL TABLETS, DOSE
PACK 10 MG (4)-20 MG (4)-30 MG (47) .................................. 50
oxacillin ............................................................................................... 15
oxaliplatin ........................................................................................... 21
oxaprozin oral tablet ........................................................................ 28
oxcarbazepine oral suspension ................................................... 24
oxcarbazepine oral tablet .............................................................. 24
OXERVATE ........................................................................................ 53
oxybutynin chloride oral syrup ..................................................... 56
oxybutynin chloride oral tablet 5 mg ........................................... 56
oxybutynin chloride oral tablet extended release 24hr ......... 56
oxycodone-acetaminophen oral tablet 10-325 mg,
2.5-325 mg, 5-325 mg, 7.5-325 mg ............................................ 28
oxycodone oral tablet 5 mg ........................................................... 28
oxycodone oral tablet 10 mg, 15 mg, 20 mg, 30 mg ............. 28
oxymorphone oral tablet extended release 12 hr ................... 28
OZEMPIC SUBCUTANEOUS PEN INJECTOR
0.25 MG OR 0.5 MG (2 MG/3 ML), 1 MG/DOSE
(4 MG/3 ML), 2 MG/DOSE (8 MG/3 ML)................................... 43
P
pacerone oral tablet 100 mg, 400 mg ........................................ 33
pacerone oral tablet 200 mg ......................................................... 33
paclitaxel ............................................................................................. 21
PACLITAXEL PROTEIN-BOUND ................................................ 21
PADCEV ............................................................................................. 21
paliperidone oral tablet extended release 24hr
1.5 mg, 9 mg ..................................................................................... 31
paliperidone oral tablet extended release 24hr
3 mg, 6 mg ......................................................................................... 31
palonosetron intravenous solution 0.25 mg/5 ml .................... 45
pamidronate ....................................................................................... 44
PANRETIN ......................................................................................... 37
pantoprazole oral tablet, delayed release (dr/ec) ................... 46
PANZYGA .......................................................................................... 47
paricalcitol oral .................................................................................. 44
paromomycin ..................................................................................... 14
Covered Drugs Index
DRUG PAGE DRUG PAGE
81
September 2024
paroxetine hcl oral suspension .................................................... 31
paroxetine hcl oral tablet 10 mg .................................................. 31
paroxetine hcl oral tablet 20 mg, 40 mg .................................... 31
paroxetine hcl oral tablet 30 mg .................................................. 31
PAXLOVID ORAL TABLETS, DOSE PACK 150-100 MG .... 11
PAXLOVID ORAL TABLETS, DOSE PACK 300 MG (150 MG
X 2)-100 MG ...................................................................................... 11
pazopanib ........................................................................................... 21
PEDIARIX (PF) ................................................................................. 47
PEDVAX HIB (PF) ........................................................................... 47
peg 3350-electrolytes ..................................................................... 45
PEGASYS SUBCUTANEOUS SOLUTION .............................. 46
PEGASYS SUBCUTANEOUS SYRINGE ................................ 46
peg-electrolyte soln ......................................................................... 45
PEMAZYRE ....................................................................................... 21
pemetrexed disodium intravenous recon soln ......................... 21
PENBRAYA (PF) .............................................................................. 47
penicillamine ...................................................................................... 50
penicillin g potassium...................................................................... 15
penicillin v potassium ...................................................................... 15
PEN NEEDLE, DIABETIC NEEDLE 29 GAUGE X 1/2" ....... 47
PENTACEL (PF) INTRAMUSCULAR KIT
15LF-48MCG-62DU -10 MCG/0.5ML ........................................ 47
pentamidine inhalation ................................................................... 14
pentamidine injection ...................................................................... 14
PENTIPS ............................................................................................ 43
pentoxifylline ...................................................................................... 35
PERIKABIVEN .................................................................................. 57
perindopril erbumine ....................................................................... 35
periogard ............................................................................................ 40
PERJETA ........................................................................................... 21
permethrin .......................................................................................... 39
perphenazine .................................................................................... 31
perphenazine-amitriptyline ............................................................ 32
PERSERIS ......................................................................................... 32
pzerpen-g ......................................................................................... 15
phenelzine .......................................................................................... 32
phenobarbital oral elixir .................................................................. 24
phenobarbital oral tablet ................................................................ 24
phenobarbital sodium injection solution .................................... 24
phenytoin oral suspension ............................................................ 24
phenytoin oral tablet, chewable ................................................... 24
phenytoin sodium extended oral capsule 100 mg, 200 mg ...... 24
phenytoin sodium extended oral capsule 300 mg .................. 24
phenytoin sodium intravenous solution ..................................... 24
PHESGO ............................................................................................ 21
philith ................................................................................................... 52
PIFELTRO .......................................................................................... 11
pilocarpine hcl ophthalmic (eye) drops 1%, 2%, 4% ............. 53
pilocarpine hcl oral ........................................................................... 40
pimozide ............................................................................................. 32
pimtrea (28) ....................................................................................... 52
pindolol ................................................................................................ 35
pioglitazone........................................................................................ 43
piperacillin-tazobactam .................................................................. 15
PIQRAY ............................................................................................... 21
pirfenidone oral capsule ................................................................. 55
pirfenidone oral tablet 267 mg ..................................................... 55
pirfenidone oral tablet 534 mg, 801 mg ..................................... 55
pitavastatin calcium ......................................................................... 36
plenamine ........................................................................................... 57
PLERIXAFOR ................................................................................... 46
PNV-DHA ........................................................................................... 57
PNV-OMEGA .................................................................................... 57
PNV-SELECT .................................................................................... 57
podolox topical solution................................................................ 37
POLIVY ............................................................................................... 21
polycin ................................................................................................. 53
polymyxin b sulf-trimethoprim ...................................................... 53
POMALYST ....................................................................................... 21
portia 28 .............................................................................................. 52
PORTRAZZA .................................................................................... 21
posaconazole oral tablet, delayed release (dr/ec) ................. 10
POTASSIUM CHLORID-D5-0.45% NACL ............................... 56
potassium chloride-0.45% nacl .................................................... 57
POTASSIUM CHLORIDE-D5-0.2% NACL
INTRAVENOUS PARENTERAL SOLUTION
20 MEQ/L ........................................................................................... 57
POTASSIUM CHLORIDE-D5-0.9% NACL ............................... 57
Covered Drugs Index
DRUG PAGE DRUG PAGE
82
September 2024
POTASSIUM CHLORIDE IN 0.9% NACL
INTRAVENOUS PARENTERAL SOLUTION
20 MEQ/L, 40 MEQ/L ..................................................................... 56
potassium chloride in 5% dex intravenous
parenteral solution 10 meq/l ......................................................... 56
POTASSIUM CHLORIDE IN 5% DEX INTRAVENOUS
PARENTERAL SOLUTION 20 MEQ/L ...................................... 56
POTASSIUM CHLORIDE IN LR-D5 INTRAVENOUS
PARENTERAL SOLUTION 20 MEQ/L ...................................... 56
potassium chloride intravenous ................................................... 56
potassium chloride in water intravenous piggyback
10 meq/100 ml, 10 meq/50 ml, 20 meq/100 ml,
20 meq/50 ml, 40 meq/100 ml ..................................................... 56
potassium chloride oral capsule, extended release ............... 56
potassium chloride oral liquid ....................................................... 56
potassium chloride oral packet .................................................... 56
potassium chloride oral tablet, er particles/crystals ............... 57
potassium chloride oral tablet extended release .................... 56
potassium citrate oral tablet extended release ....................... 56
POTELIGEO ...................................................................................... 21
PRALATREXATE ............................................................................. 21
pramipexole oral tablet ................................................................... 25
prasugrel ............................................................................................. 35
pravastatin ......................................................................................... 36
praziquantel ....................................................................................... 14
prazosin .............................................................................................. 35
PREDNISOLONE ACETATE ........................................................ 54
prednisolone oral solution ............................................................. 41
prednisolone sodium phosphate ophthalmic (eye) ................ 54
prednisolone sodium phosphate oral solution
15 mg/5 ml (3 mg/ml), 15 mg/5 ml (5 ml), 25 mg/5 ml
(5 mg/ml), 5 mg base/5 ml (6.7 mg/5 ml) .................................. 41
prednisone intensol ......................................................................... 41
prednisone oral solution ................................................................. 41
prednisone oral tablet ..................................................................... 41
prednisone oral tablets, dose pack ............................................. 41
pregabalin oral capsule 100 mg, 150 mg, 25 mg,
50 mg, 75 mg .................................................................................... 25
pregabalin oral capsule 200 mg .................................................. 25
pregabalin oral capsule 225 mg, 300 mg.................................. 25
pregabalin oral solution .................................................................. 25
PREHEVBRIO (PF) ......................................................................... 47
PREMARIN INJECTION ................................................................ 50
PREMARIN ORAL ........................................................................... 50
PREMARIN VAGINAL .................................................................... 50
premasol 10% ................................................................................... 57
PREMPRO ......................................................................................... 50
PRENATAL PLUS (CALCIUM CARB) ....................................... 57
PRENATAL VITAMIN PLUS LOW IRON ................................... 57
prevalite .............................................................................................. 36
PREVYMIS ........................................................................................ 11
PREZCOBIX ...................................................................................... 11
PREZISTA ORAL SUSPENSION ................................................ 11
PREZISTA ORAL TABLET 75 MG .............................................. 11
PREZISTA ORAL TABLET 150 MG ............................................ 11
PRIFTIN .............................................................................................. 14
primaquine ......................................................................................... 14
primidone oral tablet 125 mg ........................................................ 25
primidone oral tablet 250 mg, 50 mg ......................................... 25
PRIORIX (PF) ................................................................................... 47
PR NATAL 400 .................................................................................. 57
PR NATAL 400 EC ........................................................................... 57
PR NATAL 430 .................................................................................. 57
PR NATAL 430 EC ........................................................................... 57
probenecid ......................................................................................... 48
probenecid-colchicine ..................................................................... 48
prochlorperazine .............................................................................. 45
prochlorperazine edisylate injection solution
10 mg/2 ml (5 mg/ml) ...................................................................... 45
prochlorperazine maleate .............................................................. 45
PROCRIT ........................................................................................... 46
procto-med hc ................................................................................... 45
proctosol hc topical .......................................................................... 45
proctozone-hc ................................................................................... 45
progesterone micronized ............................................................... 50
PROGRAF INTRAVENOUS ......................................................... 21
PROGRAF ORAL GRANULES IN PACKET ............................ 21
PROLASTIN-C INTRAVENOUS SOLUTION .......................... 40
PROLIA ............................................................................................... 48
PROMACTA ORAL POWDER IN PACKET 12.5 MG ............ 35
PROMACTA ORAL POWDER IN PACKET 25 MG ............... 36
PROMACTA ORAL TABLET 12.5 MG, 25 MG, 50 MG ........ 36
Covered Drugs Index
DRUG PAGE DRUG PAGE
83
September 2024
PROMACTA ORAL TABLET 75 MG ........................................... 36
promethazine oral syrup ................................................................ 54
promethazine oral tablet ................................................................ 54
propafenone ...................................................................................... 33
propranolol oral capsule, extended release 24 hr .................. 35
propranolol oral solution ................................................................ 35
propranolol oral tablet ..................................................................... 35
propylthiouracil.................................................................................. 41
PROQUAD (PF) ............................................................................... 47
PROSOL 20% ................................................................................... 57
protriptyline ........................................................................................ 32
PULMOZYME ................................................................................... 55
PURIXAN ........................................................................................... 21
pyrazinamide ..................................................................................... 14
pyridostigmine bromide oral tablet 60 mg ................................. 27
pyridostigmine bromide oral tablet extended release ........... 27
pyrimethamine .................................................................................. 14
Q
QINLOCK ........................................................................................... 21
QUADRACEL (PF) .......................................................................... 47
quetiapine oral tablet 100 mg, 25 mg, 50 mg .......................... 32
quetiapine oral tablet 150 mg, 200 mg ...................................... 32
quetiapine oral tablet 300 mg, 400 mg ...................................... 32
QUILLICHEW ER ORAL TABLET, CHEW, IR-ER.
BIPHASIC24HR 20 MG, 30 MG .................................................. 32
QUILLICHEW ER ORAL TABLET, CHEW, IR-ER.
BIPHASIC24HR 40 MG ................................................................. 32
quinapril .............................................................................................. 35
quinapril-hydrochlorothiazide ....................................................... 35
quinidine sulfate oral tablet ........................................................... 33
quinine sulfate ................................................................................... 14
R
RABAVERT (PF) .............................................................................. 47
RADICAVA ......................................................................................... 26
raloxifene ............................................................................................ 48
ramipril ................................................................................................ 35
ranolazine ........................................................................................... 36
rasagiline ............................................................................................ 25
RAYALDEE ........................................................................................ 44
reclipsen (28) .................................................................................... 52
RECOMBIVAX HB (PF) ................................................................. 47
RECTIV ............................................................................................... 45
REGRANEX ...................................................................................... 37
REMICADE ........................................................................................ 45
RENACIDIN ....................................................................................... 56
repaglinide oral tablet 0.5 mg ....................................................... 43
repaglinide oral tablet 1 mg .......................................................... 43
repaglinide oral tablet 2 mg .......................................................... 43
REPATHA PUSHTRONEX ............................................................ 36
REPATHA SURECLICK ................................................................. 36
REPATHA SYRINGE ...................................................................... 36
RETACRIT ......................................................................................... 46
RETEVMO ORAL CAPSULE 40 MG ......................................... 21
RETEVMO ORAL CAPSULE 80 MG ......................................... 21
RETROVIR INTRAVENOUS ........................................................ 11
REXULTI ORAL TABLET ............................................................... 32
REYATAZ ORAL POWDER IN PACKET................................... 11
REZDIFFRA ...................................................................................... 40
REZLIDHIA ........................................................................................ 21
REZUROCK ...................................................................................... 21
RHOPRESSA ................................................................................... 53
ribavirin oral capsule ....................................................................... 12
ribavirin oral tablet 200 mg ............................................................ 12
rifabutin ............................................................................................... 14
rifampin ............................................................................................... 14
riluzole ................................................................................................. 40
rimantadine ........................................................................................ 12
RINGER'S INTRAVENOUS .......................................................... 57
RINGER'S IRRIGATION ................................................................ 39
RINVOQ LQ ....................................................................................... 50
RINVOQ ORAL TABLET EXTENDED RELEASE 24 HR
15 MG, 30 MG .................................................................................. 50
RINVOQ ORAL TABLET EXTENDED RELEASE 24 HR
45 MG .................................................................................................. 50
RISPERDAL CONSTA ................................................................... 32
risperidone oral solution ................................................................. 32
risperidone oral tablet 0.25 mg, 0.5 mg, 4 mg ......................... 32
Covered Drugs Index
DRUG PAGE DRUG PAGE
84
September 2024
risperidone oral tablet 1 mg .......................................................... 32
risperidone oral tablet 2 mg .......................................................... 32
risperidone oral tablet 3 mg .......................................................... 32
risperidone oral tablet, disintegrating 0.25 mg, 0.5 mg,
4 mg ..................................................................................................... 32
risperidone oral tablet, disintegrating 1 mg .............................. 32
risperidone oral tablet, disintegrating 2 mg .............................. 32
risperidone oral tablet, disintegrating 3 mg .............................. 32
ritonavir ............................................................................................... 12
rivastigmine........................................................................................ 26
rivastigmine tartrate ......................................................................... 27
RIVELSA ............................................................................................ 52
rizatriptan oral tablet ....................................................................... 26
rizatriptan oral tablet, disintegrating ........................................... 26
ROCKLATAN ..................................................................................... 53
roumilast ........................................................................................... 55
romidepsin intravenous recon soln ............................................. 21
ROMIDEPSIN INTRAVENOUS SOLUTION ............................ 21
ropinirole oral tablet ......................................................................... 25
rosuvastatin ....................................................................................... 36
ROTARIX ............................................................................................ 47
ROTATEQ VACCINE ...................................................................... 47
roweepra oral tablet 500 mg ......................................................... 25
ROZLYTREK ORAL CAPSULE 100 MG .................................. 21
ROZLYTREK ORAL CAPSULE 200 MG .................................. 21
ROZLYTREK ORAL PELLETS IN PACKET ............................ 21
RUBRACA ......................................................................................... 21
runamide oral suspension ........................................................... 25
runamide oral tablet ...................................................................... 25
RUKOBIA ........................................................................................... 12
RUXIENCE ........................................................................................ 21
RYALTRIS .......................................................................................... 55
RYBELSUS ........................................................................................ 43
RYBREVANT ..................................................................................... 21
RYDAPT ............................................................................................. 21
RYLAZE .............................................................................................. 21
RYTARY.............................................................................................. 25
S
sajazir .................................................................................................. 55
SANCUSO
......................................................................................... 45
SANDIMMUNE ORAL SOLUTION ............................................. 21
SANTYL .............................................................................................. 37
sapropterin ......................................................................................... 44
SARCLISA ......................................................................................... 21
SCEMBLIX ORAL TABLET 20 MG ............................................. 21
SCEMBLIX ORAL TABLET 40 MG
............................................. 21
SCEMBLIX ORAL TABLET 100 MG .......................................... 21
scopolamine base ............................................................................ 45
SECUADO ......................................................................................... 32
selegiline hcl ...................................................................................... 25
selenium sulde topical lotion ...................................................... 37
SELZENTRY ORAL SOLUTION
................................................. 12
SELZENTRY ORAL TABLET 25 MG ......................................... 12
SELZENTRY ORAL TABLET 75 MG ......................................... 12
SE-NATAL-19 .................................................................................... 57
SE-NATAL 19 CHEWABLE ........................................................... 57
SEREVENT DISKUS ...................................................................... 55
sertraline oral concentrate
............................................................. 32
sertraline oral tablet ......................................................................... 32
setlakin ................................................................................................ 52
sharobel .............................................................................................. 50
SHINGRIX (PF) ................................................................................ 47
SIGNIFOR .......................................................................................... 21
sildenal (pulm. hypertension) oral tablet
................................. 55
SILVER SULFADIAZINE ................................................................ 37
SIMBRINZA ....................................................................................... 53
simliya (28) ........................................................................................ 52
simpesse ............................................................................................ 52
SIMULECT ......................................................................................... 21
simvastatin
......................................................................................... 36
sirolimus.............................................................................................. 21
SIRTURO ........................................................................................... 14
SIVEXTRO INTRAVENOUS ......................................................... 14
SIVEXTRO ORAL ............................................................................ 14
SKYRIZI INTRAVENOUS .............................................................. 45
SKYRIZI SUBCUTANEOUS PEN INJECTOR
........................ 37
Covered Drugs Index
DRUG PAGE DRUG PAGE
85
September 2024
SKYRIZI SUBCUTANEOUS SYRINGE 150 MG/ML ............. 37
SKYRIZI SUBCUTANEOUS WEARABLE INJECTOR
180 MG/1.2 ML (150 MG/ML) ...................................................... 45
SKYRIZI SUBCUTANEOUS WEARABLE INJECTOR
360 MG/2.4 ML (150 MG/ML) ...................................................... 45
sodium bicarbonate intravenous syringe .................................. 57
SODIUM CHLORIDE 0.9% INTRAVENOUS ........................... 40
sodium chloride 0.45% intravenous ........................................... 57
sodium chloride 3% hypertonic .................................................... 57
SODIUM CHLORIDE 5% HYPERTONIC ................................. 57
sodium chloride intravenous ......................................................... 57
SODIUM CHLORIDE IRRIGATION ............................................ 40
sodium uoride 5000 dry mouth .................................................. 40
sodium uoride 5000 plus ............................................................. 40
sodium uoride-pot nitrate ............................................................. 40
SODIUM OXYBATE ........................................................................ 32
sodium phenylbutyrate ................................................................... 40
sodium polystyrene sulfonate oral powder ............................... 40
sodium, potassium, mag sulfates oral recon soln
17.5-3.13-1.6 gram .......................................................................... 45
SODIUM, POTASSIUM, MAG SULFATES ORAL
RECON SOLN 17.5-3.13-1.6 GRAM 2 PACK (480ML) ....... 45
SOLIQUA 100/33 ............................................................................. 43
SOLTAMOX ....................................................................................... 21
SOLU-CORTEF ACT-O-VIAL (PF) ............................................. 41
SOMATULINE DEPOT ................................................................... 21
SOMAVERT ....................................................................................... 44
sorafenib ............................................................................................. 21
sorine oral tablet 120 mg, 160 mg .............................................. 33
sotalol af ............................................................................................. 33
sotalol oral .......................................................................................... 33
SOTYLIZE .......................................................................................... 33
spironolactone oral tablet .............................................................. 35
spironolacton-hydrochlorothiaz .................................................... 35
SPRAVATO NASAL SPRAY, NON-AEROSOL 56 MG
(28 MG X 2) ....................................................................................... 32
SPRAVATO NASAL SPRAY, NON-AEROSOL 84 MG
(28 MG X 3) ....................................................................................... 32
sprintec (28) ....................................................................................... 52
SPRITAM ............................................................................................ 25
SPRYCEL ORAL TABLET 20 MG, 70 MG ............................... 21
SPRYCEL ORAL TABLET 100 MG, 140 MG, 50 MG,
80 MG .................................................................................................. 21
sps (with sorbitol) oral ..................................................................... 40
sronyx .................................................................................................. 52
SSD ...................................................................................................... 37
STAMARIL (PF) ................................................................................ 47
STELARA SUBCUTANEOUS SOLUTION ............................... 37
STELARA SUBCUTANEOUS SYRINGE 45 MG/0.5 ML ..... 37
STELARA SUBCUTANEOUS SYRINGE 90 MG/ML ............ 37
STIVARGA ......................................................................................... 21
streptomycin ...................................................................................... 14
STRIBILD ........................................................................................... 12
subvenite ............................................................................................ 25
subvenite starter (blue) kit ............................................................. 25
subvenite starter (green) kit .......................................................... 25
subvenite starter (orange) kit ........................................................ 25
SUCRAID ........................................................................................... 45
sucralfate oral tablet ........................................................................ 46
SUFLAVE ........................................................................................... 45
sulfacetamide-prednisolone .......................................................... 53
sulfacetamide sodium (acne) ....................................................... 38
sulfacetamide sodium ophthalmic (eye) drops ........................ 53
sulfadiazine ........................................................................................ 15
sulfamethoxazole-trimethoprim intravenous ............................ 15
sulfamethoxazole-trimethoprim oral suspension .................... 15
sulfamethoxazole-trimethoprim oral tablet ............................... 15
sulfasalazine oral tablet ................................................................. 45
SULFASALAZINE ORAL TABLET, DELAYED
RELEASE (DR/EC) ......................................................................... 45
sulindac ............................................................................................... 28
sumatriptan nasal spray,
non-aerosol 5 mg/actuation .......................................................... 26
sumatriptan nasal spray,
non-aerosol 20 mg/actuation ........................................................ 26
sumatriptan succinate oral ............................................................ 26
SUMATRIPTAN SUCCINATE SUBCUTANEOUS
CARTRIDGE ..................................................................................... 26
sumatriptan succinate subcutaneous pen injector ................. 26
sumatriptan succinate subcutaneous solution ........................ 26
sunitinib malate ................................................................................. 21
SUNLENCA ....................................................................................... 12
Covered Drugs Index
DRUG PAGE DRUG PAGE
86
September 2024
SUTAB ................................................................................................ 45
syeda ................................................................................................... 52
SYMPAZAN ....................................................................................... 25
SYMTUZA .......................................................................................... 12
SYNAREL .......................................................................................... 44
SYNJARDY........................................................................................ 43
SYNJARDY XR ORAL TABLET, IR - ER, BIPHASIC
24HR 10-1,000 MG, 12.5-1,000 MG, 5-1,000 MG ................. 43
SYNJARDY XR ORAL TABLET, IR - ER, BIPHASIC
24HR 25-1,000 MG ......................................................................... 43
SYNTHROID ..................................................................................... 44
T
TABLOID ............................................................................................ 22
TABRECTA ........................................................................................ 22
tacrolimus oral capsule .................................................................. 22
tacrolimus topical ............................................................................. 37
TAFINLAR ORAL CAPSULE ........................................................ 22
TAFINLAR ORAL TABLET FOR SUSPENSION .................... 22
TAGRISSO ......................................................................................... 22
TALICIA ............................................................................................... 46
TALTZ AUTOINJECTOR ................................................................ 37
TALTZ SYRINGE ............................................................................. 37
TALVEY ............................................................................................... 22
TALZENNA ORAL CAPSULE 0.1 MG, 0.35 MG, 0.5 MG,
0.75 MG, 1 MG ................................................................................. 22
TALZENNA ORAL CAPSULE 0.25 MG ..................................... 22
tamoxifen ............................................................................................ 22
tamsulosin .......................................................................................... 56
tarina 24 fe ......................................................................................... 52
tarina fe 1-20 eq (28) ...................................................................... 52
TARON-C DHA ................................................................................. 57
TASIGNA ORAL CAPSULE 50 MG ............................................ 22
TASIGNA ORAL CAPSULE 150 MG, 200 MG ........................ 22
tasimelteon ........................................................................................ 32
tazarotene topical cream ............................................................... 37
tazarotene topical gel...................................................................... 37
tazicef .................................................................................................. 13
TAZVERIK .......................................................................................... 22
TDVAX ................................................................................................ 47
TECENTRIQ ...................................................................................... 22
TECHLITE INSULIN SYR(HALF UNIT) SYRINGE 0.3 ML
31 GAUGE X 15/64", 0.3 ML 31 GAUGE X 5/16", 0.5 ML
30 GAUGE X 1/2", 0.5 ML 31 GAUGE X 15/64", 0.5 ML
31 GAUGE X 5/16" ........................................................................... 48
TECHLITE INSULIN SYRINGE SYRINGE 1 ML 30
GAUGE X 1/2", 1 ML 31 GAUGE X 15/64", 1 ML 31
GAUGE X 5/16 ................................................................................. 48
TECHLITE PEN NEEDLE NEEDLE 29 GAUGE X
1/2", 31 GAUGE X 3/16", 31 GAUGE X 5/16",
32 GAUGE X 1/4", 32 GAUGE X 5/32" ..................................... 48
TECVAYLI .......................................................................................... 22
TEFLARO ........................................................................................... 13
telmisartan ......................................................................................... 35
TEMODAR INTRAVENOUS ......................................................... 22
temsirolimus ...................................................................................... 22
TENIVAC (PF) ................................................................................... 47
tenofovir disoproxil fumarate ........................................................ 12
TEPMETKO ....................................................................................... 22
terazosin oral capsule 1 mg, 2 mg, 5 mg .................................. 35
terazosin oral capsule 10 mg ....................................................... 35
terbinane hcl oral ........................................................................... 10
terbutaline .......................................................................................... 55
terconazole ........................................................................................ 50
testosterone cypionate ................................................................... 44
testosterone enanthate .................................................................. 44
testosterone transdermal gel ........................................................ 44
testosterone transdermal gel in metered-dose
pump 12.5 mg/ 1.25 gram (1%) ................................................... 44
testosterone transdermal gel in packet 1%
(25 mg/2.5gram), 1% (50 mg/5 gram) ....................................... 44
TETANUS, DIPHTHERIA TOX PED (PF) ................................. 47
tetrabenazine oral tablet 12.5 mg ............................................... 27
tetrabenazine oral tablet 25 mg ................................................... 27
tetracycline oral capsule ................................................................ 15
THALOMID ORAL CAPSULE 100 MG, 50 MG ...................... 22
THALOMID ORAL CAPSULE 150 MG, 200 MG .................... 22
theophylline oral tablet extended release 12 hr 100 mg,
200 mg, 300 mg ............................................................................... 55
theophylline oral tablet extended release 12 hr 450 mg ...... 55
theophylline oral tablet extended release 24 hr 400 mg ...... 55
theophylline oral tablet extended release 24 hr 600 mg ...... 55
Covered Drugs Index
DRUG PAGE DRUG PAGE
87
September 2024
thioridazine ........................................................................................ 32
thiotepa ............................................................................................... 22
thiothixene .......................................................................................... 32
tiadylt er .............................................................................................. 35
tiagabine ............................................................................................. 25
TIBSOVO ........................................................................................... 22
TICE BCG .......................................................................................... 47
TICOVAC INTRAMUSCULAR SYRINGE
1.2 MCG/0.25 ML ............................................................................ 47
TICOVAC INTRAMUSCULAR SYRINGE
2.4 MCG/0.5 ML ............................................................................... 47
tigecycline .......................................................................................... 14
tilia fe ................................................................................................... 52
timolol maleate ophthalmic (eye) drops .................................... 53
timolol maleate ophthalmic (eye) gel forming solution .......... 53
timolol maleate oral ......................................................................... 35
TIS-U-SOL PENTALYTE ................................................................ 39
TIVDAK ............................................................................................... 22
TIVICAY ORAL TABLET 10 MG .................................................. 12
TIVICAY ORAL TABLET 25 MG, 50 MG ................................... 12
TIVICAY PD ....................................................................................... 12
tizanidine oral tablet ........................................................................ 27
TOBRADEX ST ................................................................................ 54
tobramycin-dexamethasone ......................................................... 54
tobramycin in 0.225% nacl ............................................................ 14
tobramycin ophthalmic (eye) ........................................................ 53
tobramycin sulfate............................................................................ 14
tolterodine oral capsule, extended release 24hr ..................... 56
tolterodine oral tablet ...................................................................... 56
TOLVAPTAN ORAL TABLET 15 MG .......................................... 44
tolvaptan oral tablet 30 mg ............................................................ 44
topiramate oral capsule, sprinkle ................................................ 25
topiramate oral tablet ...................................................................... 25
topotecan intravenous recon soln ............................................... 22
topotecan intravenous solution .................................................... 22
toremifene .......................................................................................... 22
torsemide oral ................................................................................... 35
TOUJEO MAX U-300 SOLOSTAR ............................................. 43
TOUJEO SOLOSTAR U-300 INSULIN ...................................... 43
TRADJENTA ..................................................................................... 43
tramadol-acetaminophen ............................................................... 28
tramadol oral tablet 50 mg ............................................................ 28
trandolapril ......................................................................................... 35
tranexamic acid oral ........................................................................ 50
tranylcypromine ................................................................................ 32
TRAVASOL 10% .............................................................................. 57
TRAZIMERA ...................................................................................... 22
trazodone ........................................................................................... 32
TREANDA .......................................................................................... 22
TRECATOR ....................................................................................... 14
TRELEGY ELLIPTA ........................................................................ 55
TRELSTAR INTRAMUSCULAR SUSPENSION FOR
RECONSTITUTION ........................................................................ 22
TRESIBA FLEXTOUCH U-100 .................................................... 43
TRESIBA FLEXTOUCH U-200 .................................................... 43
TRESIBA U-100 INSULIN ............................................................. 43
tretinoin (antineoplastic) ................................................................. 22
tretinoin microspheres topical gel 0.1% .................................... 38
tretinoin microspheres topical gel with pump 0.1% ................ 38
tretinoin topical cream .................................................................... 38
tretinoin topical gel 0.01% ............................................................. 38
tretinoin topical gel 0.025%, 0.05% ............................................ 38
triamcinolone acetonide dental .................................................... 40
triamcinolone acetonide injection suspension 40 mg/ml ...... 41
triamcinolone acetonide topical cream ...................................... 39
triamcinolone acetonide topical lotion ........................................ 39
triamcinolone acetonide topical ointment 0.025%,
0.1%, 0.5% ........................................................................................ 39
triamterene-hydrochlorothiazid .................................................... 35
triderm topical cream 0.1% ........................................................... 39
trientine oral capsule 250 mg ....................................................... 40
tri-estarylla ......................................................................................... 52
triuoperazine oral tablet 1 mg .................................................... 32
triuoperazine oral tablet 10 mg, 2 mg, 5 mg .......................... 32
triuridine ............................................................................................ 53
TRIJARDY XR ORAL TABLET, IR - ER, BIPHASIC
24HR 10-5-1,000 MG, 25-5-1,000 MG ...................................... 43
TRIJARDY XR ORAL TABLET, IR - ER, BIPHASIC
24HR 12.5-2.5-1,000 MG, 5-2.5-1,000 MG ............................. 43
TRIKAFTA ORAL GRANULES IN PACKET, SEQUENTIAL .... 55
Covered Drugs Index
DRUG PAGE DRUG PAGE
88
September 2024
TRIKAFTA ORAL TABLETS, SEQUENTIAL ............................ 55
tri-legest fe ......................................................................................... 52
tri-linyah .............................................................................................. 52
tri-lo-estarylla ..................................................................................... 52
tri-lo-marzia ........................................................................................ 52
tri-lo-mili .............................................................................................. 52
tri-lo-sprintec ...................................................................................... 52
trimethoprim ....................................................................................... 15
tri-mili ................................................................................................... 52
trimipramine ....................................................................................... 32
TRINATAL RX 1 ................................................................................ 57
TRINTELLIX ...................................................................................... 32
tri-nymyo ............................................................................................. 52
TRIPTODUR ..................................................................................... 22
tri-sprintec (28).................................................................................. 52
TRIUMEQ ........................................................................................... 12
TRIUMEQ PD ................................................................................... 12
trivora (28) .......................................................................................... 52
tri-vylibra ............................................................................................. 52
tri-vylibra lo ........................................................................................ 52
TRIZIVIR ............................................................................................. 12
TRODELVY ........................................................................................ 22
TROGARZO ...................................................................................... 12
TROPHAMINE 10% ........................................................................ 57
TRUEPLUS INSULIN ..................................................................... 43
TRUEPLUS PEN NEEDLE ........................................................... 43
TRULANCE ....................................................................................... 45
TRULICITY ........................................................................................ 43
TRUMENBA ...................................................................................... 47
TRUQAP ............................................................................................. 22
TRUXIMA ........................................................................................... 22
TUKYSA ORAL TABLET 50 MG.................................................. 22
TUKYSA ORAL TABLET 150 MG ............................................... 22
TURALIO ORAL CAPSULE 125 MG ......................................... 22
turqoz (28) .......................................................................................... 52
TWINRIX (PF) ................................................................................... 47
TYBLUME .......................................................................................... 52
tydemy ................................................................................................. 52
TYMLOS ............................................................................................. 48
TYPHIM VI ......................................................................................... 47
TYVASO ............................................................................................. 55
TYVASO INSTITUTIONAL START KIT ..................................... 55
TYVASO REFILL KIT ...................................................................... 55
TYVASO STARTER KIT ................................................................ 55
TZIELD ................................................................................................ 40
U
UNIFINE PENTIPS MAXFLOW ................................................... 43
UNIFINE PENTIPS NEEDLE 29 GAUGE X 1/2", 31
GAUGE X 1/4", 31 GAUGE X 3/16", 31 GAUGE X
5/16", 32 GAUGE X 1/4", 32 GAUGE X 5/32", 33
GAUGE X 5/32" ................................................................................ 43
UNIFINE PENTIPS PLUS ............................................................. 43
UNIFINE PENTIPS PLUS MAXFLOW ...................................... 43
UNIFINE SAFECONTROL ............................................................ 43
UNIFINE ULTRA PEN NEEDLE .................................................. 43
UNITHROID ....................................................................................... 44
UNITUXIN .......................................................................................... 22
ursodiol oral capsule 300 mg ....................................................... 45
ursodiol oral tablet ........................................................................... 45
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 50 MG/0.14 ML ............................. 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 75 MG/0.21 ML ............................. 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 100 MG/0.28 ML........................... 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 125 MG/0.35 ML........................... 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 150 MG/0.42 ML........................... 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 200 MG/0.56 ML........................... 32
UZEDY SUBCUTANEOUS SUSPENSION,
EXTENDED REL SYRING 250 MG/0.7 ML ............................. 32
V
valacyclovir oral tablet 1 gram ..................................................... 12
valacyclovir oral tablet 500 mg .................................................... 12
VALCHLOR ........................................................................................ 37
valganciclovir oral recon soln ....................................................... 12
valganciclovir oral tablet ................................................................ 12
Covered Drugs Index
DRUG PAGE DRUG PAGE
89
September 2024
valproate sodium .............................................................................. 25
valproic acid ....................................................................................... 25
valproic acid (as sodium salt) ....................................................... 25
valrubicin ............................................................................................ 22
valsartan-hydrochlorothiazide ...................................................... 35
valsartan oral tablet 160 mg, 40 mg, 80 mg ............................ 35
valsartan oral tablet 320 mg ......................................................... 35
VALTOCO ........................................................................................... 25
VANCOMYCIN-DILUENT COMBO NO.1 ................................. 14
VANCOMYCIN IN 0.9% SODIUM CHL INTRAVENOUS
PIGGYBACK ..................................................................................... 14
VANCOMYCIN IN DEXTROSE 5% INTRAVENOUS
PIGGYBACK 1.25 GRAM/250 ML, 1.5 GRAM/300 ML ........ 16
VANCOMYCIN IN DEXTROSE 5% INTRAVENOUS
PIGGYBACK 1 GRAM/200 ML, 500 MG/100 ML,
750 MG/150 ML ................................................................................ 14
vancomycin injection ....................................................................... 14
vancomycin intravenous recon soln 1,000 mg,
1.25 gram, 1.5 gram, 10 gram, 5 gram, 500 mg,
750 mg ................................................................................................ 14
vancomycin oral capsule 125 mg ................................................ 14
vancomycin oral capsule 250 mg ................................................ 14
vancomycin oral recon soln 25 mg/ml ....................................... 14
VANDAZOLE ..................................................................................... 50
VANFLYTA ......................................................................................... 22
VAQTA (PF) INTRAMUSCULAR SUSPENSION
25 UNIT/0.5 ML ................................................................................ 47
VAQTA (PF) INTRAMUSCULAR SUSPENSION
50 UNIT/ML ....................................................................................... 47
VAQTA (PF) INTRAMUSCULAR SYRINGE
25 UNIT/0.5 ML ................................................................................ 47
VAQTA (PF) INTRAMUSCULAR SYRINGE
50 UNIT/ML ....................................................................................... 47
varenicline .......................................................................................... 40
VARIVAX (PF) ................................................................................... 47
VARIZIG .............................................................................................. 47
VECTIBIX ........................................................................................... 22
VEKLURY .......................................................................................... 12
velivet triphasic regimen (28) ....................................................... 52
VELPHORO ....................................................................................... 40
VELTASSA ......................................................................................... 40
VEMLIDY ............................................................................................ 12
VENCLEXTA ORAL TABLET 10 MG ......................................... 22
VENCLEXTA ORAL TABLET 50 MG ......................................... 22
VENCLEXTA ORAL TABLET 100 MG ....................................... 22
VENCLEXTA STARTING PACK .................................................. 22
venlafaxine oral capsule, extended release 24hr 75 mg ........ 33
venlafaxine oral capsule, extended release 24hr 150 mg,
37.5 mg ............................................................................................... 32
venlafaxine oral tablet 50 mg, 75 mg ......................................... 33
venlafaxine oral tablet 100 mg, 25 mg, 37.5 mg ..................... 33
VENTAVIS .......................................................................................... 55
VENTOLIN HFA ............................................................................... 55
verapamil intravenous solution .................................................... 35
verapamil oral capsule, 24 hr er pellet ct .................................. 35
verapamil oral capsule, ext rel. pellets 24 hr 120 mg,
180 mg, 240 mg ............................................................................... 35
VERAPAMIL ORAL CAPSULE, EXT REL. PELLETS
24 HR 360 MG .................................................................................. 35
verapamil oral tablet ........................................................................ 35
verapamil oral tablet extended release ..................................... 35
VERQUVO ......................................................................................... 36
VERSACLOZ .................................................................................... 33
VERZENIO ........................................................................................ 22
vestura (28)........................................................................................ 52
V-GO 20 .............................................................................................. 43
V-GO 30 .............................................................................................. 43
V-GO 40 .............................................................................................. 43
vienva .................................................................................................. 52
vigabatrin ............................................................................................ 25
vigadrone ............................................................................................ 25
vigpoder .............................................................................................. 25
vilazodone .......................................................................................... 33
vinblastine .......................................................................................... 22
vincristine ........................................................................................... 22
vinorelbine .......................................................................................... 22
viorele (28) ......................................................................................... 52
VIRACEPT ORAL TABLET 250 MG ........................................... 12
VIRACEPT ORAL TABLET 625 MG ........................................... 12
VIREAD ORAL POWDER ............................................................. 12
VIREAD ORAL TABLET 150 MG, 200 MG, 250 MG ............. 12
VITRAKVI ORAL CAPSULE 25 MG ........................................... 22
Covered Drugs Index
DRUG PAGE DRUG PAGE
90
September 2024
VITRAKVI ORAL CAPSULE 100 MG ........................................ 22
VITRAKVI ORAL SOLUTION ....................................................... 22
VIVITROL ........................................................................................... 28
VIZIMPRO .......................................................................................... 23
volnea (28) ......................................................................................... 52
VONJO ................................................................................................ 23
voriconazole intravenous ............................................................... 10
voriconazole oral suspension for reconstitution ...................... 10
voriconazole oral tablet .................................................................. 10
VOSEVI .............................................................................................. 12
VOTRIENT ......................................................................................... 23
VRAYLAR ORAL CAPSULE ......................................................... 33
VUMERITY ........................................................................................ 27
vyfemla (28) ....................................................................................... 52
vylibra .................................................................................................. 52
VYNDAQEL ....................................................................................... 36
VYXEOS ............................................................................................. 23
W
warfarin ............................................................................................... 36
WATER FOR IRRIGATION, STERILE ....................................... 40
WELIREG ........................................................................................... 23
wera (28) ............................................................................................ 52
wescap-pn dha ................................................................................. 57
wesnate dha ...................................................................................... 57
WESTAB PLUS ................................................................................ 57
WESTGEL DHA ............................................................................... 57
wymzya fe .......................................................................................... 53
X
XALKORI ORAL CAPSULE .......................................................... 23
XALKORI ORAL PELLET 20 MG, 50 MG ................................ 23
XALKORI ORAL PELLET 150 MG ............................................. 23
XARELTO ........................................................................................... 36
XARELTO DVT-PE TREAT 30D START ................................... 36
XATMEP ............................................................................................. 23
XCOPRI MAINTENANCE PACK ORAL TABLET
250MG/DAY(150 MG X1-100MG X1), 350 MG/DAY
(200 MG X1-150MG X1) ................................................................ 25
XCOPRI ORAL TABLET 25 MG .................................................. 25
XCOPRI ORAL TABLET 50 MG .................................................. 25
XCOPRI ORAL TABLET 100 MG ................................................ 25
XCOPRI ORAL TABLET 150 MG, 200 MG .............................. 25
XCOPRI TITRATION PACK .......................................................... 25
XDEMVY ............................................................................................ 53
XERMELO ......................................................................................... 23
XGEVA ................................................................................................ 16
XIAFLEX ............................................................................................. 40
XIFAXAN ORAL TABLET 200 MG .............................................. 14
XIFAXAN ORAL TABLET 550 MG .............................................. 14
XIIDRA ................................................................................................ 53
XOFLUZA ORAL TABLET 40 MG, 80 MG................................ 12
XOLAIR SUBCUTANEOUS AUTO-INJECTOR
75 MG/0.5 ML ................................................................................... 55
XOLAIR SUBCUTANEOUS AUTO-INJECTOR
150 MG/ML, 300 MG/2 ML ........................................................... 55
XOLAIR SUBCUTANEOUS RECON SOLN ............................ 55
XOLAIR SUBCUTANEOUS SYRINGE 75 MG/0.5 ML ......... 56
XOLAIR SUBCUTANEOUS SYRINGE 150 MG/ML,
300 MG/2 ML .................................................................................... 56
XOSPATA ........................................................................................... 23
XPOVIO .............................................................................................. 23
XTANDI ORAL CAPSULE ............................................................. 23
XTANDI ORAL TABLET 40 MG ................................................... 23
XTANDI ORAL TABLET 80 MG ................................................... 23
XULTOPHY 100/3.6 ........................................................................ 43
Y
YERVOY ............................................................................................. 23
YF-VAX (PF) ...................................................................................... 47
YONDELIS ......................................................................................... 23
yuvafem .............................................................................................. 50
Z
zarlukast ........................................................................................... 56
ZALTRAP ........................................................................................... 23
ZANOSAR .......................................................................................... 23
ZEJULA ORAL TABLET ................................................................. 23
ZELBORAF ........................................................................................ 23
Covered Drugs Index
DRUG PAGE DRUG PAGE
91
September 2024
ZENPEP ORAL CAPSULE, DELAYED RELEASE
(DR/EC) 10,000-32,000 -42,000 UNIT, 15,000-47,000
-63,000 UNIT, 20,000-63,000- 84,000 UNIT, 25,000-
79,000- 105,000 UNIT, 3,000-10,000 -14,000-UNIT,
40,000-126,000- 168,000 UNIT, 5,000-17,000-
24,000 UNIT, 60,000-189,600- 252,600 UNIT ........................ 46
ZEPOSIA ............................................................................................ 27
ZEPOSIA STARTER KIT
(28-DAY) ............................................................................................. 27
ZEPOSIA STARTER PACK (7-DAY) .......................................... 27
ZEPZELCA ........................................................................................ 23
zidovudine oral capsule ................................................................. 12
zidovudine oral syrup ...................................................................... 12
zidovudine oral tablet ...................................................................... 12
ZIEXTENZO ...................................................................................... 46
ZIMHI ................................................................................................... 28
ziprasidone hcl oral capsule 20 mg ............................................ 33
ziprasidone hcl oral capsule 40 mg ............................................ 33
ziprasidone hcl oral capsule 60 mg, 80 mg .............................. 33
ziprasidone mesylate ...................................................................... 33
ZIRABEV ............................................................................................ 23
zirgan ................................................................................................... 53
ZOLADEX .......................................................................................... 23
zoledronic acid intravenous solution .......................................... 44
zoledronic acid-mannitol-water intravenous piggyback
4 mg/100 ml ....................................................................................... 44
zoledronic acid-mannitol-water intravenous piggyback
5 mg/100 ml ....................................................................................... 40
ZOLEDRONIC AC-MANNITOL-0.9NACL ................................. 44
ZOLINZA ............................................................................................ 23
zolpidem oral tablet ......................................................................... 33
ZONISADE ........................................................................................ 25
zonisamide oral capsule 25 mg, 50 mg ..................................... 25
zonisamide oral capsule 100 mg ................................................. 25
zovia 1-35 (28) .................................................................................. 53
ZTALMY .............................................................................................. 25
ZTLIDO ............................................................................................... 37
ZUBSOLV SUBLINGUAL TABLET 0.7-0.18 MG,
1.4-0.36 MG, 11.4-2.9 MG, 2.9-0.71 MG, 5.7-1.4 MG .......... 28
ZUBSOLV SUBLINGUAL TABLET 8.6-2.1 MG....................... 28
zumandimine (28) ............................................................................ 53
ZURZUVAE ........................................................................................ 33
ZYDELIG ............................................................................................ 23
ZYKADIA ............................................................................................ 23
ZYNLONTA ........................................................................................ 23
ZYNYZ ................................................................................................ 23
ZYPREXA RELPREVV INTRAMUSCULAR
SUSPENSION FOR RECONSTITUTION
210 MG, 300 MG ............................................................................. 33
ZYPREXA RELPREVV INTRAMUSCULAR
SUSPENSION FOR RECONSTITUTION 405 MG ................ 33
Notes
92
Notes
93
Notes
94
INT_22_822907_C 23_MLI_NOND_PDP
Multi-language Interpreter Services
English: We have free interpreter services to answer any questions you
may have about our health or drug plan. To get an interpreter, just call us
at 1‑800‑222‑6700. Someone who speaks English can help you. This is a
free service.
Spanish: Tenemos servicios de intérprete sin costo alguno para responder
cualquier pregunta que pueda tener sobre nuestro plan de salud o medicamentos.
Para hablar con un intérprete, por favor llame al 1‑800‑222‑6700. Alguien que
hable español le podrá ayudar. Este es un servicio gratuito.
Chinese Mandarin: 我们提供免费的翻译服务,帮助您解答关于健康或药物保险的任何
疑问。如果您需要此翻译服务,请致电 1‑800‑222‑6700。我们的中文工作人员很乐意帮助
您。这是一项免费服务。
Chinese Cantonese: 您對我們的健康或藥物保險可能存有疑問,為此我們提供免費的翻譯
服務。如需翻譯服務,請致電 1‑800‑222‑6700。我們講中文的人員將樂意為您提供幫助。
這是一項免費服務。
Tagalog: Mayroon kaming libreng serbisyo sa pagsasaling‑wika upang masagot
ang anumang mga katanungan ninyo hinggil sa aming planong pangkalusugan o
panggamot. Upang makakuha ng tagapagsaling‑wika, tawagan lamang kami sa
1‑800‑222‑6700. Maaari kayong tulungan ng isang nakakapagsalita ng Tagalog.
Ito ay libreng serbisyo.
French: Nous proposons des services gratuits d’interprétation pour
répondre à toutes vos questions relatives à notre régime de santé ou
d’assurance‑médicaments. Pour accéder au service d’interprétation, il vous sut
de nous appeler au 1‑800‑222‑6700. Un interlocuteur parlant français pourra
vous aider. Ce service est gratuit.
Vietnamese: Chúng tôi có dịch vụ thông dịch miễn phí để trả lời các câu hỏi về
chương sức khỏe và chương trình thuốc men. Nếu quí vị cần thông dịch viên xin
gọi 1‑800‑222‑6700 sẽ có nhân viên nói tiếng Việt giúp đỡ quí vị. Đây là dịch vụ
miễn phí.
German: Unser kostenloser Dolmetscherservice beantwortet Ihre Fragen zu
unserem Gesundheits‑ und Arzneimittelplan. Unsere Dolmetscher erreichen Sie
unter 1‑800‑222‑6700. Man wird Ihnen dort auf Deutsch weiterhelfen. Dieser
Service ist kostenlos.
Korean: 당사는 의료 보험 또는 약품 보험에 관한 질문에 답해 드리고자 무료 통역 서비스를
제공하고 있습니다. 통역 서비스를 이용하려면 전화 1‑800‑222‑6700번으로 문의해
주십시오. 한국어를 하는 담당자가 도와 드릴 것입니다. 이 서비스는 무료로 운영됩니다.
Russian: Если у вас возникнут вопросы относительно страхового или
медикаментного плана, вы можете воспользоваться нашими бесплатными
услугами переводчиков. Чтобы воспользоваться услугами переводчика,
позвоните нам по телефону 1‑800‑222‑6700. Вам окажет помощь сотрудник,
который говорит по‑pусски. Данная услуга бесплатная.
󰁵󰃔󰃘󰂋󰂀󰁵󰂅󰂝󰃀󰁯󰁲󰂷󰃁󰂭󰁹󰁸󰁵󰃁󰁭󰂔󰃑󰃁󰂬󰁵󰁲󰁯󰂀󰃛󰃀󰁵󰃕󰃈󰁯󰂁󰃅󰃀󰃏󰂵󰃀󰃃󰂀󰂏󰁹󰃅󰃀󰁯󰃄󰂋󰂈󰂋󰂹󰃈󰁯󰃉󰃈 :Arabic
󰃏󰂹󰃕󰂔1‑800‑222‑6700 󰃃󰂸󰂏󰃀󰃑󰃁󰂬󰁯󰃉󰁲󰁯󰂝󰁸󰃜󰃏󰂔󰂻󰃕󰃁󰂬󰂓󰃕󰃀󰃏󰂴󰃃󰂀󰂏󰁹󰃄󰃑󰃁󰂬󰃏󰂝󰂅󰃁󰃀󰁯󰃉󰃔󰂋󰃀
󰁵󰃕󰃈󰁯󰂁󰃄󰁵󰃄󰂋󰂉󰃀󰂍󰃌󰂻󰁸󰂋󰂬󰁯󰂕󰃅󰁲󰁵󰃕󰁲󰂏󰂭󰃀󰂋󰂅󰁹󰃔󰂛󰂉󰂘
Hindi:                      
         1‑800‑222‑6700         
         
Italian: È disponibile un servizio di interpretariato gratuito per rispondere a
eventuali domande sul nostro piano sanitario e farmaceutico. Per un interprete,
contattare il numero 1‑800‑222‑6700. Un nostro incaricato che parla italiano Le
l’assistenza necessaria. Il servizio è gratuito.
Portuguese: Dispomos de serviços de interpretação gratuitos para responder
a qualquer questão que possa ter acerca do nosso plano de saúde ou de
medicação. Para obter um intérprete, contacte‑nos através do número
1‑800‑222‑6700. Irá encontrar alguém que fale português para o(a) ajudar.
Este serviço é gratuito.
French Creole: Nou genyen sèvis entèprèt gratis pou reponn tout kesyon ou ta
genyen konsènan plan medikal medikaman nou an. Pou jwenn yon entèprèt, jis
rele nou nan 1‑800‑222‑6700. Yon moun ki pale Kreyòl kapab ede w. Sa a se yon
sèvis ki gratis.
Polish: Umożliwiamy bezpłatne skorzystanie z usług tłumacza ustnego, który
pomoże w uzyskaniu odpowiedzi na temat planu zdrowotnego lub dawkowania
leków. Aby skorzystać z pomocy tłumacza znającego język polski, należy
zadzwonić pod numer 1‑800‑222‑6700. Ta usługa jest bezpłatna.
Japanese: 当社の健康保険と薬品プランに関するご質問にお答えするために、無料の通訳
サービスがございます。通訳をご用命になるには、1‑800‑222‑6700 にお電話ください。
日本語を話す者が支援いたします。これは無料のサービスです。
Cigna Healthcare products and services are provided exclusively by or through operating subsidiaries
of The Cigna Group. The Cigna names, logos, and marks, including THE CIGNA GROUP and CIGNA
HEALTHCARE are owned by Cigna Intellectual Property, Inc. © 2023 Cigna Healthcare 968755a
1-800-222-6700 (TTY 711)
8 a.m. – 8 p.m. local time, 7 days a week.
Our automated phone system may
answer your call during weekends
from April 1 - September 30.
CignaMedicare.com
This formulary was updated on 9/1/2024. For more recent information or other questions, please contact Cigna Healthcare Customer
Service, at 1-800-222-6700 (TTY users should call 711), 8 a.m. – 8 p.m. local time, 7 days a week. Our automated phone system may
answer your call during weekends from April 1 - September 30, or visit CignaMedicare.com. Cigna Healthcare products and services
are provided exclusively by or through operating subsidiaries of The Cigna Group. The Cigna names, logos, and marks, including THE
CIGNA GROUP and CIGNA HEALTHCARE are owned by Cigna Intellectual Property, Inc. © 2024 Cigna Healthcare.
September 2024 975474_i